Reviewer #2 (Public Review):

Summary:

This manuscript highlights very important findings in the field, especially in designing clinical trials for the evaluation of antivirals.

Strengths:

The study shows significant differences between the kinetics of viral loads between serotypes, which is very interesting and should be taken into account when designing trials for antivirals.

Weaknesses:

The kinetics of the viral loads based on disease severity throughout the illness are not described, and it would be important if this could be analyzed.

Reviewer #1 (Public Review):

Summary:

The authors presented here a novel 3D fibroblast culture and transdifferentiation approach for potential meat production with GelMA hydrogel.

Strengths:

1. Reduced serum concentration for 3D chicken fibroblast culture and transdifferentiation is optimized.<br /> 2. Efficient myogenic transdifferentiation and lipogenesis as well as controlled fat deposition are achieved in the 3D GelMA.

Weaknesses:

1. While the authors stated the rationale of using fibroblasts instead of myogenic/adipogenic stem cells for meat production, the authors did not comment on the drawbacks/disadvantages of genetic engineering (e.g., forced expression of MyoD) in meat production.<br /> 2. While the authors cited one paper to state the properties and applications of GelMA hydrogel in tissue engineering and food processing, concerns/examples of the food safety with GelMA hydrogel are not discussed thoroughly.<br /> 3. In Fig. 4C, there seems no significant difference in the Vimentin expression between Fibroblast_MyoD and Myofibroblast. The conclusion of "greatly reduced in the myogenic transdifferentiated cells" is overstated.<br /> 4. The presented cell culture platform is only applied to chicken fibroblasts and should be tested in other species such as pigs and fish.

Reviewer #2 (Public Review):

The manuscript by Ma et al. tries to develop a protocol for cell-based meat production using chicken fibroblasts as three-dimensional (3D) muscle tissues with fat accumulation. The authors used genetically modified fibroblasts which can be forced to differentiate into muscle cells and formulated 3D tissues with these cells and a biphasic material (hydrogel). The degrees of muscle differentiation and lipid deposition in culture were determined by immunohistochemical, biochemical, and molecular biological evaluations. Notably, the protocol successfully achieved the process of myogenic and lipogenic stimulation in the 3D tissues.

Overall, the study is reasonably designed and performed including adequate analysis. The manuscript is clearly written with well-supported figures. While it presents valuable results in the field of cultivated meat science and skeletal muscle biology, some critical concerns were identified. First, it is unclear whether some technical approaches were really the best choice for cell-based meat production. Next, more careful evaluations and justifications would be required to properly explain biological events in the results. These points include additional evaluations and considerations with regard to myocyte alignment and lipid accumulation in the differentiated 3D tissues. The present data are very suggestive in general, but further clarifications and arguments would properly support the findings and conclusions.

Reviewer #1 (Public Review):

In this manuscript, Manessero and colleagues argue that the prefrontal cortex (PFC), given its exquisite capability to down-regulate down-stream regions central in driving emotional responses to threat, maybe a promising target to stimulate in order to reduce aberrant fear memory responses. They aim to differ from previous studies that tested the strengthening of extinction learning, by merely focusing on the expression of threat memory without extinction learning. Given that other studies have often focused on the dorsolateral prefrontal cortex as promising target to regulate fear responses, they also ran experiments to directly compare effectiveness of targeting the mPFC and dlPFC in reducing fear memory responses. These aims are all focused on what the authors describe as "implicit memory", but they also test the effects of the interventions on "explicit memory" of the presented cues. However, in the introduction, the authors do not explicitly describe what their aim or theoretical rationale to implement these tests was. Likewise, the authors implemented generalisation stimuli (i.e., cues similar to the original CS) in the implicit memory tests, but the aim of these tests is also not explained.

In order to test their hypotheses, the authors adopt a single-cue fear conditioning paradigm where participants learned to associate an auditory cue with the occurrence of short electrical stimulation across 15 repetitions of the CS-US pairing (80% reinforcement rate). One week later, for the second session, this cue was again presented 4 times, along with 2 types of generalization stimuli, that were each also presented four times. This test session took place in another environment. Conditioned skin conductance responses were measured as index of defensive responding. In the critical condition, during 10 minutes prior to these cue presentations, repetitive Transcranial Magnetic Stimulation (rTMS) was applied to specifically target the medial PFC. Another independent group of participants completed a two-alternative forced-choice (2AFC) explicit recognition test, to inquire to what extent they could recognize whether a given tone was presented during the conditioning phase (basically a source memory task). Finally, a two-alternative forced-choice (2AFC) perceptual discrimination test was presented, to ascertain that participants could discern the different tones presented. The second session was repeated yet another week later, but without any rTMS and in the original conditioning context again, to test whether any potential fear dampening effects were retained.

The observations are quite straightforward: compared to sham and an active control group, mPFC stimulation prior to fear memory retrieval resulted in an immediate reduction of conditioned responses, a difference that was consistent across all 4 test trials. Also conditioned responses to the generalization cues were reduced upon mPFC stimulation. These effects seemed to be specific for memories, since responding to novel unconditioned cues (loud female scream) were not affected by prior mPFC stimulation. Likewise, measures of explicit memory were unaffected. In separate experiments, stimulation of the mPFC also outperformed stimulation of the dlPFC. This pattern of results was again observed during the tests a week later.

The authors conclude that, since these outcomes were observed in the absence of extinction training, the rTMS procedure directly modulated the defensive responses activated by the threat memory trace. The fact that defensive responses to novel unconditioned stimuli were not affected are in line with earlier observations that the mPFC seems critical for the expression of conditioned but not innate fear. Given that dlPFC stimulation seemed less effective, the mPFC may be the most suitable candidate for future therapeutic interventions.

Major strengths:<br /> - Earlier work delving into the involvement of the prefrontal cortex in fear regulation has not only revealed a central role for the mPFC, but also for the dlPFC. An important strength of this study is that the authors therefore also directly compare groups that are targeted in either one of these regions, thereby revealing that even though stimulating the dlPFC results in some fear reduction, the effect is much stronger for mPFC. Another nice consequence of this extra group is that the earlier observations when targeting the mPFC are being replicated.

- It is important to test novel avenues to achieve enduring fear dampening effects of interventions. An intervention that only exerts immediate but transient effects does not bring much clinical value. So the fact that this study incorporates a follow-up test and then shows that the acute fear dampening effects are retained in the absence of any TMS stimulation certainly is important.

- It is only natural to show defensive responses to cues that previously have been paired with something aversive, like a shock. For this reason, generalized fear responses to cues that are similar to fear cues but in fact innocuous is considered maladaptive, and at the core of anxiety disorders. A strength of the paper is that the authors have added generalization tests in addition to (adaptive) fear retention, to ascertain that their intervention in fact also targets maladaptive responding.

Major weaknesses<br /> - There are two major weaknesses in this paper, that can have a potentially detrimental consequence for the robustness of the results and conclusions. First of all, even though comparing the effect of mPFC stimulation with other groups that have been stimulated in other brain regions is important, another comparison - perhaps an even more essential one - is lacking: is there a significant reduction in conditioned fear responses after targeting the mPFC as compared to that group's own fear acquisition (or at least the final phase of acquisition)? Instead, the authors compare fear responses with responses PRIOR to conditioning, which is not meaningful. The same goes for the long-term follow-up: also here, a comparison with fear responding prior to the intervention is lacking. Such a reduction in conditioned fear responding should be larger than any reduction (e.g., due to habituation or forgetting) in fear responding in the (sham) control groups (i.e., an overall interaction between group and fear responding should be present). Whether this is the case is unfortunately unknown, since the fear acquisition data (neither raw, nor pre-processed) are not to be found in the manuscript, and are therefore also not included in any of the analyses. Since there is also no safe control stimulus, the crucial comparison is made entirely between-subjects, and for such a comparison groups of n~20 are quite modest.

- Second, against commons practice, the authors commence by square root transforming all SCR data to normalize the data (while this should only be done in the final phase or preprocessing, if the variables entered in the statistical tests require so), only to then again normalize these obtained values by dividing by the unconditioned responses of the participants, that then are used to calculate differences scores with preconditioning. In these descriptions it is unclear which unconditioned stimulus it was (the original one, from conditioning?) and whether it was standardised to the highest response or an average of all the responses. Decisions that are taken in these early pre-processing steps can have a gigantic impact on the outcomes and conclusions, so this is not trivial. One may say that this cannot explain the group effects that have been observed, given the fact that all groups have been pre-processed in the same way. However, the mPFC group of interest seems to display relatively high unconditioned responses - standardising with these measures may result in relatively low conditioned responses in this particular group. This shortcoming is therefore closely related to the point made above: given that conditioning data would be standardised in the same vein, a test that included the within-subject comparison between acquisition and post-intervention is absolutely crucial to ascertain that the effects observed are not merely due to coincidences in pre-processing values and pre-existing group differences.

- In addition to the above-described main analyses, some other potential weaknesses concern the analysis strategy applied to the generalization tests. Several ANOVAS are being run, one to test for the pattern of generalization responses within-subjects (i.e., the CS, NS1 and NS2), and several ones to compare each of these between the three groups. But such analyses are not warranted in the absence of an overall interaction between the within subject factors and group factor. Such overall omnibus tests however are lacking, and the high number of separate anovas risks false positives (i.e., these comparisons should have been made with planned contrasts). The fact that the included factors and levels are not being described, makes it generally hard to gauge what variables exactly have been entered in every analysis.

Further remarks:<br /> - There is a possibility that a re-analysis of the data using properly preprocessed SCR data along with analyses that include comparisons with the conditioned responses during acquisition reveal a different pattern of results. Therefore, whether the authors truly achieved their aims and whether the results support their conclusions is as of yet undecided.

- Even if the pattern of results holds, then the claim that the long-term follow-up reductions of fear were achieved in the absence of any extinction cannot be made with confidence: after all, upon mPFC stimulation during the second session, the CS was presented four times, and so were each of the two generalization stimuli. So perhaps extinction was not complete, but almost certainly some extinction has taken place: it is well-known that the strongest extinction-learning typically takes place in the first trials (e.g., due to higher prediction errors). The authors do not give any alternative theoretical explanation for the enduring reduction of fear reduction, which would be interesting to learn their thoughts on.

- If the results hold and satisfiable reasons are provided as to why the effects remain visible in the follow-up, this study could be a valuable contribution to the field: it may refocus future studies to the mPFC as major target to not only promote acute fear regulation, but perhaps even more importantly form a clinical perspective, a route for enduring fear reductions.

Reviewer #2 (Public Review):

Manassaro et al. present an extensive three-session study in which they aimed to change defensive responses (skin conductance; SCR) to an aversively conditioned stimulus by targeting medial prefrontal cortex (their words) using repetitive TMS prior to retrieval. They report that stimulating mPFC using TMS abolishes SCR responses to the conditioned stimulus, and that this effect is specific for the stimulated region and the specific CS-US association, given that SCR responses to a different modality US are not changed.

I like how the authors have clearly attempted to control for several potential confounds by including multiple stimulation sites, measured SCR responses to several unconditioned stimuli, and applied the experiment in multiple contexts. However, several conceptual and practical issues remain that I think limit the value of potential conclusions drawn from this work.

The first issue that I have with this study concerns the relationship between the TMS manipulation and the theoretical background the authors present in their rationale. In the introduction the authors sketch that what they call 'mPFC' is involved in regulation of threat responses. They make a convincing case, however, almost all of the evidence they present concerns the ventromedial part of the prefrontal cortex (refs 18-25). The authors then mention that no one has ever studied the effects of 'mPFC'-TMS on threat memories. That is not surprising given that stimulating vmPFC with TMS is very difficult, if not impossible. Simulation of the electrical field that develops as a consequence from the authors manipulation (using the same TMS coil and positioning the authors use) shows that vmPFC (or mPFC for that matter) is not stimulated. The authors then continue in the methods section stating that the region they aimed for was BA10. This region they presumably do stimulate, however, that does not follow logically from their argument. BA10 is anatomically, cytoarchitectonically and functionally a wholly different area than vmPFC and I wonder if their rationale would hold given that they stimulate BA10.

The second concern I have is that although I think the authors should be praised for including both sham and active control regions, the controls might not be optimally chosen to control for the potential confounds of their condition of interest (mPFC-TMS). Namely, TMS on the forehead can be unpleasant, if not painful, whereas sham-TMS or TMS applied to the back of the head or even over dlPFC is not (or less so at the very least). Given that the SCR results after mPFC TMS show exactly the same temporal pattern as the sham-TMS but with a lower starting point, one could wonder whether a painful stimulation prior to the retrieval might have already caused habituation to painful stimulation observed in SCR in consequent CS presentations. A control region that would have been more obvious to take is the lateral part of BA10, by moving the TMS coil several centimeters to the left or right, circumventing all things potentially called medial but giving similar unpleasant sensations (pain etc).

My final concern is that the main analyses are performed on single trials of SCR responses, which is a relatively noise measure to use on single trials. This is also done in relatively small groups (n=21). I would have liked to see both the raw or at least averaged timeseries SCR data plotted, and a rationale explaining how the authors decided on the current sample sizes, if that was based on a power analyses one must have expected quite strong effects.

Reviewer #1 (Public Review):

In this manuscript, the Authors implement a delayed feedback control method and use it for the first time in biological neuronal networks. They extend a well-established computational theory and expand it into the biological realm. With this, they obtain novel evidence, never considered before, that showcases the difference between simulated neuronal networks and biological ones. Furthermore, they optimize the DFC method to achieve optimal results in the control of cell excitability in the content of biological neuronal networks, taking advantage of a closed-loop stimulation setup that, by itself, is not trivial to build and operate and that will certainly have a positive impact the fields of cellular and network electrophysiology.

Regarding the results, it would be very constructive if the Authors could share the code for the quasi-real-time interface with the Multichannel Systems software (current and older hardware versions), as this represents likely a bottleneck preventing more researchers to implement such an experimental paradigm.

On the data focusing on the effects of the DFC algorithms on neuronal behavior, the evidence is very compelling, although more care should be devoted to the statistical analyses, since some of the applied statistical tests are not appropriate. In a more biological sense, further discussion and clarification of the experimental details would improve this manuscript, making it more accessible and clearer for researchers across disciplines (i.e., ranging from computational to experimental Neuroscience) and increasing the impact of this research.

In summary, this work represents a necessary bridge between recent advances in computational neuroscience and the biological implementation of neuronal control mechanisms.

Reviewer #2 (Public Review):

This study applies a new neuromodulation algorithm, adaptive delayed feedback control (aDFC) to in vitro and in silico neuron populations to demonstrate its effectiveness at desynchronizing synchronous neural population activity. The study compares aDFC to other neuromodulation approaches such as non-adaptive DFC and random stimulation and demonstrates that in a subset of controllable networks, aDFC succeeds in reducing overall synchrony in the neural population. Further, when characterizing population firing bouts as asynchronous versus synchronous, aDFC increased the fraction of time that the neural population was in the asynchronous versus synchronous state (albeit in one network). Overall, this study is an impressive combination of computational and experimental work that details a promising new adaptive neuromodulation algorithm that may be relevant for neurological disorders where excessive synchronous brain activity is currently treated with conventional open-loop DBS.

Strengths: The authors build on existing work that has suggested DFC may be a viable algorithm for desynchronizing hyper-synchronous neural populations. They demonstrate by performing in vivo experiments that, contrary to the suggestions of previous work, DFC exacerbates oscillatory intensity. As a result, they develop a new adaptive DFC (aDFC) that updates the estimate of the population's periodicity, enabling superior desynchronization of the population. Further, aDFC enables more population spiking activity that is not just a response to the stimulation (Fig. S3), potentially making the approach conducive to reducing excessive synchronization while also being permissive to neural encoding.

Another innovation of this study is developing a framework for detecting which neural populations are controllable vs. uncontrollable, i.e. consistently responsive to stimulation vs. not consistently responsive. The authors find that populations with intermediate levels of synchrony and firing rate are controllable, whereas populations outside this regime are uncontrollable. These findings are substantiated with a neural network model, where a controllable regime is also detected. The controllable subspace in the in vivo networks and in silico networks also appear to roughly correspond (intermediate synchrony and firing rates) though a direct comparison is not made.

Finally, not only do the authors find that aDFC reduces synchrony, they further identify extended periods of time when the network is in an asynchronous state and find that aDFC can extend the amount of time that the network spends in this state. While these results are compelling, there is only a single network that is able to demonstrate this effect so it is unclear how general a property this is.

Overall, the study presents a novel closed loop neuromodulation algorithm and presents compelling data demonstrating that the algorithm reduces synchrony in in vitro and in silico neural populations.

Weaknesses: The authors point out Parkinson's disease, essential tremor, epilepsy, and dystonia as the neurological disorders that suffer from excessive neural synchronization. In two of these disorders the frequency of the neural synchronization is ~15-30 Hz (Parkinson's disease) and ~5-7 Hz (essential tremor). These frequencies are well above the ~1 Hz synchronization frequency observed in the in vitro population. While this study exhibits a nice proof of principle, how readily it would extend to populations that exhibit higher synchronization frequencies is unclear.

In addition, the study relies on computing population spiking activity of neurons. Current closed-loop neuromodulation devices are outfitted with large electrodes that can sense local field potentials. The impact of this study would have been higher and more readily translatable if the authors could have detected neural population synchronization using local field potential features.

Finally, since the authors were seeking to develop a closed-loop neuromodulation solution that exhibited an improvement over existing open-loop solutions, it would have strengthened the findings and relevance of this study to have done comparisons between aDFC and high frequency open-loop stimulation (~100-120 Hz). Without this comparison it is difficult to know how aDFC may differ from existing therapeutics.

Reviewer #1 (Public Review):

The manuscript by Grove and colleagues analyzes the role of TEAD1 transcription factors in all events regulating PNS myelin formation and maintenance and regeneration. Throughout the manuscript, the authors compare the results obtained to those they previously described in YAP/TAZ double knockout mice. Strengths of the manuscript are combined in vivo analyses by generating mutants constitutively lacking TEAD1 expression in myelinating Schwann cells (P0Cre//TEAD1f/f mice: cKO) and mutants in which TEAD1 expression can be ablated after tamoxifen-mediated recombination is myelinating Schwann cells (PlpCreER//TEAD1f/f mice: iKO). Using this approach the authors were able to assess the role of TEAD1 in all aspects related to PNS myelin: formation as well as maintenance and remyelination after injury. By exploiting these models, they were able to define the role of TEAD1 in regulating Schwann cell proliferation as well as in the cholesterol biosynthetic pathway.

Collectively, their data indicate that TEAD 1 has a composite role in PNS myelination being required for developmental myelination, but dispensable for myelin maintenance. Further, they also describe a role for TEAD1 in promoting PNS remyelination after an injury event.

Despite these strengths, there are some weaknesses that should be addressed by the authors:

1. The manuscript would benefit from better and more detailed analysis of the role of the other TEAD transcription factors, as they are likely redundant in function to TEAD1. For example, since in cKO mice some fibers can escape the sorting defect and eventually myelinate, albeit at a lower level, could they determine whether TEAD2-4 transcription factors might compensate for TEAD1 absence in this setting?

2. A striking result of the study is the morphological defects observed in the process of axonal sorting and in the Remak fibers formation of TEAD1 cKO mice. To explain the sorting defect, the authors correctly analyze Schwann cell proliferation. However, since axonal sorting is mediated by the interaction between the extracellular matrix and intracellular cytoskeleton rearrangement they should address also these two aspects. As per the Remak bundles and the poly-axonal myelination they observe, it is difficult to reconcile this "abnormal" myelination with the fact that TEAD 1 cKO mice have a very severe myelinating phenotype, which is persistent in adulthood.

3. In the analyses of the cholesterol biosynthetic pathway, TEAD1 seems to be only partly involved. Again, which is the role of any of the other TEADs?

4. Why do cKO mice die before P60?

Reviewer #2 (Public Review):

The manuscript addresses the role of TEAD1 in developmental myelination and nerve regeneration after nerve injury and establishes TEAD1 as a key component for YAP/TAZ-related Schwann cell biology. The authors use genetic and biochemical techniques, as well as immunostainings of tissues to address TEAD1's function in myelin biology. While the constitutive knockout of TEAD1 is convincing, the tamoxifen-induced variation requires some validation. Experimental procedures to study the effect of TEAD1 on myelin development and regeneration were properly performed. TEAD1 is believed to be the major driver of the TEAD family in regulating myelination in Schwann cells. However, the delineation of TEAD1 in myelin biology from the other TEAD family members TEAD2, 3, and 4 needs further verification. In particular, the biochemical techniques assessing the potentially competitive binding of TEAD1 versus TEAD2, 3, and 4 to YAP1 and TAZ (WWTR1) require a thorough functional validation. Overall, the identification of TEAD1 as the major driver of myelin in development and regeneration is a very important finding for Schwann cell biology.

Reviewer #3 (Public Review):

The Hippo signalling pathway has been implicated in organ growth through the regulation of cell proliferation and apoptosis. The main transcriptional effectors of this pathway, the Yap and Taz proteins, associate with members of the TEAD family of transcription factors to drive diverse transcriptional programs of proliferation, growth, and differentiation. It has previously been shown that YAP/TAZ are essentially required in Schwann cells for developmental myelination, homeostasis, and regenerative myelination in the peripheral nervous system. All four members of the TEAD family are expressed in the Schwann cell lineage, raising the possibility that different aspects of YAP/TAZ role in the Schwann cell lineage are underpinned by differential associations with TEAD transcription factors. In this study, Grove and colleagues provide convincing evidence that TEAD1 is the main transcription factor through which YAP/TAZ affects myelination in development and following nerve injury. A careful comparison between Schwann cell-specific and inducible Yap/Taz and TEAD1 knock out animals reveal unique and redundant roles for TEAD1 in myelination by regulating Schwann cell proliferation, Krox20-dependent myelin gene expression, and cholesterol biosynthesis. Interestingly, their study appears to reveal a YAP/TAZ independent role for TEAD1 in non-myelinating Schwann cell ensheathment of low calibre axons and Remak bundle formation. The conclusions of this study are based on rigorous biochemical, immune-histochemical, electron microscopic, and functional analysis of mutant and wild-type nerves at different stages of postnatal development and following crush nerve injury.

Perhaps the most surprising finding of this study is that TEAD1 can function independently from YAP/TAZ in one branch of the Schwann cell lineage (the authors had reported earlier that non-myelinating Schwann cells do not express YAP/TAZ).<br /> How TEAD1 transcriptional activity is modulated in these Remak Schwann cells is an interesting avenue of future research.

Reviewer #2 (Public Review):

In this paper, the authors discover that postsynaptic mitochondria in C. elegans govern glutamate receptor trafficking dynamics. The core results are two-fold. For one, they find that loss or inhibition of mcu-1 - the C. elegans mitochondrial calcium uniporter - increases GLR-1 glutamate receptor accumulation at the postsynaptic dendritic sites and enhances its trafficking dynamics. The authors hypothesize that this effect on glutamate receptors may have something to do with mitochondrial ROS production. This is because ROS is a by-product of normal oxidative phosphorylation, downstream of calcium import. Indeed, the generation of artificially high amounts of mitochondrial ROS has the opposite effect of mcu-1 loss: decreased glutamate receptor subunit accumulation. Collectively, the results support the idea that mitochondrial function can control receptor dynamics at synaptic sites. This is interesting because tight control of synaptic function likely combines several mitochondrial functions: energy production, calcium buffering, and (here) ROS signaling.

STRENGTHS

• The C. elegans genetic model is a strength because the authors are able to make refined conclusions by classical loss-of-function mutants (e.g., mcu-1) along with an impressive cytological toolkit to examine GLR-1 dynamics.

• The use of pharmacology as a second means to test those genetic conclusions is a strength.

• The authors' careful reagent verification of reporters (Ca2+, ROS, etc.) is a strength.

• The ability to link fundamental mitochondrial processes to GLR-1 exocytosis will expand how the field thinks about mitochondrial synapse function.

WEAKNESSES

For the most part, the data in the paper support the conclusions, and the authors were careful to try experiments in multiple ways. But please see below:

• (Main Point) The data are good, but they fall short of mechanism (e.g., Line 322). Figure 6 is accurate as drawn. But calcium and ROS are not abstract signals. They are likely exerting affirmative actions on specific targets. The Discussion does acknowledge this in terms of ROS and it speculates on possible targets.

The general idea seems to be that mitochondria import calcium through MCU-1 (and interacting factors). As a result, oxidative phosphorylation successfully occurs and mitochondrial ROS is a signaling by-product that signals glutamate receptors not to undergo exocytosis. But there are other interpretations of what might happen in between. In fact, if OXPHOS is disrupted, it is known that this can generate a lot more mitochondrial ROS than the normal by-product levels.

This reviewer wonders if excess ROS would cause an extreme response. Or alternatively, if scavenging ROS via pharmacological scavengers or SOD expression would reverse the effects.

Small Points

• 33.3 mHz - just making sure, do the authors mean once every 30 seconds? That would be more straightforward.

• Figure 2 is confusing. The text says that the mcu-1 mutants have a GLR-1::GFP FRAP rate that is comparable to controls (Lines 165-167). But Figure 2E suggests that it is markedly less, which is the opposite result of the slight increase in rate resulting from Ru360 treatment. And is the explanation why the GLR-1::GFP results differ from the SEP::GLR-1 results a difference between total GFP vs. surface GFP?

• I could not watch Video 2 (not sure if it is the file or just the copy I downloaded).

• It is good that the authors tried both optical stimulation and mechanical stimulation (dropping culture plates to stimulate the worms, Figure 3). Why was the mechanical stimulation set aside for further tests in the paper?

• Does this process affect all kinds of transport, or is it just the glutamate receptors? Was anything else examined?

Reviewer #3 (Public Review):

Reactive oxygen species (ROS) have been previously shown to regulate glutamate receptor phosphorylation, long-distance transport, and delivery of glutamate receptors to synapses, however, the source of ROS is unclear. In this study, the authors test if mitochondria act as a signaling hub and produce ROS in response to neuronal activity in order to regulate glutamate receptor trafficking. The authors use a variety of optogenetic tools including the calcium reporter mitoGCaMP and the ROS reporter mito-roGFP to monitor changes in calcium and ROS, respectively, in mitochondria after activating neurons with ChRimson in the genetic model organism C. elegans. Repeated stimulation of interneurons called AVA with ChRimson leads to increased calcium uptake into mitochondria in dendrites and increased mitochondrial ROS production. The mitochondrial calcium uniporter mcu-1 is required for these effects because mcu-1 genetic loss of function or treatment with Ru360, a drug that inhibits mcu-1, inhibits the uptake of calcium into mitochondria and ROS production after neuronal activation. Mcu-1 genetic loss of function is correlated with an increase in exocytosis of glutamate receptors but a decrease in glutamate receptor transport and delivery to dendrites. This study suggests that mitochondria monitor neuronal activity by taking up calcium and downregulating glutamate receptor trafficking via ROS, as a means to negatively regulate excitatory synapse function.

Strengths<br /> -The use of multiple optogenetic tools and approaches to monitor mitochondrial calcium, reactive oxygen species, and glutamate receptor trafficking in live organisms.<br /> -Identifying a novel signaling role for dendritic mitochondria which is to monitor neuronal activity (via calcium uptake into mitochondria) and generate a signal (reactive oxygen species) that regulates glutamate receptors at synapses.

Weaknesses<br /> -Although the use of KillerRed to generate ROS downstream of mcu-1 is a clever approach, the fact that activation of KillerRed results in reduced GLR-1 exocytosis, delivery, and transport raises the concern that KillerRed is generating a high level or ROS that might be toxic to cellular processes. Experiments showing that other cellular processes are not affected by KillerRed activation and testing if reduced ROS production mimics the effects of blocking mcu-1 would strengthen the conclusions in this study.

Reviewer #4 (Public Review):

Using optogenetic stimulation, the authors presented compelling evidence that neuronal activity increases mitochondrial calcium levels, facilitated by the mitochondrial uniporter MCU-1. Through ratiometric measurements, they showed that mitochondrial ROS levels also increase due to neuronal activity via MCU-1. Subsequent FRAP studies were employed to investigate the trafficking of the AMPA receptor, GLR-1. By integrating genetic and pharmacological methodologies, the recovery rate of GLR-1 was assessed. The authors concluded that increased mitochondrial ROS due to neuronal activity reduces the trafficking and exocytosis of AMPA receptors. They proposed that mitochondrial ROS serves as a homeostatic mechanism regulating AMPA receptor trafficking and abundance, thus maintaining synaptic strength. This research is crucial as it provides a direct link between mitochondrial signaling and AMPA receptor trafficking.

However, there are several significant concerns regarding the methodologies and quantifications employed in this manuscript. The authors utilized GLR-SEP to label surface AMPA receptors and relied on the "FRAP rate" as an indicator of the exocytosis rate. The absence of direct visualization of exocytosis using GLR-SEP, and the lack of direct measurements of exocytosis events, casts doubt on the conclusions about ROS's impact on AMPA receptor exocytosis. Furthermore, the "FRAP rate" determined in this study is a combination of recovery rates (incorporating both endosomal trafficking and diffusion) with the mobile fractions of AMPA receptors, potentially weakened interpretations of the findings. A more comprehensive discussion addressing the conflicting effects of MCU-1 and ROS on GLR-GFP FRAP recovery and dendritic trafficking would enable readers to grasp the intricate roles of mitochondrial calcium and ROS in modulating synaptic receptors.

Reviewer #1 (Public Review):

Payne et al. have investigated the neural basis of VOR adaptation with the goal of constraining sites and mechanisms of plasticity supporting cerebellar learning. This has been an area of intense debate for decades; previous competing models have argued extensively about the sites of plasticity and the strength of eye velocity feedback/ efference copy signals to Purkinje cells has been central to the debate. This paper nicely explores the consequences of varying the strength of this feedback and in so doing, provides a potential explanation for why Purkinje cell responses during VOR cancellation could exhibit stronger responses following learning, despite net depression of the strength of their vestibular inputs. In that sense it provides some reconciliation of existing models. The work appears to be well done and the paper is well written. The manuscript could be improved and the significance of the work clarified and enhanced by contextualizing the work more appropriately within the existing literature in this area.

Reviewer #2 (Public Review):

Payne et al. use a computational approach to predict the sites and directions of plasticity within the vestibular cerebellum that explain an unresolved controversy regarding the basis of VOR learning. Specifically, the conclusion by Miles and Lisberger (1981) that vestibular inputs onto Purkinje cells (PCs) must potentiate, rather than depress (as in the Marr/Albus/Ito model), following gain-increase learning because when the VOR is cancelled, PC firing increases rather than decreases. Payne et al. provide a novel model solution that recapitulates the results of Miles and Lisberger but, paradoxically, uses plasticity in the cerebellar cortex that weakens PC output rather than strengthens it. However, the model only succeeds when efference copy feedback to the cerebellar cortex is relatively weak thereby allowing a second feedback pathway to drive PC activity during VOR cancellation to counteract the learned change in gain. Because the model is biologically constrained, the findings are well supported. This work will likely benefit the field by providing a number of potentially experimentally testable conclusions. The findings will be of interest to a wider audience if the results can be extrapolated to other cerebellar-dependent learning behaviors rather then just VOR gain-increase learning. Overall, the manuscript is very well written with clearly delineated results and conclusions.

Reviewer #1 (Public Review):

This interesting study by Miyano combines slice electrophysiology and superresolution microscopy to address the role of RBP2 in Ca2+ channel clustering and neurotransmitter release at hippocampal mossy fiber terminals. While a number of studies demonstrated a critical role for RBPs in clustering Ca2+ channels at other synapses and some provided evidence for a role of the protein in molecular coupling of Ca2+ channels and release sites, the present study targets another key synapse that is an important model for presynaptic studies and offers access to a microdomain controlled synaptic vesicle (SV) release mechanism with low initial release probability.

Summarizing a large body of high quality work, the authors demonstrate reduced Ca2+ currents and a reduced release probability. They attribute the latter to the reduced Ca2+ influx and can restore release by increasing Ca2+ influx. Moreover they propose an altered fusion competence of the SVs, which is not so strongly supported by the data in my view.

The effects are relatively small, but I think the careful analysis of the RBP role at the mossy fiber synapse is an important contribution.

Reviewer #2 (Public Review):

Summary: The proper expression and organization of CaV channels at the presynaptic release sites are subject to coordinative and redundant control of many active zone specific molecules including RIM-BPs. Previous studies have demonstrated that ablation of RIM-BPs in various mammalian synapses causes significant impairment of synaptic transmission, either by reducing CaV expression or decoupling CaV from synaptic vesicles. The mechanisms remain unknown.

In the manuscript, Sakaba and colleagues aimed to examine the specific role of RIM-BP2 at the hippocampal mossy fiber-CA3 pyramidal cell synapse, which is well-characterized by low initial release probability and strong facilitation during repetitive stimulation. By directly recording Ca2+ currents and capacitance jumps from the MF boutons, which is very challenging but feasible, they showed that depolarization-evoked Ca2+ influx was reduced significantly (~39%) by KO of RIM-BP2, but no impacts on Ca-induced exocytosis and RRP (measured by capacitance change). They used STED microscopy to image the spatial distribution of CaV2.1 cluster but found no change in the cluster number with slight decrease in cluster intensity (~20%). They concluded that RIM-BP2 function in tonic synapses by reducing CaV expression and thus differentially from phasic synpases by decoupling CaV-SV.

In general, they provide solid data showing that RIM-BP2 KO reduces Ca influx at MF-CA3 synapse, but the phenotype is not new as Moser and colleagues have also used presynaptic recording and capacitance measurement and shown that RIM-BP2 KO reduces Ca2+ influx at hair cell active zone (Krinner et al., 2017), although at different synapse model expressing CaV1.3 instead of CaV2.1. Further, the concept that RIM-BP2 plays diverse functions in transmitter release at different central synapses has also been proposed with solid evidence (Brockmann et al., 2019).

for - key insight - multicellularity - memory wiping

• key insight
  • individuals have information in their memories about survival
  • when they merge and join, they pool their information and you can't tell whose memories came from whom initially
  • this memory wiping is a key aspect of multcellularity

investigate - salience of memory wiping for multicellularity - This is a very important biological behavior. - Perform a literature review to understand examples of this

question - biological memory wiping - can it be extrapolated to social superorganism?

Joint Public Review:

In this manuscript, the authors examined the role of transcription readout and intron retention in increasing transcription of transposable elements during aging in mammals. It is assumed that most transposable elements have lost the regulatory elements necessary for transcription activation. Using available RNA-seq datasets, the authors showed that an increase in intron retention and readthrough transcription during aging contributes to an increase in the number of transcripts containing transposable elements.

Previously, it was assumed that the activation of transposable elements during aging is a consequence of a gradual imbalance of transcriptional repression and a decrease in the functionality of heterochromatin (de repression of transcription in heterochromatin). Therefore, this is an interesting study with important novel conclusion.

The authors revised the manuscript in accordance with the comments. Overall, the manuscript is useful because it shows that there is no direct connection between increased levels of transposon RNA and aging, and further demonstrates the disorganization of the transcriptional apparatus during aging.

Reviewer #2 (Public Review):

This manuscript illustrates the power of "combined" research, incorporating a range of tools, both old and new to answer a question. This thorough approach identifies a novel target in a well-established signalling pathway and characterises a new player in Drosophila CNS development.

Largely, the experiments are carried out with precision, meeting the aims of the project, and setting new targets for future research in the field. It was particularly refreshing to see the use of multi-omics data integration and Targeted DamID (TaDa) findings to triage scRNA-seq data. Some of the TaDa methodology was unorthodox, however, this does not affect the main finding of the study. The authors (in the revised manuscript) have appropriately justified their TaDa approaches and mentioned the caveats in the main text.

Their discovery of Spar as a neuropeptide precursor downstream of Alk is novel, as well as its ability to regulate activity and circadian clock function in the fly. Spar was just one of the downstream factors identified from this study, therefore, the potential impact goes beyond this one Alk downstream effector.

Reviewer #3 (Public Review):

Summary:

The receptor tyrosine kinase Anaplastic Lymphoma Kinase (ALK) in humans is nervous system expressed and plays an important role as an oncogene. A number of groups have been studying ALK signalling in flies to gain mechanistic insight into its various roles. In flies, ALK plays a critical role in development, particularly embryonic development and axon targeting. In addition, ALK also was also shown to regulate adult functions including sleep and memory. In this manuscript, Sukumar et al., used a suite of molecular techniques to identify downstream targets of ALK signalling. They first used targeted DamID, a technique that involves a DNA methylase to RNA polymerase II, so that GATC sites in close proximity to PolII binding sites are marked. They performed these experiments in wild type and ALK loss of function mutants (using an Alk dominant negative ALkDN), to identify Alk responsive loci. Comparing these loci with a larval single cell RNAseq dataset identified neuroendocrine cells as an important site of Alk action. They further combined these TaDa hits with data from RNA seq in Alk Loss and Gain of Function manipulations to identify a single novel target of Alk signalling - a neuropeptide precursor they named Sparkly (Spar) for its expression pattern. They generated a mutant allele of Spar, raised an antibody against Spar, and characterised its expression pattern and mutant behavioural phenotypes including defects in sleep and circadian function.

Strengths:

The molecular biology experiments using TaDa and RNAseq were elegant and very convincing. The authors identified a novel gene they named Spar. They also generated a mutant allele of Spar (using CrisprCas technology) and raised an antibody against Spar. These experiments are lovely, and the reagents will be useful to the community. The paper is also well written, and the figures are very nicely laid out making the manuscript a pleasure to read.

Weaknesses:

The manuscript has improved substantially in the revision. Yet, some concerns remain around the genetics and behavioural analysis which is incomplete and confusing. The authors generated a novel allele of Spar - Spar ΔExon1 and examined sleep and circadian phenotypes of this allele and of RNAi knockdown of Spar. The RNAi knockdown is a welcome addition. However, the authors only show one parental control the GAL4 / +, but leave out the other parental control i.e. the UAS RNAi / + e.g. in Fig. 9. It is important to show both parental controls.

Further, the sleep and circadian characterisation could be substantially improved. It is unclear how sleep was calculated - what program was used or what the criteria to define a sleep bout was. In the legend for Fig 8c, it says sleep was shown as "percentage of time flies spend sleeping measured every 5min across a 24h time span". Sleep in flies is (usually) defined as at least 5 min of inactivity. With this definition, I'm not sure how one can calculate the % time asleep in a 5 min bin! Typically people use 30min or 60min bins. The sleep numbers for controls also seem off to me e.g. in Fig. 8H and H' average sleep / day is ~100. Is this minutes of sleep? 100 min / day is far too low, is it a typo? The same applies to Figure 8, figure supplement 2. Other places e.g. Fig 8 figure supplement 1, avg sleep is around 1000 min / day. The numbers for sleep bouts are also too low to me e.g. in Fig 9 number of sleep bouts avg around 4, and in Fig. 8 figure supplement 2 they average 1 sleep bout. There are several free software packages to analyse sleep data (e.g. Sleep Mat, PMID 35998317, or SCAMP). I would recommend that the authors reanalyse their data using one of these standard packages that are used routinely in the field. That should help resolve many issues.

The circadian anticipatory activity analyses could also be improved. The standard in the field is to perform eduction analyses and quantify anticipatory activity e.g. using the method of Harrisingh et al. (PMID: 18003827). This typically computed as the ratio of activity in the 3hrs preceding light transition to activity in the 6hrs preceding light transition. The programs referenced above should help with this.

Finally, in many cases I'm not sure that the appropriate statistical tests have been used e.g. in Fig 8c, 8e, 8h t-tests have been used when are three groups in the figure. The appropriate test here would an ANOVA, followed by post-hoc comparisons.

Reviewer #1 (Public Review):

The authors present a study focused on addressing the key challenge in drug discovery, which is the optimization of absorption and affinity properties of small molecules through in silico methods. They propose active learning as a strategy for optimizing these properties and describe the development of two novel active learning batch selection methods. The methods are tested on various public datasets with different optimization goals and sizes, and new affinity datasets are curated to provide up-to-date experimental information. The authors claim that their active learning methods outperform existing batch selection methods, potentially reducing the number of experiments required to achieve the same model performance. They also emphasize the general applicability of their methods, including compatibility with popular packages like DeepChem.

Strengths:

Relevance and Importance: The study addresses a significant challenge in the field of drug discovery, highlighting the importance of optimizing absorption and affinity properties of small molecules through in silico methods. This topic is of great interest to researchers and pharmaceutical industries.

Novelty: The development of two novel active learning batch selection methods is a commendable contribution. The study also adds value by curating new affinity datasets that provide chronological information on state-of-the-art experimental strategies.<br /> Comprehensive Evaluation: Testing the proposed methods on multiple public datasets with varying optimization goals and sizes enhances the credibility and generalizability of the findings. The focus on comparing the performance of the new methods against existing batch selection methods further strengthens the evaluation.

Weaknesses:

Lack of Technical Details: The feedback lacks specific technical details regarding the developed active learning batch selection methods. Information such as the underlying algorithms, implementation specifics, and key design choices should be provided to enable readers to understand and evaluate the methods thoroughly.

Evaluation Metrics: The feedback does not mention the specific evaluation metrics used to assess the performance of the proposed methods. The authors should clarify the criteria employed to compare their methods against existing batch selection methods and demonstrate the statistical significance of the observed improvements.

Reproducibility: While the authors claim that their methods can be used with any package, including DeepChem, no mention is made of providing the necessary code or resources to reproduce the experiments. Including code repositories or detailed instructions would enhance the reproducibility and practical utility of the study.

Suggestions for Improvement:

Elaborate on the Methodology: Provide an in-depth explanation of the two active learning batch selection methods, including algorithmic details, implementation considerations, and any specific assumptions made. This will enable readers to better comprehend and evaluate the proposed techniques.

Clarify Evaluation Metrics: Clearly specify the evaluation metrics employed in the study to measure the performance of the active learning methods. Additionally, conduct statistical tests to establish the significance of the improvements observed over existing batch selection methods.

Enhance Reproducibility: To facilitate the reproducibility of the study, consider sharing the code, data, and resources necessary for readers to replicate the experiments. This will allow researchers in the field to validate and build upon your work more effectively.

Conclusion:<br /> The authors' study on active learning methods for optimizing drug discovery presents an important and relevant contribution to the field. The proposed batch selection methods and curated affinity datasets hold promise for improving the efficiency of drug discovery processes. However, to strengthen the study, it is crucial to provide more technical details, clarify evaluation metrics, and enhance reproducibility by sharing code and resources. Addressing these limitations will further enhance the value and impact of the research.

Reviewer #2 (Public Review):

The authors presented a well-written manuscript describing the comparison of active-learning methods with state-of-art methods for several datasets of pharmaceutical interest. This is a very important topic since active learning is similar to a cyclic drug design campaign such as testing compounds followed by designing new ones which could be used to further tests and a new design cycle and so on. The experimental design is comprehensive and adequate for proposed comparisons.

1) Text in figures still very small and difficult to read. Please redraw the figures increasing the font size: 10-12pt is ideal in comparison with the main text. In my opinion, it seems like the authors drew the Figure properly but there is an automatic resizing by inserting it in the document. Please consider ensuring that the font size will remain legible in the final document.

2) I think this work will benefit from a comparison of obtained models to other models reported in the literature and the interpretability of models (e.g. contribution of molecule groups to the modeled activity) as it is required by OECD guide for QSAR purposes.

Reviewer #2 (Public Review):

Summary:

This paper tests the idea that schooling can provide an energetic advantage over solitary swimming. The present study measures oxygen consumption over a wide range of speeds, to determine the differences in aerobic and anaerobic cost of swimming, providing a potentially valuable addition to the literature related to the advantages of group living.

Strengths:<br /> The strength of this paper is related to providing direct measurements of the energetics (oxygen consumption) of fish while swimming in a group vs solitary. The energetic advantages of schooling has been claimed to be one of the major advantages of schooling and therefore a direct energetic assessment is a useful result.

Weaknesses:

1) Regarding the fish to water volume ratio, the arguments raised by the authors are valid. However, the ratio used is still quite high (as high as >2000 in solitary fish), much higher than that recommended by Svendsen et al (2006). Hence this point needs to be discussed in the ms (summarising the points raised in the authors' response)

2) Wall effects: Fish in a school may have been swimming closer to the wall. The fact that the convex hull volume of the fish school did not change as speed increased is not a demonstration that fish were not closer to the wall, nor is it a demonstration that wall effect were not present. Therefore the issue of potential wall effects is a weakness of this paper.

3) The authors stated "Because we took high-speed videos simultaneously with the respirometry measurements, we can state unequivocally that individual fish within the school did not swim closer to the walls than solitary fish over the testing period". This is however not quantified.

4) Statistical analysis. The authors have dealt satisfactorily with most of the comments.<br /> However :<br /> (a) the following comment has not been dealt with directly in the ms "One can see from the graphs that schooling MO2 tends to have a smaller SD than solitary data. This may well be due to the fact that schooling data are based on 5 points (five schools) and each point is the result of the MO2 of five fish, thereby reducing the variability compared to solitary fish."<br /> (b) Different sizes were used for solitary and schooling fishes. The authors justify using larger fish as solitary to provide a better ratio of respirometer volume to fish volume in the tests on individual fish. However, mass scaling for tail beat frequency was not provided. Although (1) this is because of lack of data for this species and (2) using scaling exponent of distant species would introduce errors of unknown magnitude, this is still a weakness of the paper that needs to be acknowledged here and in the ms.

Reviewer #3 (Public Review):

Zhang and Lauder characterized both aerobic and anaerobic metabolic energy contributions in schools and solitary fishes in the Giant danio (Devario aequipinnatus) over a wide range of water velocities. By using a highly sophisticated respirometer system, the authors measure the aerobic metabolisms by oxygen uptake rate and the non-aerobic oxygen cost as excess post-exercise oxygen consumption (EPOC). With these data, the authors model the bioenergetic cost of schools and solitary fishes. The authors found that fish schools have a J-shaped metabolism-speed curve, with reduced total energy expenditure per tail beat compared to solitary fish. Fish in schools also recovered from exercise faster than solitary fish. Finally, the authors conclude that these energetic savings may underlie the prevalence of coordinated group locomotion in fish.

The conclusions of this paper are mostly well supported by data.

Reviewer #1 (Public Review):

Summary:<br /> The authors describe their work on finding optimal ways of infusing organoids into mice. They describe five delivery methods and compare organoid survival two weeks after delivery. This work is concluded with the use of a vascularized chamber being the most optimal for organoid viability.

Strengths:<br /> The aim is to have a preclinical, translational model to test methods of organoid infusion. This is important and timely to the field.

Weaknesses:<br /> - A clear aim seems to be missing, although I can extract this from the manuscript. The approach is described a bit cryptically. The manuscript could use a bit more explanation here and there.<br /> - Although the authors themselves argue in the introduction that the use of mice is not optimal, they show a mouse study in which human-derived iPSC organoids are infused in mice.<br /> - As far as I can extract from the Methods section, only one iPSC line was used. Given the huge donor variance, it is essential to repeat the work with multiple iPSC lines.<br /> - I am missing the right control groups, especially for the surgical groups. And the group size is very variable (3 to 7 mice per group). Three per group is then somewhat small in size.

Reviewer #2 (Public Review):

Summary:<br /> In this study, human induced pluripotent stem cell (hiPSC)-derived liver progenitor cell organoids were transplanted into four different transplantation sites in a mouse model of liver disease, using five organoid delivery methods. Organoids were transplanted into the vascularised chamber device established in the groin, or into the liver, spleen, and subcutaneous fat. Results show that the vascularised chamber had the highest organoid survival, 5.1x higher than the site with the second highest survival (p=0.0002), being the intra-hepatic scaffold approach. Animals with the vascularised chamber also had the highest human albumin levels (0.33 {plus minus} 0.09 ng/mL). No organoid survival was observed when delivered into the liver without a scaffold, or when injected into the spleen. Meager survival occurred in transplantations into subcutaneous fat.

Strengths:<br /> A systematic study with a clear line of experiments and well-presented results. The manuscript is well-written and easy to follow. The results and conclusions drawn are convincing.

Weaknesses:<br /> Although the number of organoids and albumin secretion is visibly higher in the vascularised chamber device, the organoids possess relatively higher Sox9+ cells compared to HNFa4a+ cells suggesting higher biliary differentiation than hepatic differentiation. On the other hand, although the intrahepatic scaffold approach, with a relatively smaller number of organoids and less albumin secretion, showed higher hepatic differentiation (although non-significant) suggesting that better scaffolds could be researched further to assess the clinical application of intrahepatic scaffold-based organoid transplantation.

Reviewer #1 (Public Review):

This is a very well-written and performed study describing a TOPBP1 separation of function mutation, resulting in defective MSCI maintenance but normal sex body formation. The phenotype differs from that of a previous TOPBP1 null allele, in which both MSCI and sex body formation were defective. Additional defects in CHK phosphorylation and SETX localization are also described.

Strengths:

The study is very rigorous, with a remarkably large number spectrum of techniques deployed to support the conclusions

Weaknesses

The study claims that MSCI is initiated but not maintained in the mutant. I think alternative hypotheses are possible.

Reviewer #2 (Public Review):

Summary:<br /> This paper described the role of BRCT repeat 5 in TOPBP1, a DNA damage response protein, in the maintenance of meiotic sex chromosome inactivation (MSCI). By analyzing a Topbp1 mutant mouse with amino acid substitutions in BRCT repeat 5, the authors found reduced phosphorylation of a DNA/RNA helicase, Sentaxin, and decreased localization of the protein to the X-Y sex body in pachynema. Moreover, the authors also found decreased repression of several genes on the sex chromosomes in the male mice.

Strengths:<br /> The works including phospho-proteomics and single-cell RNA sequencing with lots of data have been done with great care and most of the results are convincing.

Weaknesses:<br /> No weakness.

Reviewer #3 (Public Review):

The work presented by Ascencao and coworkers aims to deepen into the process of sex chromosome inactivation during meiosis (MSCI) as a critical factor in the regulation of meiosis progression in male mammals. For this purpose, they have generated a transgenic mouse model in which a specific domain of TOPBP1 protein has been mutated, hampering the binding of a number of protein partners and interfering with the regulatory cascade initiated by ATR. Through the use of immunolocalization of an impressive number of markers of MSCI, phosphoproteomics and single cell RNA sequencing (scRNAseq), the authors are able to show that despite a proper morphological formation of the sex body and the incorporation of most canonical MSCI makers, sex chromosome-liked genes are reactivated at some point during pachytene and this triggers meiosis progression breakdown, likely due to a defective phosphorylation of the helicase SETX.<br /> The manuscript presents a clear advance in the understanding of MSCI and meiosis progression with two main strengths. First, the generation of a mouse model with a very uncommon phenotype. Second, the use of a vast methodological approach. The results are well presented and illustrated. Nevertheless, the discussion could be still a bit tuned by the inclusion of some ideas, and perhaps speculations, that have not been considered.

Reviewer #1 (Public Review):

Summary:

In this study, the authors developed a mathematical model to predict human biological ages using physiological traits. This model provides a way to identify environmental and genetic factors that impact aging and lifespan.

Strengths:

1. The topic addressed by the authors - human age predication using physiological traits - is an extremely interesting, important, and challenging question in the aging field. One of the biggest challenges is the lack of well-controlled data from a large number of humans. However, the authors took this challenge and tried their best to extract useful information from available data.

2. Some of the findings can provide valuable guidelines for future experimental design for human and animal studies. For example, it was found that this mathematical model can best predict age when all different organ and physiological systems are sampled. This finding makes sense in general but can be, and has been, neglected when people use molecular markers to predict age. Most of those studies have used only one molecular trait or different traits from one tissue.

Weaknesses:

1. As I mentioned above, the Biobank data used here are not designed for this current study, so there are many limitations for model development using these data, e.g., missing data points and irrelevant measurements for aging. This is a common caveat for human studies and has been discussed by the authors.

2. There is no validation dataset to verify the proposed model. The authors suggested that human biological age can be predicted with high accuracy using 12 simple physiological measurements. It will be super useful and convincing if another biobank dataset containing those 12 traits can be applied to the current model.

Reviewer #2 (Public Review):

In this manuscript, Libert et al. develop a model to predict an individual's age using physiological traits from multiple organ systems. The difference between the predicted biological age and the chronological age -- ∆Age, has an effect equivalent to that of a chronological year on Gompertz mortality risk. By conducting GWAS on ∆Age, the authors identify genetic factors that affect aging and distinguish those associated with age-related diseases. The study also uncovers environmental factors and employs dropout analysis to identify potential biomarkers and drivers for ∆Age. This research not only reveals new factors potentially affecting aging but also shows promise for evaluating therapeutics aimed at prolonging a healthy lifespan. This work represents a significant advancement in data-driven understanding of aging and provides new insights into human aging. Addressing the points raised would enhance its scientific validity and broaden its implications.

Major points:

1. Enhance the description and clarity of model evaluation.

The manuscript requires additional details regarding the model's evaluation. The authors have stated "To develop a model that predicts age, we experimented with several algorithms, including simple linear regression, Gradient Boosting Machine (GBM) and Partial Least Squares regression (PLS). The outcomes of these approaches were almost identical". It is currently unclear whether the 'almost identical outcomes' mentioned refer to the similarity in top contribution phenotypes, the accuracy of age prediction, or both. To resolve this ambiguity, it would be beneficial to include specific results and comparisons from each of these models.

Furthermore, the authors mention "to test for overfitting, a PLS model had been generated on randomly selected 90% of individuals and tested on the remaining 10% with similar results". To comprehensively assess the model's performance, it is crucial to provide detailed results for both the test and validation datasets. This should at least include metrics such as correlation coefficients and mean squared error for both training and test datasets.

2. External validation and generalization of results

To enhance the robustness and generalizability of the study's findings, it is crucial to perform external validation using an independent population. Specifically, conducting validation with the participants of the 'All of Us' research program offers a unique opportunity. This diverse and extensive cohort, distinct from the initial study group, will serve as an independent validation set, providing insights into the applicability of the study's conclusions across varied demographics.

Reviewer #1 (Public Review):

The manuscript by Kadkova et al. describes an electrophysiological analysis of 3 neurodevelopmental disease-causing SNAP-25 mutations in hippocampal neuron autaptic cultures. The work expands on a prior study of these 3 mutations, along with several others in SNAP-25, that was performed in acutely dissociated hippocampal cultures by another group (Alten et al, 2021). Most of the physiology defects found are pretty similar for the 3 mutations the two research groups characterized, with differences largely found in the effects on the size of the readily releasable pool (RRP) of SVs. These differences could be due to technical differences in the approach but are also likely to reflect in part differences in autapses as a model that have been previously described. In addition to the physiological analysis in cultured neurons, the current work extends the analysis beyond the prior study by analyzing the effects of these SNAP-25 mutations in in vitro liposome fusion assays with purified proteins, and some modeling of the effects on energy landscapes during priming and fusion.

The authors use lentiviral expression of wildtype or one of the 3 mutants in SNAP-25 autaptic neurons and assay neuronal survival and synaptic output. The authors also combine wildtype with each of the 3 mutants as well, given these diseases manifest as spontaneous mutations in only 1 of the SNAP-25 alleles, suggesting a dominant effect. The authors observe that the V48F and D166Y alleles (that are suggested to disrupt the Syt1-SNAP-25/SNARE interface) result in a very large increase in spontaneous release that exceeds the Syt1 null mutant alone, suggesting an effect on spontaneous SV release beyond a lack of Syt1 regulation of SNARE-mediated fusion. In contrast, Syt1 nulls have a much more severe loss of evoked release, through both V48F and D166Y also have modest decreases in release. They find both mutants also cause a decrease in the RRP. Applying some modeling for these results, the authors suggest V48F and D166Y lowers the energy barrier for fusion, creating the enhanced spontaneous release rates and causing a decrease of the RRP. They also find evidence for reduced SV priming. In contrast, a SNAP-25 I167N disease mutation in the SNARE assembly interaction layer causes dramatic decreases in both evoked and spontaneous release, consistent with a disruption to SNARE assembly/stability. In vitro fusion assays with these mutant SNAP-25 alleles was also done and provided supportive evidence for these interpretations for all 3 alleles. The ability to control calcium, Syt1, PIP2 and Complexin levels in the in vitro assays provided additional information on defining the precise steps of the fusion process these mutations disrupt. Together, the study indicates the I167N mutation acts as a dominant-negative allele to block fusion, while the other two alleles have both loss- and gain-of function properties that cause more complex disruptions that decrease evoked release while dramatically enhancing spontaneous fusion.

Overall, these results build on prior work and shed light on how disruptions to the SNAP-25 t-SNARE alter the process of SV priming and fusion.

Reviewer #2 (Public Review):

Kádková, Murach, Pedersen, and colleagues studied how three disease-causing missense mutations in SNAP25 affect synaptic vesicle exocytosis. These mutations have previously been studied by Alten et al., 2021. The authors observed similar impairments in spontaneous and evoked release as Alten et al., 2021, but the measurement of readily releasable pool (RRP) size differed between the two studies. The authors found that the V48F and D166Y mutations affect the interaction with the Ca2+ sensor synaptotagmin-1 (Syt1), but do not entirely phenocopy Syt1 loss-of-function because they also exhibit a gain-of-function. Thus, these mutations affect multiple aspects of the energy landscape for vesicle priming and fusion. The I67N mutation specifically increases the fusion energy barrier without affecting upstream vesicle priming.

The strength of the study includes careful and technically excellent dissection of the synaptic release process and a combination of electrophysiology, biophysics, and modeling approaches. This study gained a deeper mechanistic understanding of these mutations in vesicle exocytosis than the previous study but did not result in a paradigm shift in our understanding of SNAP25-associated encephalopathy because the same spontaneous and evoked release phenotypes were previously identified.

Comments on revised version:

The authors fully addressed the two previous technical concerns and improved the introduction of the paper.

Reviewer #1 (Public Review):

Summary:<br /> Moon et al analyse ECoG data obtained during speech listening and focus on the relationship of two aspects: 1) delays between voltage signals at individual electrodes to other electrodes in the vicinity and 2) the power of those signals in a range of spectral bands. They find that high power in frequencies below 30 Hz is correlated with longer delays. They further look for this pattern of results in an oscillator model.

Strengths:<br /> The manuscript examines whether a finding made in cats in the late 90s generalises to intracranial recordings from humans. Specifically, the amplitude of low-frequency oscillations should be related to the delay of cross-correlation between areas. The authors find evidence for such a relationship and show this in individual participants. After inspecting this phenomenon from many different angles, they also added an oscillator model and claimed that they found a similar pattern there. As such, the manuscript reports an extensive body of work carried out on high-quality data.

Weaknesses:<br /> The manuscript's readability and flow could be optimised: terms are used that aren't explained, and the structure seems somewhat convoluted. Showing single-subject results is laudable, however, the authors could consider adding group results that integrate across participants, and perhaps relaying single-participant plots to the supplemental material. The manuscript would benefit if analyses were motivated more clearly. Sometimes, I am unsure why a given analysis was carried out, why it was carried out in a specific way, and what question it was intended to answer.

Reviewer #2 (Public Review):

Summary:<br /> In the paper "Inter-regional Delays Fluctuate in the Human Cerebral Cortex," the authors aim to investigate how global changes in the power of brain oscillations affect the latency and strength of cortico-cortical couplings. They measured changes in brain oscillations and inter-regional couplings using human intracranial recordings. Additionally, the authors employed oscillator models to elucidate their empirical findings.

Strengths:<br /> The authors tested their hypotheses using human intracranial data, which provides a direct measurement of brain activity with high spatial and temporal resolution. This offers a unique insight into the interplay between oscillatory power and inter-regional coupling in the human brain.

Weaknesses:<br /> The authors had access to only a subset of brain regions. Although this limitation is common in many intracranial studies, their discussion of global changes in brain oscillations is impacted by the lack of whole-brain coverage, and thus the global nature of these oscillations should be interpreted with caution.

The description of the analysis procedure is not always clear.

Summary of main concerns:<br /> My primary concerns relate to possible circularity in the analysis and the incomplete reporting of statistical results. For instance, correlation values are often provided without associated p-values, making it difficult to assess their significance. Furthermore, in some sections of the text, it is unclear whether specific results are supported by any statistical tests.

Crucial information is buried in the supplemental materials (e.g., the figure showing results for broad-band high-frequency power). Some details about the specific paradigm are missing in the methods section, making it challenging to determine if additional controls are necessary in the analyses. I encourage the authors to clarify certain aspects of the analysis and results to ensure their conclusions are substantiated by the data. Should the results be robust, I believe the study will be significant for researchers interested in brain oscillations and beyond.

Reviewer #3 (Public Review):

Summary:<br /> This is my assessment of the manuscript entitled "Inter-regional delays fluctuate in the human cerebral cortex" submitted by Moon et al. to eleventh article deals with an interesting question, namely: how do different areas in the brain synchronize with each other. As the title indicates, the article shows that interregional activity can be more or less out of sync, and that the degree of synchronicity depends on the global power of low and high-frequency oscillations.

Overall, I found the paper interesting, although, as written, it is sometimes not clear why studying these inter-regional delays is important. For a broader audience, it is necessary to better emphasize the relevance of inter-regional delays, and what we learn from studies like this beyond the mechanistic aspect of how waves spread in the human brain. Also, it is important to explain why the task (listening to audio) was chosen, and what this task offers in comparison to, for example, studying spontaneous activity. I understand that intra-cranial data from humans is precious and difficult to obtain, so I am not asking for more data, just for a clear honest explanation of why this task was chosen.

Beyond these minor formatting issues, I have two main concerns on the data analysis and interpretation. In a nutshell, they deal with:

- Cross-correlating alpha power with inter-electrode lags computed from raw signals where alpha itself is included. IMO this could lead to obvious high correlation values simply because low-frequency signals spread passively (with some delays) across electrodes. High-frequency signals spread less and are thus less correlated in neighboring electrodes.

- Possible influence of the referencing scheme on the data. I could not find any information about where reference and ground electrodes were located but I fear that epochs of zero-lag coherence could be simply due to common referencing. Non-zero lag synchrony could be explained by generators becoming more or less active close to the recording electrodes. This is probably the most parsimonious explanation of the activity observed and explaining it does not require any coupled oscillators.

Strengths:<br /> The paper relies on a strong dataset from intracranial recordings in humans. Conceptually the paper has strong value as it seeks to explore global and local activity dynamics within the human brain.

Weaknesses:<br /> There are a number of methodological issues that need to be clarified, which could potentially influence the results obtained and their interpretation (i.e. corr-correlating alpha with itself, the influence of the referencing scheme on inter-electrode lags).

Reviewer #1 (Public Review):

Summary:<br /> In this important work, the authors propose and test a model for the control of murine ultrasonic vocalizations (USV) in which two independent mechanisms, involving changes in laryngeal opening or airflow, control vocal tone. They present compelling experimental evidence for this dual control model by demonstrating the ability of freely behaving adult mice to generate vocalizations with various intonations by modulating both the breathing pattern and the laryngeal muscles. They also present novel evidence that these mechanisms are encoded in the brainstem vocalization central neural pattern generator, particularly in the component in the medulla called the intermediate reticular oscillator (iRO). The results presented clearly advance understanding of the developmental nature of the iRO, its ability to intrinsically generate and control many of the dynamic features of USV including those related to intonation, and its coordination with/control of expiratory airflow patterns. This work will interest neuroscientists investigating the neural generation and control of vocalization, breathing, and more generally, neuromotor control mechanisms.

Strengths:<br /> Important features and novelty of this work include:

1) The study employs an effective combination of anatomical, molecular, and functional/ behavioral approaches to examine the hypothesis and provide novel data indicating that variations in expiratory airflow can change the pitch patterns of adult murine USV.

2) The results significantly extend the authors' previous work that identified the iRO in neonatal mice by now presenting data that functionally demonstrates the existence of the critical Penk+Vglut2+ iRO neurons in adult mice, indicating that the iRO neurons maintain their function in generating vocalization throughout development.

3) The results convincingly demonstrate that the iRO neurons encode and can generate vocalizations by modulating both breathing and the laryngeal muscles.

4) The anatomical mapping and tracing results establish an important set of input and output circuit connections to the iRO, including input from the vocalization-promoting subregions of the midbrain periaqueductal gray (PAG), as well as output axonal projections to laryngeal motoneurons, and to the respiratory rhythm generator in the preBötzinger complex.

5) These studies advance the important concept that the brainstem vocalization pattern generator integrates with the medullary respiratory pattern generator to control expiratory airflow as a key mechanism to produce various USV types characterized by different pitch patterns.

Weaknesses:<br /> A limitation is that the cellular and circuit mechanisms by which the vocalization pattern generator integrates with the respiratory pattern generator to control expiratory airflow have not been fully worked out, requiring future studies.

Reviewer #2 (Public Review):

Summary:<br /> Both human and non-human animals modulate the frequency of their vocalizations to communicate important information about context and internal state. While regulation of the size of the laryngeal opening is a well-established mechanism to regulate vocal pitch, the contribution of expiratory airflow to vocal pitch is less clear. To consider this question, this study first characterizes the relationship between the dominant frequency contours of adult mouse ultrasonic vocalizations (USVs) and expiratory airflow using whole-body plethysmography. Next, the authors build off of their previous work characterizing intermediate reticular oscillator (iRO) neurons in mouse pups to establish the existence of a genetically similar population of neurons in adults and show that artificial activation of iRO neurons elicits USV production in adults. Third, the authors examine the acoustic features of USV elicited by optogenetic activation of iRO and find that a majority of natural USV types (as defined by pitch contour) are elicited by iRO activation.

Strengths:<br /> Strengths of the study include the novel consideration of expiratory airflow as a mechanism to regulate vocal pitch and the use of intersectional methods to identify and activate the iRO in adult mice. The establishment of iRO neurons as a brainstem population that regulates vocal production across development is an important finding.

Weaknesses:<br /> The study does not include statistical analyses to compare the observed relationships between expiratory airflow and USV pitch to a null model in which expiratory airflow and USV pitch are unrelated. The findings of the study also do not provide clear evidence to support the authors' model in which distinct brainstem populations (iRO and RAm) independently regulate expiratory airflow and laryngeal adduction. Although this study establishes iRO as an important population that regulates USV production in adult mice, the question of whether and how different brainstem populations contribute differentially to vocal production remains an important open question. Lastly, the addition of statistical analyses would help to strengthen the study's conclusion that iRO activation positively biases the relationship between expiratory airflow and USV pitch across multiple USV types.

Reviewer #1 (Public Review):

Summary:<br /> This work studies spatiotemporal patterns of structure-function coupling in developing brains, using a large set of imaging data acquired from children and young adults aged 5-22. Magnetic resonance imaging data of brain structure and function were obtained from a publicly available database, from which structural and functional features and measures were derived. The authors examined the spatial patterns of structure-function coupling and how they evolve with brain development. This work further examined correlations between brain structure-function coupling and behaviour, and explored evolutionary, microarchitectural and genetic bases that could potentially account for the observed patterns.

Strengths:<br /> The strength of this work is the use of currently available state-of-the-art analysis methods, along with a large set of high-quality imaging data, and comprehensive examination of structure-function coupling in developing brains. The results are comprehensive and illuminative.

Weakness:<br /> As in most other studies, transcriptomic and cellular architectures of structure-function coupling were characterized only on the basis of a common atlas in this work.

The authors have achieved their aims in this study, and the findings provide mechanistic insights into brain development, which could inspire further basic and clinical studies along this line.

Reviewer #2 (Public Review):

Summary:<br /> Feng et al. investigated dynamic changes in functional and structural connectivity relationships across a broad age range from childhood to early adulthood (6-22 years) using the large open-source HCP-Development database of multimodal magnetic resonance imaging (MRI). Employing a multilinear model, the study integrates three white-matter structural descriptors derived from diffusion tractography with 'microstructure profile covariance' (MPC) descriptors of relationships between cortical regions in terms of regional T1w/T2w ratio, and evaluates the coupling between these structural connectome (SC) descriptors and functional connectivity (FC) as adjusted coefficients of determination, i.e. how well the structural descriptors correspond to the functional connectivity derived from resting-state functional MRI.

The findings reveal a global increase in SC-FC coupling over development. At a regional level, coupling exhibited distinct profiles of age-related increases and decreases within and between functional networks. Individual variability captured by the presented measures of SC-FC coupling was implicated as a potential marker for the prediction of general intelligence scores. Additionally, the investigation extended to associating changes in SC-FC coupling with age to regional gene expression profiles (derived from Allen Human Brain Atlas that analysed six neurotypical adult brains), suggesting positive associations with oligodendrocyte-related pathways and negative associations with astrocyte-related genes.

Strengths:<br /> Overall, the paper offers an interesting and valuable contribution to our understanding of structure-function relationships in the context of brain development. The commendable efforts to assess robustness across various methodologies, including brain parcellation and tractography, and reproducibility analyses on different data subsets enhance the paper's credibility. Combining cortical MPC with more usual white-matter descriptors of structural connectivity is interesting and provides (potentially) complementary information for the study of structure-function relationships with age. Analysing the changes in SC-FC coupling in relation to profiles of evolutionary expansion and functional principal gradients shows a good effort to position the present observations on SC-FC coupling within the previously described work.

Weaknesses:<br /> Although the paper has many strengths, some aspects of the analysis need to be clarified to further support the proposed conclusions. In particular:

* The authors propose that combining cortical and white-matter connectivity measures yields a more comprehensive descriptor of SC-FC coupling. While this is likely true, the claim is not directly tested by assessing different descriptors separately and then in combination to compare the benefits of incorporating additional information for the description of SC-FC coupling.

* The authors report changes in SC-FC coupling with myelin content (reporting a positive association of coupling with regional myelin) and report positive associations between SC-FC correlation with age and expression of oligodendrocyte-related genes. Given that the computation of SC-FC coupling involves the T1w/T2w ratios within cortical regions (recognised as a myelin marker), it's plausible that these findings may be influenced by potential bias introduced by myelin-related measures in the coupling computation process.

* The authors investigate the predictive power of SC-FC coupling, suggesting non-random (but weak) prediction of individual variability in general intelligence (after age correction). However, again the benefit of using SC-FC coupling measures over using each modality alone is not evaluated. Such comparison might indicate whether the coupling is an informative measure in itself or whether it might be informative only to the extent to which it is a proxy measure of SC and FC (in case the predictive power of each separate modality is much higher).

* Generally, more information on quality assessment of tractography and parcellations (including potential age effects on processing given the wide age range of the participants), additional details on the distribution of cognitive scores used in the predictive section, and further clarifications regarding the design choices and validation strategy would provide the reader with a more detailed understanding of the cohort and proposed analytical pipeline (these minor comments are included in the private recommendations to authors).

Reviewer #1 (Public Review):

He et al. investigate the requirement and function of Blimp1 (encoded by Prdm1) in murine NK cells and ILC1. Employing a conditional knockout mouse model (Prdm1flox x Ncr1cre), the authors describe impaired abundance and maturation of Prdm1-deficient NK cells and ILC1 in different tissues. Blimp1-deficient NK cells have reduced expression of cytotoxic molecules (Gzmb, Prf1) and, in some instances, Ifng production, and Prdm1flox x Ncr1cre mice show impaired tumor control in experimental metastasis models. Using single-cell RNA sequencing analysis, the authors propose that Prdm1 regulates JunB expression and NK cell maturation. Based on in silico analyses, the authors suggest manifold intercellular communication between NK/ILC1 and macrophages. Without following up on any of these potentially interesting suggestions, the authors conclude their study reiterating that Prdm1 regulates IFNg-production of tumor-infiltrating NK cells and ILC1.

Many of the reported functions of Blimp1 in NK cells have previously been identified using a mixed-chimera strategy comparing Prdm1 WT and KO NK cells (Kallies et al., Blood 2011). Here, the authors expand on these findings using a conditional model to delete Prdm1 in NK/ILC1 and single-cell sequencing and provide a more refined analysis of the functions of Blimp1 in these cells. Cell-chat analysis suggests close interactions of Blimp-dependent NK/ILC1 subsets with hepatic macrophages, but these suggestions are not followed up by experiments. Potentially interesting differences in the macrophage compartment of Ncr1-Cre x Prdm1-fl/fl mice are suggested by the scc-RNA-Seq data but are not validated e.g. by FACS. The study falls short in providing new mechanistic insights. Nevertheless, it is an interesting confirmation of "old" suggestions in a more refined setting, and the provided single-cell mRNA-Seq data represents a potentially valuable resource for the community. There are some control analyses that are required to support the conclusions of the authors, and I have a few suggestions that would help to improve the manuscript.

Major comments:

- The authors do not control for the potential effects of Cre expression. Expression of Cre from within the Ncr1 locus (using the mouse model established by Narni-Mancinelli et al.) has significant effects on NK cells and especially ILC1s (reducing their frequency and absolute numbers and altering their functionality. The authors should characterize the Ncr1cre mice used here (developed by Shanghai Model Organism Center) in this regard and should use proper controls (Ncr1Cre+ Prdm1wt/wt as control for Ncr1Cre+ Prdm1fl/fl, instead of WT littermates) for all of their key data, e.g. those depicted in Fig 1FG, 2ADFH, 7D, S2,3,4.

- Several of the phenotypic findings on NK cells have been described before by Kallies et al. in 2011 (Ref 29), although using a different genetic Prdm1-ablation model (Prdm1-GFP/GFP knockin/knockout model). This study reported impaired NK cell maturation, reduced Gzmb expression, impaired in vivo cytotoxicity against subcutaneous RMA-S cells, impaired in vitro proliferation, comparable in vitro killing, increase in BM NK cell numbers. The authors should discuss/mention this more prominently in their manuscript, and highlight where they confirm or refine these previous findings, and where they actually provide new information.

- What is the reason to refer to the enriched cluster in Blimp1-deficient NK cells as "Junbhi"? There is no follow-up for a function of Junb, and there are many other genes upregulated in these cells. Most critically, these cells seem to represent exactly the c-Kithi cells that Kallies et al. already showed and discussed in their paper. The authors should stain for Kit, and also refer to this. Also, MacKay et al. performed Blimp1-Chip-Seq (in T cells), maybe it would be interesting to check to which of the identified DEGs Blimp1 can bind.

- cNK cells are considered circulating cells, that transiently pass through the liver. Previous studies have suggested almost identical gene expression patterns in hepatic and splenic NK cells. In functional tests, they often "perform" identically. I am therefore a bit surprised that the authors find a differential dependency of Blimp1 for the IFNg production of splenic (no role of Blimp1) versus hepatic (Blimp1 regulating IFNg production) NK cells (Fig S3). Do the authors have any suggestions on that? The analyses are performed by 12+4h stimulations with IL12/18, which could involve the effects of altered bystander cells (as suggested by Figure 6). Therefore, these analyses should be provided upon standard 4h stimulations with IL12/18 and also with PMA/I under BFA. Note: liver and splenic cNK cells look quite different in the chosen histograms in Figures 7 A, B, C, yet there is massive variability in these analyses - is there any systematic/technical problem?

- Figure 4 H/I - In contrast to NK cells in Fig 4E, F, the KO and WT ILC1s seem to co-cluster largely. Authors should validate differentially expressed genes. How strong is the effect of Blimp1 in ILC1s? Or is Blimp1 a critical TF driving effector differentiation in NK cells, while it has only subtle effects in ILC1 (these may be regulated by Hobit?)? This seems an interesting finding that should at least be discussed. For these types of small differences in ILC1, FACS confirmation analyses should be performed and findings be reevaluated using Cre-expressing controls (see above).

The authors describe and discuss some of Figure 1 and 2 data as if Blimp1 would be involved in alternative NK versus ILC1 fates, but there is no evidence for this.

- There are several recent studies suggesting a role for Hobit, homologue of Blimp1, in NK cells and in ILC1, and in the control of liver metastases. The authors should discuss similar and unique functions of Hobit and Blimp1, also in the regulation of gene expression patterns, and should refer to these studies.

- Figure 4: The authors should discuss (and cross-validate) their liver gene expression analyses in the context of published datasets of NK and ILC1, such as the ones by Lopez et al, Friedrich et al, Ducimetiere et al and Yomogida et al.

Reviewer #2 (Public Review):

Summary:<br /> This study offers a significant advancement in understanding liver innate lymphoid cell (ILC) biology by elucidating the role of the transcription factor Prdm1. It shows that Prdm1 is crucial in maintaining the balance between conventional natural killer (cNK) cells and ILC1s in the liver, with knockout models revealing a vital role in cancer defense mechanisms. Despite not affecting direct cytotoxicity, Prdm1 deficiency leads to increased cancer metastasis and reduced secretion of key molecules like IFN-γ, pointing to its importance in immune regulation. The use of single-cell RNA sequencing further underscores Prdm1's role in cellular communication within the liver's immune milieu. This study is a robust contribution to the field, providing insights that could inform new immunotherapy approaches for liver cancer.

Strengths:<br /> The study's strength lies in its comprehensive approach, combining the specificity of Prdm1 conditional deletion in Ncr1-cre mice with integrative omics analyses and cutting-edge cytometry to delineate Prdm1's role in liver Type 1 ILC biology and its functional implications in tumor immunity. This multifaceted strategy not only clarifies Prdm1's influence on ILC composition and maturation but also conveys potential therapeutic insights for liver cancer immunotherapy.

Weaknesses:<br /> A notable weakness of the study is the limited scope of in vivo disease models, primarily relying on the B16F10 melanoma model, which may not fully capture the complex behavior of Type 1 ILCs across diverse cancer types. Furthermore, the absence of direct human data, such as the effects of PRDM1 deletion in human NK cells or stem cells during their differentiation into NK and ILC1, leaves a gap in translating these findings to clinical settings.

Reviewer #1 (Public Review):

Summary:<br /> Functionally important alternative isoforms are gold nuggets found in a swamp of errors produced by the splicing machinery.

The architecture of eukaryotic genomes, when compared with prokaryotes, is characterised by a preponderance of introns. These elements, which are still present within transcripts, are rapidly removed during the splicing of messenger RNA (mRNA), thus not contributing to the final protein. The extreme rarity of introns in prokaryotes, and the elimination of these introns from mRNAs before translation into protein, raises questions about the function of introns in genomes. One explanation comes from functional biology: introns are thought to be involved in post-transcriptional regulation and in the production of translational variants. The latter function is possible when the positions of the edges of the spliced intron vary. While some light has been shed on specific examples of the functional role of alternative splicing, to what extent are they representative of all introns in metazoans?

In this study, the hypothesis of a functional role for alternative splicing, and therefore to a certain extent for introns, is evaluated against another explanation coming from evolutionary biology: isoforms are above all errors of imprecision by the molecular machinery at work during splicing. This hypothesis is based on a principle established by Motoo Mikura, which has become central to population genetics, explaining that the evolutionary trajectory of a mutation with a given effect is intimately linked to the effective population size (Ne) where this mutation emerges. Thus, the probability of fixation of a weakly deleterious mutation increases when Ne decreases, and the probability of fixation of a weakly advantageous mutation increases when Ne increases. The genomes of populations with low Ne are therefore expected to accumulate more weakly deleterious mutations and fewer weakly advantageous mutations than populations with high Ne. In this framework, if splicing errors have only small effects on the fitness of individuals, then natural selection cannot increase the precision of the splicing machinery, allowing tolerance for the production of alternative isoforms.

In the past, the debate opposed one-off observations of effectively functional isoforms on the one hand, to global genomic quantities describing patterns without the possibility of interpreting them in detail. The authors here propose an elegant quantitative approach in line with the expected continuous variation in the effectiveness of selection, both between species and within genomes. The result describing the inter-specific pattern on a large scale confirms what was already known (there is a negative relationship between effective size and average alternative splicing rate). The essential novelty of this study lies in 1) the quantification, for each intron studied, of the relative abundance of each isoform, and 2) the analysis of a relationship between this abundance and the evolutionary constraints acting on these isoforms.

What is striking is the light shed on the general very low abundance of alternative isoforms. Depending on the species, 60% to 96% of cases of alternatively spliced introns lead to an isoform whose abundance is less than 5% of the total variants for a given intron.

In addition to the fact that 60%-96% of the total isoforms are more than 20 times less abundant than their majority form, this large proportion of alternative isoforms exhibit coding-phase shift at rates similar to what would be expected by chance, i.e. for a third of them, which reinforces the idea that there is no particular constraint on these isoforms.

The remaining 4%-40% of isoforms see their coding-phase shift rate decrease as their relative abundance increases. This result represents a major step forward in our understanding of alternative splicing and makes it possible to establish a quantitative model directly linking the relative abundance of an isoform with a putative functional role concerning only those isoforms produced in abundance. Only the (rare) isoforms which are abundantly produced are thought to be involved in a biological function.

Within the same genome, the authors show that only highly expressed genes, i.e. those that tend to be more constrained on average, are also the genes with the lowest alternative splicing rates on average.

The comparison between species in this study reveals that the smaller the effective size of a species, the more its genome produces isoforms that are low in abundance and low in constraint. Conversely, species with a large effective size relatively reduce rare isoforms, and increase stress on abundant isoforms.

To sum up:<br /> • the higher the effective size of a species, the fewer introns are spliced.<br /> • highly expressed genes are spliced less.<br /> • when splicing occurs, it is mainly to produce low-abundance isoforms.<br /> • low-abundance isoforms are also less constrained.

Taken together, these results reinforce a quantitative view of the evolution of alternative splicing as being mainly the product of imprecision in the splicing machinery, generating a great deal of molecular noise. Then, out of all this noise, a few functional gold nuggets can sometimes emerge. From the point of view of the reviewer, the evolutionary dynamics of genomes are depressing. The small effective population sizes are responsible for the accumulation of multiple slightly deleterious introns. Admittedly, metazoan genomes try to get rid of these introns during RNA maturation, but this mechanism is itself rendered imprecise by population sizes.

Strengths:<br /> • The authors simultaneously study the effects of effective population size, isoform abundance, and gene expression levels on the evolutionary constraints acting on isoforms. Within this framework, they clearly show that an isoform becomes functionally important only under certain rare conditions.<br /> • The authors rule out an effect putatively linked to variations in expression between different organs which could have biased comparisons between different species.

Weaknesses:<br /> • While the longevity of organisms as a measure of effective size seems to work overall, it may not be relevant for discriminating within a clade. For example, within Hymenoptera, we might expect them to have the same overall longevity, but that effective size would be influenced more by the degree of sociality: solitary bees/ants/wasps versus eusocial. I am therefore certain that the relationship shown in Figure 4D is currently not significant because the measure of effective size is not relevant for Hymenoptera. The article would have been even more convincing by contrasting the rates of alternative splicing between solitary versus social hymenopterans.<br /> • When functionalist biologists emphasise the role of the complexity of living things, I'm not sure they're thinking of the comparison between "drosophila" and "homo sapiens", but rather of a broader evolutionary scale. Which gives the impression of an exaggeration of the debate in the introduction.

Reviewer #2 (Public Review):

Summary:<br /> Two hypotheses could explain the observation that genes of more complex organisms tend to undergo more alternative splicing. On one hand, alternative splicing could be adaptive since it provides the functional diversity required for complexity. On the other hand, increased rates of alternative splicing could result through nonadaptive processes since more complex organisms tend to have smaller effective population sizes and are thus more prone to deleterious mutations resulting in more spurious splicing events (drift-barrier hypothesis). To evaluate the latter, B́enitiere et al. analyzed transcriptome sequencing data across 53 metazoan species. They show that proxies for effective population size and alternative splicing rates are negatively correlated. Furthermore, the authors find that rare, nonfunctional (and likely erroneous) isoforms occur more frequently in more complex species. Additionally, they show evidence that the strength of selection on splice sites increases with increasing effective population size and that the abundance of rare splice variants decreases with increased gene expression. All of these findings are consistent with the drift-barrier hypothesis.

This study conducts a comprehensive set of separate analyses that all converge on the same overall result and the manuscript is well organized. Furthermore, this study is useful in that it provides a modified null hypothesis that can be used for future tests of adaptive explanations for variation in alternative splicing.

Strengths:<br /> The major strength of this study lies in its complementary approach combining comparative and population genomics. Comparing evolutionary trends across phylogenetic diversity is a powerful way to test hypotheses about the origins of genome complexity. This approach alone reveals several convincing lines of evidence in support of the drift-barrier hypothesis. However, the authors also provide evidence from a population genetics perspective (using resequencing data for humans and fruit flies), making results even more convincing.

The authors are forward about the study's limitations and explain them in detail. They elaborate on possible confounding factors as well as the issues with data quality (e.g. proxies for Ne, inadequacies of short reads, heterogeneity in RNA-sequencing data).

Weaknesses:<br /> The authors primarily consider insects and mammals in their study. This only represents a small fraction of metazoan diversity. Sampling from a greater diversity of metazoan lineages would make these results and their relevance to broader metazoans substantially more convincing. Although the authors are careful about their tone, it is challenging to reconcile these results with trends across greater metazoans when the underlying dataset exhibits ascertainment bias and represents samples from only a few phylogenetic groups. Relatedly, some trends (such as Figure 1B-C) seem to be driven primarily by non-insect species, raising the question of whether some results may be primarily explained by specific phylogenetic groups (although the authors do correct for phylogeny in their statistics). How might results look if insects and mammals (or vertebrates) are considered independently?

Throughout the manuscript, the authors refer to infrequently spliced (mode <5%) introns as "minor introns" and frequently spliced (mode >95%) as "major introns". This is extremely confusing since "minor introns" typically represent introns spliced by the U12 spliceosome, whereas "major introns" are those spliced by the U2 spliceosome. Furthermore, it remains unclear whether the study only considers major introns or both major and minor introns. Minor introns typically have AT-AC splice sites whereas major introns usually have GT/GC-AG splice sites, although in rare cases the U2 can recognize AT-AC (see Wu and Krainer 1997 for example). The authors also note that some introns show noncanonical AT-AC splice sites while these are actually canonical splice sites for minor introns.

Reviewer #1 (Public Review):

Summary:

This important work advances our understanding of sperm motility regulation during fertilization by uncovering the midpiece/mitochondria contraction associated with motility cessation and structural changes in the midpiece actin network as its mode of action. The evidence supporting the conclusion is solid, with rigorous live cell imaging using state-of-the-art microscopy, although more functional analysis of the midpiece/mitochondria contraction would have further strengthened the study. The work will be of broad interest to cell biologists working on the cytoskeleton, mitochondria, cell fusion, and fertilization.

Strengths:

The authors demonstrate that structural changes in the flagellar midpiece F-actin network are concomitant to midpiece/mitochondrial contraction and motility arrest during sperm-egg fusion by rigorous live cell imaging using state-of-art microscopy.

Weaknesses:

Many interesting observations are listed as correlated or in time series but do not necessarily demonstrate the causality and it remains to be further tested whether the sperm undergoing midpiece contraction are those that fertilize or those that are not selected. Further elaboration of the function of the midpiece contraction associated with motility cessation (a major key discovery of the manuscript) would benefit from a more mechanistic study.

Reviewer #2 (Public Review):

The authors used various microscopy techniques, including super-resolution microscopy, to observe the changes that occur in the midpiece of mouse sperm flagella. Previously, it was shown that actin filaments form a double helix in the midpiece. This study reveals that the structure of these actin filaments changes after the acrosome reaction and before sperm-egg fusion, resulting in a thinner midpiece. Furthermore, by combining midpiece structure observation with calcium imaging, the authors show that changes in intracellular calcium concentrations precede structural changes in the midpiece. The cessation of sperm motility by these changes may be important for fusion with the egg. Elucidation of the structural changes in the midpiece could lead to a better understanding of fertilization and the etiology of male infertility. The conclusions of this manuscript are largely supported by the data, but there are several areas for improvement in data analysis and interpretation. Please see the major points below.

1. It is unclear whether an increased FM4-64 signal in the midpiece precedes the arrest of sperm motility. This needs to be clarified in order to argue that structural changes in the midpiece cause sperm motility arrest. The authors should analyze changes in both motility and FM4-64 signal over time for individual sperm.

2. It is possible that sperm stop moving because they die. Figure 1G shows that the FM4-64 signal is increased in the midpiece of immotile sperm, but it is necessary to show that the FM4-64 signal is increased in sperm that are not dead and retain plasma membrane integrity by checking sperm viability with propidium iodide or other means.

3. It is unclear how the structural change in the midpiece causes the entire sperm flagellum, including the principal piece, to stop moving. It will be easier for readers to understand if the authors discuss possible mechanisms.

4. The mitochondrial sheath and cell membrane are very close together when observed by transmission electron microscopy. The image in Figure 9A with the large space between the plasma membrane and mitochondria is misleading and should be corrected. The authors state that the distance between the plasma membrane and mitochondria approaches about 100 nm after the acrosome reaction (Line 330 - Line 333), but this is a very long distance and large structural changes may occur in the midpiece. Was there any change in the mitochondria themselves when they were observed with the DsRed2 signal?

5. In the TG sperm used, the green fluorescence of the acrosome disappears when sperm die. Figure 1C should be analyzed only with live sperm by checking viability with propidium iodide or other means.

Reviewer #3 (Public Review):

While progressive and also hyperactivated motility are required for sperm to reach the site of fertilization and to penetrate the oocyte's outer vestments, during fusion with the oocyte's plasma membrane it has been observed that sperm motility ceases. Identifying the underlying molecular mechanisms would provide novel insights into a crucial but mostly overlooked physiological change during the sperm's life cycle. In this publication, the authors aim to provide evidence that the helical actin structure surrounding the sperm mitochondria in the midpiece plays a role in regulating sperm motility, specifically the motility arrest during sperm fusion but also during earlier cessation of motility in a subpopulation of sperm post acrosomal exocytosis.

The main observation the authors make is that in a subpopulation of sperm undergoing acrosomal exocytosis and sperm that fuse with the plasma membrane of the oocyte display a decrease in midpiece parameter due to a 200 nm shift of the plasma membrane towards the actin helix. The authors show the decrease in midpiece diameter via various microscopy techniques all based on membrane dyes, bright-field images and other orthogonal approaches like electron microscopy would confirm those observations if true but are missing. The lack of additional experimental evidence and the fact that the authors simultaneously observe an increase in membrane dye fluorescence suggests that the membrane dyes instead might be internalized and are now staining intracellular membranes, creating a false-positive result. The authors also propose that the midpiece diameter decrease is driven by changes in sperm intracellular Ca2+ and structural changes of the actin helix network. Important controls and additional experiments are needed to prove that the events observed by the authors are causally dependent and not simply a result of sperm cells dying.

Reviewer #1 (Public Review):

Summary:

Numerous pathways have been proposed to elucidate the nongenomic actions of progesterone within both male and female reproductive tissues. The authors employed the Xenopus oocyte system to investigate the PLA2 activity of ABHD2 and the downstream lipid mediators in conjunction with mPRb and P4, on their significance in meiosis. The research has been conducted extensively and is presented clearly.

Strengths:

While the interaction between membranous PR and ABHD2 is not a novel concept, this present study exhibits several strengths:

1. mPRbeta, a member of the PAQR family, has been elusive in terms of detailed signal transduction. Through mutation studies involving the Zn binding domain, the authors discovered that the hydrolase activity of mPRbeta is not essential for meiosis and oocyte maturation. Instead, they suggest that ABHD2, acting as a coreceptor of mPRbeta, demonstrates phospholipase activity, indicating that downstream lipid mediators may play a dominant role when stimulated by progesterone.

2. Extensive exploration of downstream signaling pathways and the identification of several potential meiotic activity-related lipid mediators make this aspect of the study novel and potentially significant.

Weaknesses:

However, there are some weaknesses and areas that need further clarification:

1. The mechanism governing the molecular assembly of mPRbeta and ABHD2 remains unclear. Are they constitutively associated or is their association ligand-dependent? Does P4 bind not only to mPRbeta but also to ABHD2, as indicated in Figure 6J? In the latter case, the reviewer suggests that the authors conduct a binding experiment using labeled P4 with ABHD2 to confirm this interaction and assess any potential positive or negative cooperativity with a partner receptor.

2. The authors have diligently determined the metabolite profile using numerous egg cells. However, the interpretation of the results appears incomplete, and inconsistencies were noted between Figure 2B and Supplementary Figure 2C. Furthermore, PGE2 and D2 serve distinct roles and have different elution patterns by LC-MS/MS, thus requiring separate measurements. In addition, the extremely short half-life of PGI2 necessitates the measurement of its stable metabolite, 6-keto-PGF1a, instead. The authors also need to clarify why they measured PGF1a but not PGF2a.

3. Although they propose PGs, LPA, and S1P are important downstream mediators, the exact roles of the identified lipid mediators have not been clearly demonstrated, as receptor expression and activation were not demonstrated. While the authors showed S1PR3 expression and its importance by genetic manipulation, there was no observed change in S1P levels following P4 treatment (Supplementary Figure 2D). It is essential to identify which receptors (subtypes) are expressed and how downstream signaling pathways (PKA, Ca, MAPK, etc.) relate to oocyte phenotypes.

These clarifications and further experiments would enhance the overall impact and comprehensiveness of the study.

Reviewer #2 (Public Review):

Summary:

This interesting paper examines the earliest steps in progesterone-induced frog oocyte maturation, an example of non-genomic steroid hormone signaling that has been studied for decades but is still very incompletely understood. In fish and frog oocytes it seems clear that mPR proteins are involved, but exactly how they relay signals is less clear. In human sperm, the lipid hydrolase ABHD2 has been identified as a receptor for progesterone, and so the authors here examine whether ABHD2 might contribute to progesterone-induced oocyte maturation as well. The main results are:

1. Knocking down ABHD2 makes oocytes less responsive to progesterone, and ectopically expressing ABHD2.S (but not the shorter ABHD2.L gene product) partially rescues responsiveness. The rescue depends upon the presence of critical residues in the protein's conserved lipid hydrolase domain, but not upon the presence of critical residues in its acyltransferase domain.

2. Treatment of oocytes with progesterone causes a decrease in sphingolipid and glycerophospholipid content within 5 min. This is accompanied by an increase in LPA content and arachidonic acid metabolites. These species may contribute to signaling through GPCRs. Perhaps surprisingly, there was no detectable increase in sphingosine-1-phosphate, which might have been expected given the apparent substantial hydrolysis of sphingolipids. The authors speculate that S1P is formed and contributes to signaling but diffuses away.

3. Pharmacological inhibitors of lipid-metabolizing enzymes support, for the most part, the inferences from the lipidomics studies, although there are some puzzling findings. The puzzling findings may be due to uncertainty about whether the inhibitors are working as advertised.

4. Pharmacological inhibitors of G-protein signaling support a role for G-proteins and GPCRs in this signaling, although again there are some puzzling findings.

5. Reticulocyte expression supports the idea that mPR and ABHD2 function together to generate a progesterone-regulated PLA2 activity.

6. Knocking down or inhibiting ABHD2 inhibited progesterone-induced mPRinternalization, and knocking down ABHD2 inhibited SNAP2520-induced maturation.

Strengths:

All in all, this could be a very interesting paper and a nice contribution. The data add a lot to our understanding of the process, and, given how ubiquitous mPR and AdipoQ receptor signaling appear to be, something like this may be happening in many other physiological contexts.

Weaknesses:

I have several suggestions for how to make the main points more convincing.

Main criticisms:

1. The ABHD2 knockdown and rescue, presented in Fig 1, is one of the most important findings. It can and should be presented in more detail to allow the reader to understand the experiments better. E.g.: the antisense oligos hybridize to both ABHD2.S and ABHD2.L, and they knock down both (ectopically expressed) proteins. Do they hybridize to either or both of the rescue constructs? If so, wouldn't you expect that both rescue constructs would rescue the phenotype since they both should sequester the AS oligo? Maybe I'm missing something here.

In addition, it is critical to know whether the partial rescue (Fig 1E, I, and K) is accomplished by expressing reasonable levels of the ABHD2 protein, or only by greatly overexpressing the protein. The author's antibodies do not appear to be sensitive enough to detect the endogenous levels of ABHD2.S or .L, but they do detect the overexpressed proteins (Fig 1D). The authors could thus start by microinjecting enough of the rescue mRNAs to get detectable protein levels, and then titer down, assessing how low one can go and still get rescue. And/or compare the mRNA levels achieved with the rescue construct to the endogenous mRNAs.

Finally, please make it clear what is meant by n = 7 or n = 3 for these experiments. Does n = 7 mean 7 independently lysed oocytes from the same frog? Or 7 groups of, say, 10 oocytes from the same frog? Or different frogs on different days? I could not tell from the figure legends, the methods, or the supplementary methods. Ideally one wants to be sure that the knockdown and rescue can be demonstrated in different batches of oocytes, and that the experimental variability is substantially smaller than the effect size.

2. The lipidomics results should be presented more clearly. First, please drop the heat map presentations (Fig 2A-C) and instead show individual time course results, like those shown in Fig 2E, which make it easy to see the magnitude of the change and the experiment-to-experiment variability. As it stands, the lipidomics data really cannot be critically assessed.

[Even as heat map data go, panels A-C are hard to understand. The labels are too small, especially on the heat map on the right side of panel B. The 25 rows in panel C are not defined (the legend makes me think the panel is data from 10 individual oocytes, so are the 25 rows 25 metabolites? If so, are the individual oocyte data being collapsed into an average? Doesn't that defeat the purpose of assessing individual oocytes?) And those readers with red-green colorblindness (8% of men) will not be able to tell an increase from a decrease. But please don't bother improving the heat maps; they should just be replaced with more informative bar graphs or scatter plots.]

3. The reticulocyte lysate co-expression data are quite important and are both intriguing and puzzling. My impression had been that to express functional membrane proteins, one needed to add some membrane source, like microsomes, to the standard kits. Yet it seems like co-expression of mPR and ABHD2 proteins in a standard kit is sufficient to yield progesterone-regulated PLA2 activity. I could be wrong here - I'm not a protein expression expert - but I was surprised by this result, and I think it is critical that the authors make absolutely certain that it is correct. Do you get much greater activities if microsomes are added? Are the specific activities of the putative mPR-ABHD2 complexes reasonable?

Reviewer #3 (Public Review):

Summary:

The authors report two P4 receptors, ABHD2 and mPRβ that function as co-receptors to induce PLA2 activity and thus drive meiosis. In their experimental studies, the authors knock down ABHD2 and demonstrated inhibition of oocyte maturation and inactivation of Plk1, MAPK, and MPF, which indicated that ABHD2 is required for P4-induced oocyte maturation. Next, they showed three residues (S207, D345, H376) in the lipase domain that are crucial for ABHD2 P4-mediated oocyte maturation in functional assays. They performed global lipidomics analysis on mPRβ or ABHD2 knockdown oocytes, among which the downregulation of GPL and sphingolipid species were observed, and enrichment in LPA was also detected using their metabolomics method. Furthermore, they investigated pharmacological profiles of enzymes predicted to be important for maturation based on their metabolomic analyses and ascertained the central role of PLA2 in inducing oocyte maturation downstream of P4. They showed the modulation of S1P/S1PR3 pathway on oocyte maturation and the potential role for Gαs signaling and potentially Gβγ downstream of P4.

Strengths:

The authors make a very interesting finding that ABHD2 has PLA2 catalytic activity but only in the presence of mPRβ and P4. Finally, they provided supporting data for a relationship between ABHD2/PLA2 activity and mPRβ endocytosis and further downstream signaling. Collectively, this research report defines early steps in nongenomic P4 signaling, which has broad physiological implications.

Weaknesses:

There were concerns with the pharmacological studies presented. Many of these inhibitors are used at high (double-digit micromolar) concentrations that could result in non-specific pharmacological effects and the authors have provided very little data in support of target engagement and selectivity under the multiple experimental paradigms. In addition, the use of an available ABHD2 small molecule inhibitor was lacking in these studies.

Reviewer #1 (Public Review):

Summary:

In this study, Yue et al. re-processed publicly available DNA methylation data (published in 2012 and 2017 from the Meissner lab) from pre- and post-implantation mouse embryos. Against the global wave of genome-wide reduction of DNA methylation occurring during pre-implantation development, they detected a slight increase (~1% on average) of DNA methylation at gene promoter regions during the transition from 8-cell to blastocyst stage. They claim that many such promoters are located in the X chromosome. Subsequently, they knocked down Dnmt3b (presumably because of its upregulation during the transition from the 8-cell to blastocyst stage) and detected the aberrant patterning of H3K27me3 in the mutant female embryos. Based on this observation, they claim that imprinted X-chromosome inactivation is impaired in the Dnmt3b-Kd pre-implantation embryos. Finally, they propose a model where such an increase of DNA methylation together with H3K27me3 regulates imprinted X-chromosome inactivation in the pre-implantation embryos. While their observation is of potential interest, the current version of the work fails to provide enough evidence to support their conclusions. Below are suggestions and comments on the manuscript.

Major issues:

1. Sex of the embryos of the genome-wide bisulfite-sequencing data<br /> The authors re-analyzed publicly available genome-wide DNA methylation data from the Meissner lab published in 2012 and 2017. The former used reduced representation bisulfite sequencing (RRBS) and the latter used whole-genome bisulfite sequencing (WGBS). Based mainly on the RRBS data, Yue et al. detected de novo DNA methylated promoters during the transition from 8-cell to blastocyst against the global wave of genome-wide DNA demethylation. They claim that such promoter regions are enriched at the "inactive" X chromosome. However, it would be difficult to discuss DNA methylation at inactive X-chromosomes as the RRBS data were derived from a mixture of male and female embryos. It would also be notable that the increase of DNA methylation at these promoter regions is ~1% on average. Such a slight increase in DNA methylation during pre-implantation development could also be due to the developmental variations between the embryos or between the sexes of embryos.

2. Imprinted X-chromosome inactivation and evaluation of H3K27me3 (related to Figures 2C, D; 3F; Figure2-supplement 2 F, G; Figure3-supplement 3G)<br /> Based on the slight change in the H3K27me3 signals in the Dnmt3b-Kd blastocysts, the authors claim that imprinted X-chromosome inactivation is impaired in the mutant embryo. It would be not easy to reach this conclusion from such a rough analysis of H3K27me3 presented in Figure 2C, D. Rigorous quantification/evaluation of the H3K27me3 signals in the Dnmt3b-Kd embryos should be considered. Additional evidence for the impairment of H3K27me3 in the mutant embryos should also be provided (expression of a subset of X-linked genes by RNA-FISH or RT-PCR etc.). Though technically challenging, high-resolution genome-wide approach such as ChIP-seq of H3K27me3 in the Dnmt3b-kd female embryos (with traceable SNPs between maternal and paternal X chromosome to distinguish inactive and active X-chromosome) could more precisely evaluate regions that lose H3K27me3 in the X-chromosome (de novo DNA methylated promoters from 8-cell to blastocyst, for example).

3. Analysis of the developmental potential of Dnmt3b-kd embryos<br /> While the authors claim that Dnmt3b-mediated de novo DNA methylation plays an important role in imprinted X-chromosome inactivation, it remains unclear whether the analysis presented in Figure 4 is derived from "female" embryos. This analysis seemed confusing as the authors claim that de novo DNA methylation in the promoter regions during the transition from 8-cell to blastocyst regulates imprinted X-chromosome inactivation, but this should not happen in the male embryos. Was the impairment of embryonic proliferation and differentiation observed in both male and female embryos? Or is this specific to the female embryos? We think that the sex of the embryos would be critical for the analysis presented in Figure 4.

Reviewer #2 (Public Review):

Summary:

Here, Yue et al. set out to determine if the low DNMT3B expression that is observed prior to de novo DNA methylation (before the blastocyst stage) has a function. Re-analyzing existing DNA methylation data from Smith et al. (2012) they find a small DNA methylation gain over a subset of promoters and gene bodies, occurring between the 8-cell and blastocyst stages, and refer to this as "minor de novo DNA methylation". They attempt to assess the relevance/functionality of this minor DNA methylation gain, and report reduced H3K27me3 in Dnmt3b knockdown (KD) trophoblast cells that normally undergo imprinted X-chromosome inactivation (iXCI) before the blastocyst stage. In addition, they assess the proliferation, differentiation, metabolic function, implantation rate, and live birth rate of Dnmt3b KD blastocysts.

Strengths:

Working with early embryos is technically demanding, making the well-designed experiments from this manuscript useful to the epigenetics community. Particularly, the DNMT3B expression and 5-mC staining at different embryonic stages.

Weaknesses:

- Throughout the manuscript, please represent DNA methylation changes as delta DNA methylation instead of fold change.

- Detailed methods on the re-analysis of the DNA methylation data from Smith et al. 2012 are missing from the materials and methods section. Was a minimum coverage threshold used?

- Detailed methods on the establishment and validation of Dnmt3b KO blastocysts and 5-aza-dC treated blastocysts are missing (related to Figure 2).

- Detailed methods on the re-analysis of the ChIPseq data from Liu et al. 2016 are missing from the materials and methods section.

- Some of the data represented in bar graphs does not look convincing/significant. Maybe this data can be better represented differently, such as in box plots or violin plots, which would better represent the data.

- The relevance and rationale for experiments using 5-aza-dC treatment is unclear.

Reviewer #1 (Public Review):

Summary:

This manuscript reports experiments designed to dissect the function of N-cadherin during mammalian folliculogenesis, using the mouse as a model system. Prior studies have shown that this is the principal cadherin expressed by the follicular granulosa cells. Two main strategies are used - small-molecule inhibitors that target N-cadherin and a conditional knockout where the gene encoding N-cad is deleted in granulosa cells. The authors also take advantage of the ability to reproduce key events of folliculogenesis, such as oocyte meiotic maturation, in vitro. Four main conclusions are drawn from the studies: (i) cadherin-based cell contact is required to maintain cadherin (N-cad in the granulosa cells; E-cad in the oocyte) at the plasma membrane; (ii) N-cad is required for cumulus layer expansion; (iii) N-cad is required for meiotic maturation of the oocyte; (iv) N-cad is required for ovulation.

Strengths:

The experiments are logically conceived, clearly described and presented, and carefully interpreted. A key strength of the paper is that multiple approaches have been used (drugs, knockouts, immunofluorescence, PLA, in vitro and in vivo studies). Taken together, they clearly establish essential roles for N-cadherin during folliculogenesis.

It is intriguing that, when cadherin activity is impaired, the cadherins are lost from the plasma membrane. This suggests that, in a multicellular context, interactions with other cadherins, either in cis within the same cell or in trans with a neighboring cell, are required to maintain cadherins at the membrane. Hence, beyond their significance for understanding female reproductive biology, these experiments have broader implications for cell biology.

Weaknesses:

A few points could be considered or clarified by the authors:

The YAP experiments were confusing to the reviewer. CRS-066 increased YAP activity, as indicated by increased expression of target genes. Since CRS-066 prevents expansion, this result suggests that YAP antagonizes expansion. Therefore, blocking YAP should favor expansion. Yet, the YAP inhibitor impaired expansion. In the reviewer's eyes, these results seem to be contradictory.

It is intriguing that the inhibitors were able to efficiently block oocyte maturation. Oocytes from which the cumulus granulosa cells have been removed (denuded) will mature in vitro in the absence of LH or EGF. Since the effect of the inhibitors is to break the contact between the cumulus cells and oocyte, one might have predicted that this would not impair the ability of the oocytes to mature. Perhaps the authors could comment on this.

Regarding the experiments where the inhibitors were administered intra-peritoneally, the authors might comment on the rationale for choosing the doses that were used. An additional point to consider is that, since N-cadherin is expressed in a variety of tissues, an effect of interfering with N-cadherin at these non-ovarian sites could indirectly influence ovarian function.

Reviewer #2 (Public Review):

Summary:

The manuscript entitled "N-cadherin mechanosensing in ovarian follicles controls oocyte maturation and ovulation" aimed to investigate the role of N-cadherin in different ovarian physiological processes, including cumulus oocyte expansion, oocyte maturation, and ovulation. The authors performed several in vitro and in vivo mice experiments, using diverse techniques to reinforce their results.

First, they identified two compounds (N-cadherin antagonists) that block the adhesion of periovulatory COCs to fibronectin through screening a small molecule library, using the xCELLigenceTM system, performing proper and complementary controls. Second, the authors showed the presence of N-cadherin adherens junctions between granulosa cells and cumulus cells and at the interface of cumulus cell transzonal projections and the oocyte throughout folliculogenesis. And that these adherens complexes between cumulus cells and oocytes were disrupted when inhibited N-cadherin, as observed by nice representative confocal images. Then, the authors assessed COC expansion and oocyte meiotic maturation to determine whether the loss of oocyte membrane β-catenin and E-cadherin upon N-cadherin inhibitor treatment disrupts the bi-directional communication between cumulus cells and the oocyte. Indeed, N-cadherin antagonists disrupted both processes (cumulus expansion and oocyte meiotic). However, the expression of known mediators of COC expansion (E.g., Areg and Ptgs2) were either increased or unaffected. Nevertheless, RNA-Seq showed consistent effects on cell signaling mRNA genes by the antagonist CRS-066.

In vivo studies using mice were also achieved using stimulated protocols (together with one of the antagonists or vehicle) or granulosa-specific Cdh2 Knockouts to further analyze the role of N-cadherin. N-cadherin antagonist CRS-066 (but not LCRF-0006) significantly reduced mouse ovulation compared to controls. RNA-sequencing data analysis identified distinct gene expression profiles in CRS-066 treated compared to control ovaries. Ovulation in CdhFl/FL; Amhr2Cre mice after stimulation were also significantly reduced; multiple large unruptured follicles were observed in these granulosa-specific Cdh2 mutant ovaries, and the mRNA expression of Areg and Ptgs2 were reduced.

The authors conclude that their study identified N-cadherin as a mechanosensory regulator important in ovarian granulosa cell differentiation able to respond to hormone stimuli both in vivo and in vitro, demonstrating a critical role for N-cadherin in ovarian follicular development and ovulation. They highlighted the potential to inhibit ovulation by targeting this signaling mechanism.

Strengths:<br /> This remarkable manuscript is very well designed, performed, and discussed. The authors analyzed different aspects, and their data supports their conclusions.

Weaknesses:<br /> This study was performed using the mouse as a research model; further studies in larger animals and humans would be interesting and warranted.

Minor comments:

Some results are intriguing. While the AREG y PTGS2 mRNA increased within the COC in vitro by the N-cadherin antagonists, in vivo, the treatment induced a significant increase in both genes when analyzing the whole ovary. What are the authors' ideas that could explain these discrepancies in outcomes?

The authors stated that the ovaries from mice treated in the same manner and collected either before hCG treatment (eCG 44 h) or 11 h after hCG showed equivalent numbers of follicles at each stage of development from primary to antral. However, in Panel l from Figure 5, there is a significant increase in the number of antral follicles in the CRS-066 group (hCG 11 h) compared to the vehicle. Could the author discuss it in the manuscript?

Reviewer #1 (Public Review):

Weinberger et al. use different fate-mapping models, the FIRE model and PLX-diet to follow and target different macrophage populations and combine them with single-cell data to understand their contribution to heart regeneration after I/R injury. This question has already been addressed by other groups in the field using different models. However, the major strength of this manuscript is the usage of the FIRE mouse model that, for the first time, allows specific targeting of only fetal-derived macrophages.

The data show that the absence of resident macrophages is not influencing infarct size but instead is altering the immune cell crosstalk in response to injury, which is in line with the current idea in the field that macrophages of different origins have distinct functions in tissues, especially after an injury.

To fully support the claims of the study, specific targeting of monocyte-derived macrophages or the inhibition of their influx at different stages after injury would be of high interest.

In summary, the study is well done and important for the field of cardiac injury. But it also provides a novel model (FIRE mice + RANK-Cre fate-mapping) for other tissues to study the function of fetal-derived macrophages while monocyte-derived macrophages remain intact.

Reviewer #2 (Public Review):

In this study Weinberger et al. investigated cardiac macrophage subsets after ischemia/reperfusion (I/R) injury in mice. The authors studied a ∆FIRE mouse model (deletion of a regulatory element in the Csf1r locus), in which only tissue resident macrophages might be ablated. The authors showed a reduction of resident macrophages in ∆FIRE mice and characterized its macrophages populations via scRNAseq at baseline conditions and after I/R injury. 2 days after I/R protocol ∆FIRE mice showed an enhanced pro inflammatory phenotype in the RNAseq data and differential effects on echocardiographic function 6 and 30 days after I/R injury. Via flow cytometry and histology the authors confirmed existing evidence of increased bone marrow-derived macrophage infiltration to the heart, specifically to the ischemic myocardium. Macrophage population in ∆FIRE mice after I/R injury were only changed in the remote zone. Further RNAseq data on resident or recruited macrophages showed transcriptional differences between both cell types in terms of homeostasis-related genes and inflammation. Depleting all macrophage using a Csf1r inhibitor resulted in a reduced cardiac function and increased fibrosis.

Reviewer #1 (Public Review):

Summary:

In this manuscript by Xiong L et al., the authors have uncovered an important link between innate immune signaling and hair regeneration. The authors provide convincing evidence supporting the critical roles of TLR2 in sensing CEP levels in hair follicles, counteracting the action of BMP signaling, and facilitating the activation of HFSCs during the hair cycle and wound repair. Importantly, the authors also propose that decreased CEP production and TLR2 expression might be factors contributing to the decreased hair regeneration associated with aging.

Strengths:

The experiments in this manuscript are well-designed and presented. The authors provided extensive evidence supporting the roles of TLR2 signaling in regulating hair follicle stem cell functions. Importantly, the findings from this paper could have sustained impacts on our understanding of the roles of innate immunity in regulating tissue regeneration in the absence of inflammation.

Weaknesses:

1. The central conclusion of this study is that the activation of TLR2 can suppress BMP signaling. However, the molecular link between TLR2 and BMP signaling is still missing. Given the importance of this finding, it would be intriguing to further investigate how TLR2 activation suppresses BMP signaling. A better characterization of the molecular-level interaction between TLR2 and BMP signaling can further enhance the impact of this study.

2. The authors imply that the decreased CEP level in aged mice could lead to deficient TLR2 signaling, which could further cause aging-associated hair regeneration defects. But this has not been demonstrated. What are the BMPs and pSmad1/5 levels in aged skin? Another important experiment to confirm the importance of this link during aging would be to inject CEP into the aged skin and examine whether this could restore hair regeneration in aged mice.

3. The impacts of CEP/TLR2 on proliferation of keratinocytes is still weak. How much of this effect is a result of NFkB activation, and how much is simply due to inhibiting BMP signaling?

Updated comments on the revised manuscript:<br /> The authors have addressed my previous questions.

Reviewer #3 (Public Review):

Summary:

In the manuscript by Xiong and colleagues, the roles of TLR2 in hair follicle cycle regulation were investigated. By analyzing published dataset and using immunostaining and transgenic TLR2-GFP reporter mice, the authors showed that TLR2 expression is increased in the late telogen compared to the early telogen, implying that it is important for the transition between telogen to anagen hair cycle. They found that the genetic deletion of Tlr2 in hair follicle stem cells delays hair cycle entry in both homeostatic and wound-induced hair follicle regeneration. In addition, they found that CEP is an endogenous TLR2 activating ligand and triggers the progression of hair cycle in a TLR2-dependent manner. Mechanistically, the activation of TLR2 signaling antagonizes BMP signaling which is critical for the maintenance of hair follicle stem cell quiescence. Clinically, they showed that TLR2 expression is decreased in aging and high-fat diet condition, suggesting that the dysfunctional regulation of TLR2 pathway is responsible for age-related and obesity-related hair thinning and hair loss phenotypes.

Strengths:

Overall, this study presents the role and mechanism of TLR2 in regulating hair follicle regeneration. The functional interrogation parts using HFSC-specific TLR2 genetic deletion is solid, and an endogenous regulator, CEP, is identified.

Weaknesses:<br /> 1)<br /> - In SFig1A, the IF staining of TLR2 and Tlr2-GFP expression seem almost 100% co-localized, which is not usual experimentally.<br /> - In Fig 2J, the relative expression levels of Tlr2 in anagen, telogen, catagen HFSCs were tested. But it is just relative comparison and does not mean whether the expression level is meaningful or not. To make this convincing, adding other cell types such as dermal fibroblasts and immunes to the comparison as negative and positive controls would be a good idea.<br /> - In Fig 2K, the expression of Tlr2 is comparable or a bit lesser in epidermal cells and HFSCs, but the expressions of TLR2 (IF) and Tlr2-GFP in epidermal cells have not been presented at all in the manuscript. As the authors used K15-CrePR1 mice to delete Tlr2 in HFSCs specifically, showing TLR2 IF staining in TLR2-HFSC-KO mice would be nice evidence of significant expression of TLR2 in HFSCs. (still TLR2 expression in epidermis, but no TLR2 expression in HFSCs).<br /> - In Fig 1B, it is still unclear whether TLR2 staining is in epithelial cell or in dermal cells. TLR2 staining patterns in Fig 1B, SFig 1A, and rebuttal seem different. In Fig S1B and rebuttal, TLR2 expression in HFSCs, HG, DP cells, but in Fig 1B, most of HG and DP cells are not TLR2+.<br /> - Together, this reviewer still does not think that there is a clear and solid evidence of Tlr2 expression in HFSCs. Searching the Tlr2 expression in published bulk and single cell RNA-seq dataset would be helpful.

2)<br /> - In SFig 4B, C, the activation of BMP signaling was hindered by TLR2 signaling activation by PAM3CSK4. But it is in vitro data, and cultured HFSCs are different from in vivo HFSCs, and particularly the changes of HFSCs from quiescence to activation can hardly be recapitulated in vitro.<br /> - In Fig 4H, it is curious that in TLR2-HFSC-KO mice, P21 HFSCs showed no pSMAD1/5/9, but it is increased in P24.<br /> - Also, it is wondered that if ID1 and ID2, key target genes, are increased in TLR2-HFCS-KO.<br /> - The author suggested that BMP7 is a key connection between TLR2 signaling and BMP signaling. It is curious whether BMP7 is a direct target of TLR2 pathway? Are there Nfkb (putative) binding sites in cis-regulatory regions of BMP7?

3)<br /> - In Fig 6C, CEP expression is close to hair follicle in both anagen and telogen. Also, in Telogen, CEP expression is strong and very close to HFSCs. But In rebuttal Fig 2, CEP is localized to sebaceous gland, where MPO, a CEP producing enzyme, is expressed. Which one is correct? Also, if CEP is strongly expressed in Telogen (Fig 6C), how can HFSCs stay in quiescence with decreased BMP signaling?

Reviewer #1 (Public Review):

Summary:

In the article titled "Hammerhead-type FXR agonists induce an eRNA FincoR that ameliorates nonalcoholic steatohepatitis in mice," the authors explore the role of the Farnesoid X Receptor (FXR) in treating metabolic disorders like NASH. They identify a new liver-specific long non-coding RNA (lncRNA), FincoR, regulated by FXR, notably induced by agonists such as tropifexor. The study shows that FincoR plays a significant role in enhancing the efficacy of tropifexor in mitigating liver fibrosis and inflammation associated with NASH, suggesting its potential as a novel therapeutic target. The study makes a promising contribution to understanding the role of FincoR in alleviating liver fibrosis in NASH, providing initial insights into the mechanisms involved. While it offers a valuable starting point, there is potential for further exploration into the functional roles of FincoR and their specific actions in human NASH cases. Building upon the current findings to elucidate more detailed mechanistic pathways through which FincoR exerts its therapeutic effects in liver disease would elevate the research's significance and potential impact in the field.

Strengths:

This study stands out for its comprehensive and unbiased approach to investigating the role of FincoR, a liver-specific lncRNA, in the treatment of NASH. Key strengths include: 1) The application of advanced sequencing methods like GRO-seq and RNA-seq offered a comprehensive and unbiased view of the transcriptional changes induced by tropifexor, particularly highlighting the role of FincoR. 2) Utilizing a genetic mouse model of FXR KO and a FincoR liver-specific knockdown (FincoR-LKD) mouse model provided a controlled and relevant environment for studying NASH, allowing for precise assessment of tropifexor's therapeutic effects. 3) The inclusion of tropifexor, an FDA-approved FXR agonist, adds significant clinical relevance to the study. It bridges the gap between experimental research and potential therapeutic application, providing a direct pathway for translating these findings into real-world clinical benefits for NASH patients. 4) The study's rigorous experimental design, incorporating both negative and positive controls, ensured that the results were specifically attributable to the action of FincoR and tropifexor.

Weaknesses:

The study presents several notable weaknesses that could be addressed to strengthen its findings and conclusions: 1) The authors focus on FincoR, but do not extensively test other lncRNAs identified in Figure 1A. A more comprehensive approach, such as rescue experiments with these lncRNAs, would provide a better understanding of whether similar roles are played by other lncRNAs in mitigating NASH. 2) FincoR was chosen for further study primarily because it is the most upregulated lncRNA induced by GW4064. Including another GW4064-induced lncRNA as a control in functional studies would strengthen the argument for FincoR's unique role in NASH. 3) The study does not conclusively demonstrate whether FincoR is specifically expressed in hepatocytes or other liver cell types. Conducting FincoR RNA-FISH with immunofluorescent experiments or RT-PCR, using markers for different liver cell types, would clarify its expression profile. 4) Understanding the absolute copy number of FincoR is crucial. Determining whether there are sufficient copies of FincoR to function as proposed would lend more credibility to its suggested role. 5) The manuscript, although technically proficient, does not thoroughly address the relevance of these findings to human NASH. Questions like the conservation of FincoR in humans and its potential role in human NASH should be discussed.

Reviewer #2 (Public Review):

Summary:

Nonalcoholic fatty liver disease (NASH), recently renamed as metabolic dysfunction-associated steatohepatitis (MASH) is a leading cause of liver-related death. Farnesoid X receptor (FXR) is a promising drug target for treating NASH and several drugs targeting FXR are under clinical investigation for their efficacy in treating NASH. The authors intended to address whether FXR mediates its hepatic protective effects through the regulation of lncRNAs, which would provide novel insights into the pharmacological targeting of FXR for NASH treatment. The authors went from an unbiased transcriptomics profiling to identify a novel enhancer-derived lncRNA FincoR enriched in the liver and showed that the knockdown of FincoR in a murine NASH model attenuated part of the effect of tropifexor, an FXR agonist, namely inflammation and fibrosis, but not steatosis. This study provides a framework for how one can investigate the role of noncoding genes in pharmacological intervention targeting known protein-coding genes. Given that many disease-associated genetic variants are located in the non-coding regions, this study, together with others, may provide useful information for improved and individualized treatment for metabolic disorders.

Strengths:

The study leverages both transcriptional profile and epigenetic signatures to identify the top candidate eRNA for further study. The subsequent biochemical characterization of FincoR using FXR-KO mice combined with Gro-seq and Luciferase reporter assays convincingly demonstrates this eRNA as a FXR transcriptional target sensitive to FXR agonists. The use of in vitro culture cells and the in vivo mouse model of NASH provide multi-level evaluation of the context-dependent importance of the FincoR downstream of FXR in the regulation of functions related to liver dysfunction.

Weaknesses:

As discussed, future work to dissect the mechanisms by which FincoR facilitates the action of FXR and its agonists is warranted. It would be helpful if the authors could base this on the current understanding of eRNA modes of action and the observed biochemical features of FincoR to speculate potential molecular mechanisms explaining the observed functional phenotype. It is unclear if this eRNA is conserved in humans in any way, which will provide relevance to human disease. Additionally, the eRNA knockdown was achieved by deletion of an upstream region of the eRNA transcription. A more direct approach to alter eRNA levels, e.g., overexpression of FincoR in the liver would provide important data to interpret its functional regulation.

Reviewer #1 (Public Review):

Glaucoma is the leading cause of irreversible blindness worldwide, affecting more than 80 million people. Primary open angle glaucoma (POAG) is the prevalent form of glaucoma, while prevalence of primary angle closure glaucoma (PACG) is highest in Asia compared to over the world. Early detection of glaucoma and severity prediction is mandatory, and therefore the main aim of this study focused on characterizing the metabolite profile associated with PACG, identify potential blood diagnostic markers, assess their specificity for PACG and verify their applicability to predict progression of visual field loss. To this end, Li et al. implemented a 5-phases multicenter prospective study to identify novel candidate biomarkers of PACG. A total of 616 individuals were recruited, identifying 1464 distinct metabolites in the serum by metabolomics and chemiluminescence immunoassays. By applying different machine learning algorithms the metabolite androstenedione showed good discrimination between PACG and control subjects, both the discovery and validation phases. This metabolite also showed alterations in the aqueous humor and higher levels of androstenedione seemed to be associated with faster loss of visual field. Overall, the authors claimed that serum androstenedione levels may provide a new biomarker for early detection and monitoring/predicting PACG severity/progression.

Strengths:

• Omics research on glaucoma is constrained by inadequate sample sizes, a dearth of validation sets to corroborate findings and absence of specificity analyses. The 5-phases study designed try overcoming these limitations. The proposed study design is very robust, with well described discovery set (1 and 2), validation phase (1 and 2), supplemental phase and cohort phase. Large and well-characterized patients with adequate control subjects contributed to the robustness of the results.<br /> • Combining untargeted and targeted metabolomics using mass spectrometry instruments (high resolution and low resolution) with an additional chemiluminiscence immunoassay determining androstenedione levels<br /> • Androstenedione achieved better diagnostic accuracy across the discovery and validation sets, with AUC varying between 0.85 and 1.0. Interestingly, baseline androstenedione levels can predict glaucoma progression via visual field loss results.<br /> • Positive correlation was observed between levels of androstenedione in serum and aqueous humor of PACG patients.<br /> • A level higher of 1.66 ng/mL of the metabolite androstenedione seems to imply high risk of visual field loss. Androstenedione may serve as predictor of glaucomatous visual field progression.

Weaknesses:

• A single biomarker seems very unlikely to be of much help in the detection of glaucoma due to the etiological heterogeneity of the disease, the existence of different subtypes, and the genetic variability among patients. Rather, a panel of biomarkers may provide more useful information for clinical prediction, including better sensitivity and specificity. The inclusion of additional metabolites already identifying in the study, in combination, may provide more reliable and correct assignment results.<br /> • The number of samples in the supplementary phase is low, larger samples sizes are mandatory to confirm the diagnostic accuracy.<br /> • Cohorts from different populations are needed to verify the applicability of this candidate biomarker.<br /> • Sex hormones seem to be associated also with other types of glaucoma, such as primary open-angle glaucoma (POAG), although the molecular mechanisms are unclear (see doi:10.1167/iovs.17-22708). The inclusion of patients diagnosed with other subtypes of glaucoma, like POAG, may contribute to determine the sensitivity and specificity of the proposed biomarker. Androstenedione levels should be determined in POAG, NTG or PEXG patients.<br /> • In addition, the levels of androstenedione were found significantly altered during other diseases as described by the authors or by conditions like polycystic ovary syndrome, limiting the utility of the proposed biomarker.<br /> • Uncertainty of the androstenedione levels compromises its usefulness in clinical practice.

Reviewer #2 (Public Review):

Summary:

The objective of authors using metabolomics analysis of primary angle closure glaucoma (PACG) is to demonstrate that serum androstenedione is a novel biomarker that can be used to diagnose PACG and predict visual field progression.

Strengths:

Use of widely targeted and untargeted metabolite detection conditions. Use of liquid chromatography-tandem mass spectrometry and a chemiluminescence method for confirmation of androstenedione.

The authors have incorporated the relevant changes in their manuscript and improved the presentation.

Reviewer #1 (Public Review):

The authors of the manuscript "High-resolution kinetics of herbivore-induced plant volatile transfer reveal tightly clocked responses in neighboring plants" assessed the effects of herbivory induced maize volatiles on receiver plants over a period of time in order to assess the dynamics of the responses of receiver plants. Different volatile compound classes were measured over a period of time using PTR-ToF-MS and GC-MS, under both natural light:dark conditions, and continuous light. They also measured gene expression of related genes as well as defense related phytohormones. The effects of a secondary exposure to GLVs on primed receiver plants was also measured.

The paper addresses some interesting points, however some questions arise regarding some of the methods employed. Firstly, I am wondering why VOCs (as measured by GC-MS) were not quantified. While I understand that quantification is time consuming and requires more work, it allows for comparisons to be made between lines of the same species, as well as across other literature on the subject. Simply relying on the area under the curve and presenting results using arbitrary units is not enough for analyses like these. AU values do not allow for conclusions regarding total quantities, and while I understand that this is not the main focus of this paper, it raises a lot of uncertainty for readers (for example, the references cited show that TMTT has been found to accumulate at similar levels of caryophyllene, however the AU values reported are an order of magnitude higher for TMTT. Again, without actual quantification this is meaningless, but for readers it is confusing).

With regards to the correlation analyses shown in figure 6, the results presented in many of the correlation plots are not actually informative. While there is a trend, I do not think that this is an appropriate way to show the data, as there are clearly other relationships at play. The comparison between plants under continuous light and normal light:dark conditions is interesting.

This paper addresses a very interesting idea and I look forward to seeing further work that builds on these ideas.

Reviewer #2 (Public Review):

The exact dynamics of responses to volatiles from herbivore-attacked neighbouring plants have been little studied so far. Also, we still lack evidence whether herbivore-induced plant volatiles (HIPVs) induce or prime plant defences of neighbours. The authors investigated the volatile emission patterns of receiver plants that respond to the volatile emission of neighbouring sender plants which are fed upon by herbivorous caterpillars. They applied a very elegant approach (more rigorous than the current state-of-the-art) to monitor temporal response patterns of neighbouring plants to HIPVs by measuring volatile emissions of senders and receivers, senders only and receivers only. Different terpenoids were produced within 2 h of such exposure in receiver plants, but not during the dark phase. Once the light turned on again, large amounts of terpenoids were released from the receiver plants. This may indicate a delayed terpene burst, but terpenoids may also be induced by the sudden change in light. As one contrasting control, the authors also studied the time-delay in volatile emission when plants were just kept under continuous light. Here they also found a delayed terpenoid production, but this seemed to be lower compared to the plants exposed to the day-night-cycle. Another helpful control was now performed for the revision in which the herbivory treatment was started in the evening hours and lights were left on. This experiment revealed that the burst of terpenoid emission indeed shifted somewhat. Circadiane and diurnal processes must thus interact.

Interestingly, internal terpene pools of one of the leaves tested here remained more comparable between night and day, indicating that their pools stay higher in plants exposed to HIPVs. In contrast, terpene synthases were only induced during the light-phase, not in the dark-phase. Moreover, jasmonates were only significantly induced 22 h after onset of the volatile exposure and thus parallel with the burst of terpene release.

An additional experiment exposing plants to the green leaf volatile (glv) (Z)-3-hexenyl acetate revealed that plants can be primed by this glv, leading to a stronger terpene burst. The results are discussed with nice logic and considering potential ecological consequences. All data are now well discussed.

Overall, this study provides intriguing insights in the potential interplay between priming and induction, which may co-occur, enhancing (indirect and direct) plant defence. Follow-up studies are suggested that may provide additional evidence.

Reviewer #1 (Public Review):

Summary:<br /> Overall, this study provides a meticulous comparison of developmental transcriptomes between two sub-species of the annelid Streblospio benedicti. Different lineages of S. benedicti maintain one of two genetically programmed alternative life histories, the ancestral planktotrophic or derived lecithotrophic forms of development. This contrast is also seen at the inter-species level in many marine invertebrate taxa, such as echinoderms and molluscs. The authors report relatively (surprisingly?) modest differences in transcriptomes overall but also find some genes whose expression is essentially morph-specific (which they term "exclusive").

Strengths:<br /> The study is based on a dense and appropriately replicated sampling of early development. The tight clustering of each stage/morph combination in PCA space suggests the specimens were accurately categorized. The similar overall trajectories of the two morphs were surprising to me for two stages: 1) the earliest stage (16-cell), at which we might expect maternal differences due to the several-fold difference in zygote size, and 2) the latest stage (1-week), where there appears to be the most obvious morphological difference. This is why we need to do experiments!

The examination of F1 hybrids was another major strength of the study. It also produced one of the most surprising results: though intermediate in phenotype, F1 embryos have the most distinct transcriptomes, and reveal a range of fixed, compensatory differences in the parental lines.

Weaknesses:<br /> Overall I really enjoyed this paper, but I see a few places where it can be tightened and made more insightful. These relate to better defining the basis for "exclusive" expression (regulation or gene presence/absence?), providing more examples of how specific genes related to trophic mode behave, and placing the study in the context of similar work in other phyla.

Reviewer #2 (Public Review):

The manuscript by Harry and Zakas determined the extent to which gene expression differences contribute to developmental divergence by using a model that has two distinct developmental morphs within a single species. Although the authors did collect a valuable dataset and trends in differential expression between the two morphs of S. benedicti were presented, we found limitations about the methods, system, and resources that the authors should address.

We have two major points:

1. Background information about the biological system needs to be clarified in the introduction of this manuscript. The authors stated that F1 offspring can have intermediate larval traits compared to the parents (Line 81). However, the authors collected F1 offspring at the same time as the mother in the cross. If offspring have intermediate larval traits, their developmental timeline might be different than both parents and necessitate the collection of offspring at different times to obtain the same stages as the parents. Could the authors (1) explain why they collected offspring at the same time as parents given that other literature and Line 81 state these F1 offspring develop at intermediate rates, and (2) add the F1 offspring to Figure 1 to show morphological and timeline differences in development?

Additionally, the authors state (Lines 83-85) that they detail the full-time course of embryogenesis for both the parents and the F1 crosses. However, we do not see where the authors have reported the full-time course for embryogenesis of the F1 offspring. Providing this information would shape the remaining results of the manuscript.

2. We have several concerns about the S. benedicti genome and steps regarding the read mapping for RNA-seq:

The S. benedicti genome used (Zakas et al. 2022) was generated using the PP morph. The largest scaffolds of this assembly correspond to linkage groups, showing the quality of this genome. The authors should point out in the Methods and/or Results sections that the quality of this genome means that PP-specific gene expression can be quantified well. However, the challenges and limitations of mapping LL-specific expression data to the PP genome should be discussed.

It is possible that the authors did not find exclusive gene expression in the LL morph because they require at least one gene to be turned on in one morph as part of the data-cleaning criteria. Because the authors are comparing all genes to the PP morph, they could be missing true exclusive genes responsible for the biological differences between the two morphs. Did they make the decision to only count genes expressed in one stage of the other morph because the gene models and mapping quality led to too much noise?

The authors state that the mapping rates between the two morphs are comparable (Supplementary Figure 1). However, there is a lot of variation in mapping the LL individuals (~20% to 43%) compared to the PP individuals. What is the level of differentiation within the two morphs in the species (pi and theta)? The statistical tests for this comparison should be added and the associated p-value should be reported. The statistical test used to compare mapping rates between the two morphs may be inappropriate. The authors used Salmon for their RNA alignment and differential expression analysis, but it is possible that a different method would be more appropriate. For example, Salmon has some limitations as compared to Kallisto as others have noted. The chosen statistical test should be explained, as well as how RNA-seq data are processed and interpreted.

What about the read mapping rate and details for the F1 LP and PL individuals? How did the offspring map to the P genome? These details should be included in Supplementary Figure 1. Could the authors also provide information about the number of genes expressed at each stage in the F1 LP and PL samples in S Figure 2? How many genes went into the PCA? Many of these details are necessary to evaluate the F1 RNA-seq analyses.

Generally, the authors need to report the statistics used in data processing more thoroughly. The authors need to report the statistics used to (1) process and evaluate the RNA-seq data and (2) determine the significance between the two morphs (Supplementary Figures 1 and 2).

Reviewer #2 (Public Review):

Summary:

Zhou et al report development of a new method, Rec-Seq, that allows rigorous quantitation of the efficiency of 48S ribosomal pre-initiation complex (PIC) formation on messenger RNAs at transcriptome scale in vitro. With a next-generation deep-sequencing approach, Rec-Seq allows precisely targeted dissection of the roles of translation initiation factors in PIC assembly. This level of molecular precision is important to understanding mechanisms of translational control, making Rec-Seq a significant methodological advance. The authors leverage Rec-Seq to investigate the relative roles of two key helicase enzymes, Ded1p and eIF4A. While past work has pointed to differing roles for Ded1p and eIF4A helicase activity in PIC assembly, unambiguous interpretation of prior in-vivo data has been hindered by technical requirements for performing the experiments in cells. Rec-Seq circumvents these challenges, providing robust mechanistic insights. The authors find that Ded1p stimulates PIC formation selectively on mRNAs with long, structured leaders in the Rec-Seq system, while eIF4A provides much more general stimulation across mRNAs. The findings substantiate the past in-vivo results, along with adding new insights. They contrast with evidence that Ded1p promotes translation by suppressing inhibitory upstream initiation through structural remodeling, or through formation of intracellular, phase-separated granules. The conclusions of the study are generally well-supported by the data.

Strengths:

The quantitative nature of Rec-Seq, which uses an internal standard to measure absolute recruitment efficiencies, is an important strength.

The methodology decisively overcomes past experimental limitations, allowing the authors to make clear conclusions with regard to the relative roles of Ded1p and eIF4A in PIC formation. An important and useful addition to the toolbox for studying translation and translational control mechanisms, Rec-Seq substantially expands the throughput and scope of mechanistic analyses for translation initiation.

One significant finding to emerge is that the in-vitro reconstituted system used here recapitulates effects of in-vivo perturbations of translation initiation. Despite the lack of a cellular environment and its components, PIC formation appears to operate much as it does in the cell. Importantly, this highlights an inherent "modularity" to the system that is especially of interest in the context of how regulatory machinery beyond the PIC may control translation.

Weaknesses:

Several findings in this report are quite surprising and may require additional work to fully interpret. Primary among these is the finding that Ded1p stimulates accumulation of PICs at internal site in mRNA coding sequences at an incidence of up to ~50%. The physiological relevance of this is unclear.

A limitation of the methodology is that, as an endpoint assay, Rec-Seq does not readily decouple effects of Ded1p on PIC-mRNA loading from those on the subsequent scanning step where the PIC locates the start codon. Considering that Ded1p activity may influence each of these initiation steps through distinct mechanisms - i.e., binding to the mRNA cap-recognition factor eIF4F, or direct mRNA interaction outside eIF4F - additional studies may be needed to gain deeper mechanistic insights.

As the authors note, the achievable Ded1p concentrations in Rec-Seq may mask potential effects of Ded1p-based granule formation on translation initiation. Additional factors present in the cell could potentially also promote this mechanism. Consequently, the results do not fully rule out granule formation as a potential parallel Ded1p-mediated translation-inhibitory mechanism in cells.

Reviewer #3 (Public Review):

Summary:

The manuscript of Zhou et al. reports a genome wide study of in vitro translation initiation using a novel version of ribosome profiling. Here they probe the role of the key RNA helicase, Ded1 in yeast translation initiation using a reconstituted biochemical system and all polyA+ mRNAs in the cell. The authors use ribosome profiling to identify mRNAs that assemble a preinitiation complex at the AUG start codon (48S PIC). They confirm that Ded1 is required for efficient initiation in highly structured RNAs, leading to an increase in PIC formation at the start codon, and nicely correlate their results with prior in vivo investigations using mutant Ded1s.

Strengths:

Rigorous in vitro biochemistry, careful correlation with in vivo results, genome wide analysis. Novel sequencing-based assay.

Weaknesses:

The slow nature of the biochemical experiments could bias results.

Reviewer #1 (Public Review):

Summary:

The authors have developed and optimized a footprinting assay to monitor the recruitment of mRNAs to a reconstituted translation initiation system. This assay is named Recruitment-Sequencing (Rec-Seq) and enables the analysis of many purified mRNAs in the reconstituted system.

This system possesses the ability to determine how competition occurs between mRNAs for the initiation machinery. This is the first approach using a reconstituted system that enables this important feature, and this is an important advance for the field.

Strengths:

Using purified mRNAs in a fully reconstituted system and being able to monitor start site selection is an important advance. The method enables one to observe changes in mRNA recruitment and start site selection in response to the absence or presence of different initiation components or accessory proteins.

Weaknesses:

Start site fidelity in purified reconstituted systems can be dramatically altered in different buffer conditions. Interpretation of the observed changes to start site selection in mRNAs in the absence or presence of Ded1 using only the one buffer condition used is therefore limited.

Reviewer #2 (Public Review):

The authors investigate the transcriptional regulation of cysteine dioxygenase (CDO-1) in C. elegans and its role in maintaining cysteine homeostasis. They show that high cysteine levels activate cdo-1 transcription through the hypoxia-inducible transcription factor HIF-1. Using transcriptional and translational reporters for CDO-1, the authors propose that a negative feedback pathway involving RHY-1, CYSL-1, EGL-9 and HIF-1 in regulating cysteine homeostasis.

Genetics is a notable strength of this study. The forward genetic screen, gene interaction and epistasis analyses are beautifully designed and rigorously conducted, yielding solid and unambiguous conclusions on the genetic pathway regulating CDO-1. The writing is clear and accessible, contributing to the overall high quality of the manuscript.<br /> Addressing the specifics of cysteine supplementation and interpretation regarding the cysteine homeostasis pathway would further clarify the paper and strengthen the study's conclusions.

First, the authors show that the supplementation of exogenous cysteine activates cdo-1p::GFP. Rather than showing data for one dose, the author may consider presenting dose-dependency results and whether cysteine activation of cdo-1 also requires HIF-1 or CYSL-1, which would be important data given the focus and major novelty of the paper in cysteine homeostasis, not the cdo-1 regulatory gene pathway. While the genetic manipulation of cdo-1 regulators yields much more striking results, the effect size of exogenous cysteine is rather small. Does this reflect a lack of extensive condition optimization or robust buffering of exogenous/dietary cysteine? Would genetic manipulation to alter intracellular cysteine or its precursors yield similar or stronger effect sizes?

Second, there remain several major questions regarding the interpretation of the cysteine homeostasis pathway. How much specificity is involved for the RHY-1/CYSL-1/EGL-9/HIF-1 pathway to control cysteine homeostasis? Is the pathway able to sense cysteine directly or indirectly through its metabolites or redox status in general? Given the very low and high physiological concentrations of intracellular cysteine and glutathione (GSH, a major reserve for cysteine), respectively, there is a surprising lack of mention and testing of GSH metabolism. In addition, what are the major similarities and differences of cysteine homeostasis pathways between C. elegans and other systems (HIF dependency, transcription vs post-transcriptional control)? These questions could be better discussed and noted with novel findings of the current study that are likely C. elegans specific or broadly conserved.

All of my comments and questions above have been satisfactorily addressed in the revised manuscript.

Reviewer #3 (Public Review):

There has been a long-standing link between the biology of sulfur-containing molecules (e.g., hydrogen sulfide gas, the amino acid cysteine, and its close relative cystine, et cetera) and the biology of hypoxia, yet we have a poor understanding of how and why these two biological processes and are co-regulated. Here, the authors use C. elegans to explore the relationship between sulfur metabolism and hypoxia, examining the regulation of cysteine dioxygenase (CDO1 in humans, CDO-1 in C. elegans), which is critical to cysteine catabolism, by the hypoxia inducible factor (HIF1 alpha in humans, HIF-1 in C. elegans), which is the key terminal effector of the hypoxia response pathway that maintains oxygen homeostasis. The authors are trying to demonstrate that (1) the hypoxia response pathway is a key regulator of cysteine homeostasis, specifically through the regulation of cysteine dioxygenase, and (2) that the pathway responds to changes in cysteine homeostasis in a mechanistically distinct way from how it responds to hypoxic stress.

Briefly summarized here, the authors initiated this study by generating transgenic animals expressing a CDO-1::GFP protein chimera from the cdo-1 promoter so that they could identify regulators of CDO-1 expression through a forward genetic screen. This screen identified mutants with elevated CDO-1::GFP expression in two genes, egl-9 and rhy-1, whose wild-type products are negative regulators of HIF-1, raising the possibility that cdo-1 is a HIF-1 transcriptional target. Indeed, the authors provide data showing that cdo-1 regulation by EGL-9 and RHY-1 is dependent on HIF-1 and that regulation by RHY-1 is dependent on CYSL-1, as expected from other published findings of this pathway. The authors show that exogenous cysteine activates cdo-1 expression, reflective of what is known to occur in other systems. Moreover, they find that exogenous cysteine is toxic to worms lacking CYSL-1 or HIF-1 activity, but not CDO-1 activity, suggesting that HIF-1 mediates a survival response to toxic levels of cysteine and that this response requires more than just the regulation of CDO-1. The authors validate their expression studies using a GFP knockin at the cdo-1 locus, and they demonstrate that a key site of action for CDO-1 is the hypodermis. They present genetic epistasis analysis supporting a role for RHY-1, both as a regulator of HIF-1 and as a transcriptional target of HIF-1, in offsetting toxicity from aberrant sulfur metabolism. The authors use CRISPR/Cas9 editing to mutate a key amino acid in the prolyl hydroxylase domain of EGL-9, arguing that EGL-9 inhibits CDO-1 expression through a mechanism that is largely independent of the prolyl hydroxylase activity.

Overall, the data seem rigorous, and the conclusions drawn from the data seem appropriate. The experiments test the hypothesis using logical and clever molecular genetic tools and design. The sample size is a bit lower than is typical for C. elegans papers; however, the experiments are clearly not underpowered, so this is not an issue. The paper is likely to drive many in the field (including the authors themselves) into deeper experiments on (1) how the pathway senses hypoxia and sulfur/cysteine/H2S using these distinct mechanisms/modalities, (2) how oxygen and sulfur/cysteine/H2S homeostasis influence one another, and (3) how this single pathway evolved to sense and respond to both of these stress modalities.

My previous concerns have been addressed. The authors are commended on an excellent body of research.

Reviewer #4 (Public Review):

Summary:<br /> This is a revised manuscript that describes a role for cdo-1 in regulating cellular cysteine levels. The authors show that expression of cdo-1, predicted to encode a cysteine dioxygenase, is regulated by HIF-1, the conserved hypoxia-induced transcription factor. The expression of cdo-1 is controlled by the RHY-1/CYSL-1/EGL-9/HIF-1 pathway that has been demonstrated to be involved in the response to H2S.

Strengths:<br /> The new finding of this study is that cdo-1, predicted to encode a cysteine dioxygenase, is expressed in the hypodermis and that hypodermal expression rescues at least one phenotype of the cdo-1(mg622) mutant (ability to survive toxic sulfite accumulation in Moco-deficient conditions). Using sulfite toxicity is an interesting reporter for cellular cysteine abundance.

Weaknesses:<br /> The authors claim more than once that the H2S/Cys responsive pathway is RHY-1 - CYSL-1 - EGL-9 - HIF-1. Their data don't seem to support this claim, as they show that Pcdo-1::GFP is induced in rhy-1 mutants incubated with cysteine. It is therefore not appropriate to claim that "HIF-1-induced cysteine catabolism requires the activity of rhy-1" that they include in the description of the model in Fig 6. There is simply no evidence at all that RHY-1 has any role in modulating the activity of CDO-1 other than through transcriptional activation via HIF-1.

I don't find the arguments that this pathway is required for cysteine homeostasis per se (as claimed in the last sentence of the introduction). The authors expose worms to excess cysteine for 48 hours in liquid culture with bacteria. It is well known in these conditions that the bacteria will produce H2S from the cysteine in the culture. All of the cysteine exposure data shown can be explained by the effect of H2S exposure. This would explain why hif-1 and cysl-1 mutants die but cdo-1 mutants do not, for example. The authors don't provide any data to rule out the possibility that bacterial H2S production underlies these results. This explains why the pathway described in this work is the same as has been previously described. Similarly, there is no evidence at all to support their assertion that there are "other pathways" induced by HIF-1 to deal with sulfite produced by cysteine catabolism. However, if the main problem is H2S production (perhaps by bacteria) then cdo-1 would not be relevant and the mutants would be viable as observed.

In a couple of places, the authors seem to argue that H2S-induced expression is limited to the hypodermis and hypoxia-induced gene expression is mostly in the intestine. This is consistent with the expression of cdo-1 (this work) and nhr-57 (Budde and Roth) but it is not appropriate to generalize this. Previous work from the Ruvkun lab (Ma et al) show that the CYSL-1 regulates expression of HIF-1 targets in neurons. Moreover, HIF-1 protein accumulates in the nucleus of nearly all cells, and there is no reason to believe that there are changes in the expression of other genes in different tissues.

Reviewer #1 (Public Review):

Summary:<br /> This study reports that IT neurons have biased representations toward low spatial frequency (SF) and faster decoding of low SFs than high SFs. High SF-preferred neurons, and low SF-preferred neurons to a lesser degree, perform better category decoding than neurons with other profiles (U and inverted U shaped). SF coding also shows more sparseness than category coding in the earlier phase of the response and less sparseness in the later phase. The results are also contrasted with predictions of various DNN models.

Strengths:<br /> The study addressed an important issue on the representations of SF information in a high-level visual area. Data are analyzed with LDA which can effectively reduce the dimensionality of neuronal responses and retain category information.

Weaknesses:<br /> The results are likely compromised by improper stimulus timing and unmatched spatial frequency spectrums of stimuli in different categories.

The authors used a very brief stimulus duration (35ms), which would degrade the visual system's contrast sensitivity to medium and high SF information disproportionately (see Nachmias, JOSAA, 1967). Therefore, IT neurons in the study could have received more degraded medium and high SF inputs compared to low SF inputs, which may be at least partially responsible for higher firing rates to low Sf R1 stimuli (Figure 1c) and poorer recall performance with median and high SF R3-R5 stimuli in LDA decoding. The issue may also to some degree explain the delayed onset of recall to higher SF stimuli (Figure 2a), preferred low SF with an earlier T1 onset (Figure 2b), lower firing rate to high SF during T1 (Figure 2c), somewhat increased firing rate to high SF during T2 (because weaker high SF inputs would lead to later onset, Figure 2d).

Figure 3b shows greater face coding than object coding by high SF and to a lesser degree by low SF neurons. Only the inverted-U-shaped neurons displayed slightly better object coding than face coding. Overall the results give an impression that IT neurons are significantly more capable of coding faces than coding objects, which is inconsistent with the general understanding of the functions of IT neurons. The problem may lie with the selection of stimulus images (Figure 1b). To study SF-related category coding, the images in two categories need to have similar SF spectrums in the Fourier domain. Such efforts are not mentioned in the manuscript, and a look at the images in Figure 1b suggests that such efforts are likely not properly made. The ResNet18 decoding results in Figure 6C, in that IT neurons of different profiles show similar face and object coding, might be closer to reality.

Reviewer #2 (Public Review):

Summary:<br /> This paper aimed to examine the spatial frequency selectivity of macaque inferotemporal (IT) neurons and its relation to category selectivity. The authors suggest in the present study that some IT neurons show a sensitivity for the spatial frequency of scrambled images. Their report suggests a shift in preferred spatial frequency during the response, from low to high spatial frequencies. This agrees with a coarse-to-fine processing strategy, which is in line with multiple studies in the early visual cortex. In addition, they report that the selectivity for faces and objects, relative to scrambled stimuli, depends on the spatial frequency tuning of the neurons.

Strengths:<br /> Previous studies using human fMRI and psychophysics studied the contribution of different spatial frequency bands to object recognition, but as pointed out by the authors little is known about the spatial frequency selectivity of single IT neurons. This study addresses this gap and they show that at least some IT neurons show a sensitivity for spatial frequency and interestingly show a tendency for coarse-to-fine processing.

Weaknesses and requested clarifications:<br /> 1. It is unclear whether the effects described in this paper reflect a sensitivity to spatial frequency, i.e. in cycles/ deg (depends on the distance from the observer and changes when rescaling the image), or is a sensitivity to cycles /image, largely independent of image scale. How is it related to the well-documented size tolerance of IT neuron selectivity?

2. The authors' band-pass filtered phase scrambled images of faces and objects. The original images likely differed in their spatial frequency amplitude spectrum and thus it is unclear whether the differing bands contained the same power for the different scrambled images. If not, this could have contributed to the frequency sensitivity of the neurons.

3. How strong were the responses to the phase-scrambled images? Phase-scrambled images are expected to be rather ineffective stimuli for IT neurons. How can one extrapolate the effect of the spatial frequency band observed for ineffective stimuli to that for more effective stimuli, like objects or (for some neurons) faces? A distribution should be provided, of the net responses (in spikes/s) to the scrambled stimuli, and this for the early and late windows.

4. The strength of the spatial frequency selectivity is unclear from the presented data. The authors provide the result of a classification analysis, but this is in normalized units so that the reader does not know the classification score in percent correct. Unnormalized data should be provided. Also, it would be informative to provide a summary plot of the spatial frequency selectivity in spikes/s, e.g. by ranking the spatial frequency bands for each neuron based on half of the trials and then plotting the average responses for the obtained ranks for the other half of the trials. Thus, the reader can appreciate the strength of the spatial frequency selectivity, considering trial-to-trial variability. Also, a plot should be provided of the mean response to the stimuli for the two analysis windows of Figure 2c and 2d in spikes/s so one can appreciate the mean response strengths and effect size (see above).

5. It is unclear why such brief stimulus durations were employed. Will the results be similar, in particular the preference for low spatial frequencies, for longer stimulus durations that are more similar to those encountered during natural vision?

6. The authors report that the spatial frequency band classification accuracy for the population of neurons is not much higher than that of the best neuron (line 151). How does this relate to the SNC analysis, which appears to suggest that many neurons contribute to the spatial frequency selectivity of the population in a non-redundant fashion? Also, the outcome of the analyses should be provided (such as SNC and decoding (e.g. Figure 1D)) in the original units instead of undefined arbitrary units.

7. To me, the results of the analyses of Figure 3c,d, and Figure 4 appear to disagree. The latter figure shows no correlation between category and spatial frequency classification accuracies while Figure 3c,d shows the opposite.

8. If I understand correctly, the "main" test included scrambled versions of each of the "responsive" images selected based on the preceding test. Each stimulus was presented 15 times (once in each of the 15 blocks). The LDA classifier was trained to predict the 5 spatial frequency band labels and they used 70% of the trials to train the classifier. Were the trained and tested trials stratified with respect to the different scrambled images? Also, LDA assumes a normal distribution. Was this the case, especially because of the mixture of repetitions of the same scrambled stimulus and different scrambled stimuli?

9. The LDA classifiers for spatial frequency band (5 labels) and category (2 labels) have different chance and performance levels. Was this taken into account when comparing the SNC between these two classifiers? Details and SNC values should be provided in the original (percent difference) instead of arbitrary units in Figure 5a. Without such details, the results are impossible to evaluate.

10. Recording locations should be described in IT, since the latter is a large region. Did their recordings include the STS? A/P and M/L coordinate ranges of recorded neurons?

11. The authors should show in Supplementary Figures the main data for each of the two animals, to ensure the reader that both monkeys showed similar trends.

12. The authors found that the deep nets encoded better the spatial frequency bands than the IT units. However, IT units have trial-to-trial response variability and CNN units do not. Did they consider this when comparing IT and CNN classification performance? Also, the number of features differs between IT and CNN units. To me, comparing IT and CNN classification performances is like comparing apples and oranges.

13. The authors should define the separability index in their paper. Since it is the main index to show a relationship between category and spatial frequency tuning, it should be described in detail. Also, results should be provided in the original units instead of undefined arbitrary units. The tuning profiles in Figure 3A should be in spikes/s. Also, it was unclear to me whether the classification of the neurons into the different tuning profiles was based on an ANOVA assessing per neuron whether the effect of the spatial frequency band was significant (as should be done).

14. As mentioned above, the separability analysis is the main one suggesting an association between category and spatial frequency tuning. However, they compute the separability of each category with respect to the scrambled images. Since faces are a rather homogeneous category I expect that IT neurons have on average a higher separability index for faces than for the more heterogeneous category of objects, at least for neurons responsive to faces and/or objects. The higher separability for faces of the two low- and high-pass spatial frequency neurons could reflect stronger overall responses for these two classes of neurons. Was this the case? This is a critical analysis since it is essential to assess whether it is category versus responsiveness that is associated with the spatial frequency tuning. Also, I do not believe that one can make a strong claim about category selectivity when only 6 faces and 3 objects (and 6 other, variable stimuli; 15 stimuli in total) are employed to assess the responses for these categories (see next main comment). This and the above control analysis can affect the main conclusion and title of the paper.

15. For the category decoding, the authors employed intact, unscrambled stimuli. Were these from the main test? If yes, then I am concerned that this represents a too small number of stimuli to assess category selectivity. Only 9 fixed + 6 variable stimuli = 15 were in the main test. How many faces/ objects on average? Was the number of stimuli per category equated for the classification? When possible use the data of the preceding selectivity test which has many more stimuli to compute the category selectivity.

Reviewer #1 (Public Review):

Summary:<br /> This manuscript dissects the contribution of the CaBP 1 and 2 on the calcium current in the cochlear inner hair cells. The authors measured the calcium current inactivation from the double knock-out CaBP1 and 2 and showed that both proteins contribute to voltage-dependent and calcium-dependent inactivation. Synaptic release was reduced in the double KO. As a consequence, the authors observed a depressed activity within the auditory nerve. Taken together, this study identifies a new player that regulates the stimulation-secretion coupling in the auditory sensory cells.

Strengths:<br /> In this study, the authors bring compelling evidence that CaBP 1 and 2 are both involved in the inactivation of the calcium current, from cellular up to system level, and by taking care to probe different experimental conditions such as different holding potentials and by rescuing the phenotype with the re-expression of CaBP2. Indeed, while changing the holding potential worsens the secretion, it completely changes the kinetics of the inactivation recovery. It alerts the reader that probing different experimental conditions that may be closer to physiology is better suited to uncovering any deleterious phenotype. This gave pretty solid results.

Weaknesses:<br /> Although this study clearly points out that CaBP1 is involved in the calcium current inactivation, it is not clear how CaBP1 and CaBP2 act together (but this is probably beyond the scope of the study). Another point is that the authors re-express CaBP2 to largely rescue the phenotype in the double KO but no data are available to know whether the re-expression of both CaBP1 and CaBP2 would achieve a full recovery and what would be the effect of the sole re-expression of CaBP1 in the double KO.

Reviewer #2 (Public Review):

Summary:<br /> In the manuscript by Oestreicher et al, the authors use patch-clamp electrophysiology, immunofluorescent imaging of the cochlea, auditory function tests, and single-unit recordings of auditory afferent neurons to probe the unique properties of calcium signaling in cochlear hair cells that allow rapid and sustained neurotransmitter release. The calcium-binding proteins (CaBPs) are thought to modify the inactivation of the Cav1.3 calcium channels in IHCs that initiate vesicle fusion, reducing the calcium-dependent inactivation (CDI) of the channels to allow sustained calcium influx to support neurotransmitter release. The authors use knockout mice of Cabp1 and Cabp2 in a double knockout (Cabp1/2 DKO) to show that these molecules are required for enabling sustained calcium currents by reducing CDI and enabling proper IHC neurotransmitter release. They further support their evidence by re-introducing Cabp2 using an injection of AAV containing the Cabp2 sequence into the cochlea, which restores some of the auditory function and reduces CDI in patch-clamp recordings.

Strengths:<br /> Overall the data is convincing that Cabp1/2 is required for reducing CDI in cochlear hair cells, allowing their sustained neurotransmitter release and sound encoding. Figures are well-prepared, recordings are careful and stats are appropriate, and the manuscript is well-written. The discussion appropriately considers aspects of the data that are not yet explained and await further experimentation.

Weaknesses:<br /> There are some sections of the manuscript that pool data from different experiments with slightly different conditions (wt data from a previous paper, different calcium concentrations, different holding voltages, tones vs clicks, etc). This makes the work harder to follow and more complicated to explain. However, the major conclusion, that cabp1 and 2 work together to reduce calcium-dependent inactivation of L-type calcium channels in cochlear inner hair cells, still holds.

Another weakness is that the authors used injections of AAV-containing sequences for Cabp2, but do not present data from sham surgeries. In most cases, the improvement of hearing function with AAV injection is believable and should be attributed to the cabp2 function. However, in at least one instance (Figure 4B), the results of the AAV injection experiments may be overinterpreted - the authors show that upon AAV injection, the hair cells have a much longer calcium current recovery following a large, long depolarization to inactivate the calcium channels. Without comparison to sham surgery, it is not known if this result could be a subtle result of the surgery or indeed due to the Cabp2 expression.<br /> It would be great to see the auditory nerve recordings in AAV-injected animals that have a recovery of ABRs. However, this is a challenging experiment that requires considerable time and resources, so is not required.

Reviewer #3 (Public Review):

Summary:<br /> The authors attempted to unravel the role of the Ca2+-binding proteins CaBP1 and CaBP2 for the hitherto enigmatic lack of Ca2+-dependent inactivation of Ca2+ currents in sensory inner hair cells (IHCs). As Ca2+ currents through Cav1.3 channels are crucial for exocytosis, the lack of inactivation of those Ca2+ currents is essential for the indefatigable sound encoding by IHCs. Using a deaf mouse model lacking both CaBP1 and CaBP2, the authors convincingly demonstrate that both CaBP1 and CaBP2 together confer a lack of inactivation, with CaBP2 being far more effective. This is surprising given the mild phenotype of the single knockouts, which has been published by the authors before. Re-admission of CaBP2 through viral gene transfer into the inner ear of double-knockout mice largely restored hearing function, normal Ca2+ current properties, and exocytosis.

Strengths:<br /> 1. In vitro electrophysiology: perforated patch-clamp recordings of Ca2+/Ba2+ currents of inner hair cells (IHCs) from 3-4 week-old mice - very difficult recordings - necessary to not interfere with intracellular Ca2+ buffers, including CaBP1 and CaBP2.<br /> 2. Capacitance (exocytosis) recordings from IHCs in perforated patch mode.<br /> 3. The insight that a negative holding potential might underestimate the impact of lack of CaBP1/2 on the inactivation of ICa in IHCs. As the physiological holding potential is much more positive than a preferred holding potential in patch clamp experiments it has a strong impact on inactivation in the pauses between depolarization mimicking receptor potentials.<br /> This truly advances our thinking about the stimulation of IHCs and accumulating inactivation of the Cav1.3 channels.<br /> 4. Insight that the voltage sine method with usual voltage excursions (35 mV) to determine the membrane capacitance (for exocytosis measurements) also favors the inactivated state of Cav1.3 channels<br /> 5. Use of double ko mice (for both CaBP1 and CaBP2, DKO) and use of DKO with virally injected CaBP2-eGFP into the inner ear.<br /> 6. Use of DKO animals/IHCs/SGNs after virus-mediated CaBP2 gene transfer shows a great amount of rescue of the normal ICa inactivation phenotype.<br /> 7. In vivo measurements of SGN AP responses to sound, which is highly demanding.<br /> 8. In vivo measurements of hearing thresholds, DPOAE characteristics, and ABR wave I amplitudes/latencies of DKO mice and DKO+injected mice compared to WT mice.

Very thorough analysis and presentation of the data, excellent statistical analysis.

The authors achieved their aims. Their results fully support their conclusions. The methods used by the authors are state-of-the-art.

The impacts on the field are the following:<br /> Regulation of inactivation of Cav1.3 currents is crucial for the persistent functioning of Cav1.3 channels in sensory transduction.<br /> The findings of the authors better explain the phenotype of the human autosomal recessive DFNB93, which is based on the malfunction of CaBP2.<br /> Future work - by the authors or others - should address the molecular mechanisms of the interaction of CaBP1 and 2 in regulating Cav1.3 inactivation.

Weaknesses:<br /> I do not see weaknesses.<br /> What is not explained (but was not the aim of the authors) is how the CaBPs 1 and 2 interact with the Cav1.3 channels and with each other to reduce CDI. Also, why DFNB93, which is based on mutation of the CaBP2 gene, lead to a severe phenotype in humans in contrast to the phenotype of the CaBP2 ko mouse.

Reviewer #1 (Public Review):

Summary:<br /> The authors introduced their previous paper with the concise statement that "the relationships between lineage-specific attributes and genotypic differences of tumors are not understood" (Chen et al., JEM 2019, PMID: 30737256). For example, it is not clear why combined loss of RB1 and TP53 is required for tumorigenesis in SCLC or other aggressive neuroendocrine (NE) cancers, or why the oncogenic mutations in KRAS or EGFR that drive NSCLC tumorigenesis are found so infrequently in SCLC. This is the main question addressed by the previous and current papers.

One approach to this question is to identify a discrete set of genetic/biochemical manipulations that are sufficient to transform non-malignant human cells into SCLC-like tumors. One group reported the transformation of primary human bronchial epithelial cells into NE tumors through a complex lentiviral cocktail involving the inactivation of pRB and p53 and activation of AKT, cMYC, and BCL2 (PARCB) (Park et al., Science 2018, PMID: 30287662). The cocktail previously reported by Chen and colleagues to transform human pluripotent stem-cell (hPSC)-derived lung progenitors (LPs) into NE xenografts was more concise: DAPT to inactivate NOTCH signaling combined with shRNAs against RB1 and TP53. However, the resulting RP xenografts lacked important characteristics of SCLC. Unlike SCLC, these tumors proliferated slowly and did not metastasize, and although small subpopulations expressed MYC or MYCL, none expressed NEUROD1.

MYC is frequently amplified or expressed at high levels in SCLC, and here, the authors have tested whether inducible expression of MYC could increase the resemblance of their hPSC-derived NE tumors to SCLC. These RPM cells (or RPM T58A with stabilized cMYC) engrafted more consistently and grew more rapidly than RP cells, and unlike RP cells, formed liver metastases when injected into the renal capsule. Gene expression analyses revealed that RPM tumor subpopulations expressed NEUROD1, ASCL1, and/or YAP1.

The hPSC-derived RPM model is a major advance over the previous RP model. This may become a powerful tool for understanding SCLC tumorigenesis and progression and for discovering gene dependencies and molecular targets for novel therapies. However, the specific role of cMYC in this model needs to be clarified.

cMYC can drive proliferation, tumorigenesis, or apoptosis in a variety of lineages depending on concurrent mutations. For example, in the Park et al., study, normal human prostate cells could be reprogrammed to form adenocarcinoma-like tumors by activation of cMYC and AKT alone, without manipulation of TP53 or RB1. In their previous manuscript, the authors carefully showed the role of each molecular manipulation in NE tumorigenesis. DAPT was required for NE differentiation of LPs to PNECs, shRB1 was required for expansion of the PNECs, and shTP53 was required for xenograft formation. cMYC expression could influence each of these steps, and importantly, could render some steps dispensable. For example, shRB1 was previously necessary to expand the DAPT-induced PNECs, as neither shTP53 nor activation of KRAS or EGFR had no effect on this population, but perhaps cMYC overexpression could expand PNECs even in the presence of pRB, or even induce LPs to become PNECs without DAPT. Similarly, both shRB1 and shTP53 were necessary for xenograft formation, but maybe not if cMYC is overexpressed. If a molecular hallmark of SCLC, such as loss of RB1 or TP53, has become dispensable with the addition of cMYC, this information is critically important in interpreting this as a model of SCLC tumorigenesis.

To interpret the role of cMYC expression in hPSC-derived RPM tumors, we need to know what this manipulation does without manipulation of pRB, p53, or NOTCH, alone or in combination. Seven relevant combinations should be presented in this manuscript: (1) cMYC alone in LPs, (2) cMYC + DAPT, (3) cMYC + shRB1, (4) cMYC + DAPT + shRB1, (5) cMYC + shTP53, (6) cMYC + DAPT + shTP53, and (7) cMYC + shRB1 + shTP53. Wild-type cMYC is sufficient; further exploration with the T58A mutant would not be necessary.

This reviewer considers that there should be a presentation of the effects of these combinations on LP differentiation to PNECs, expansion of PNECs as well as other lung cells, xenograft formation and histology, and xenograft growth rate and capacity for metastasis. If this could be clarified experimentally, and the results discussed in the context of other similar approaches such as the Park et al., paper, this study would be a major addition to the field.

Reviewer #2 (Public Review):

Summary:<br /> Chen et al use human embryonic stem cells (ESCs) to determine the impact of wildtype MYC and a point mutant stable form of MYC (MYC-T58A) in the transformation of induced pulmonary neuroendocrine cells (PNEC) in the context of RB1/P53 (RP) loss (tumor suppressors that are nearly universally lost in small cell lung cancer (SCLC)). Upon transplant into immune-deficient mice, they find that RP-MYC and RP-MYC-T58A cells grow more rapidly, and are more likely to be metastatic when transplanted into the kidney capsule, than RP controls. Through single-cell RNA sequencing and immunostaining approaches, they find that these RPM tumors and their metastases express NEUROD1, which is a transcription factor whose expression marks a distinct molecular state of SCLC. While MYC is already known to promote aggressive NEUROD1+ SCLC in other models, these data demonstrate its capacity in a human setting that provides a rationale for further use of the ESC-based model going forward. Overall, these findings provide a minor advance over the previous characterization of this ESC-based model of SCLC published in Chen et al, J Exp Med, 2019.

The major conclusion of the paper is generally well supported, but some minor conclusions are inadequate and require important controls and more careful analysis.

Strengths:<br /> 1. Both MYC and MYC-T58A yield similar results when RP-MYC and RP-MYCT58A PNEC ESCs are injected subcutaneously, or into the renal capsule, of immune-deficient mice, leading to the conclusion that MYC promotes faster growth and more metastases than RP controls.

2. Consistent with numerous prior studies in mice with a neuroendocrine (NE) cell of origin (Mollaoglu et al, Cancer Cell, 2017; Ireland et al, Cancer Cell, 2020; Olsen et al, Genes Dev, 2021), MYC appears sufficient in the context of RB/P53 loss to induce the NEUROD1 state. Prior studies also show that MYC can convert human ASCL1+ neuroendocrine SCLC cell lines to a NEUROD1 state (Patel et al, Sci Advances, 2021); this study for the first time demonstrates that RB/P53/MYC from a human neuroendocrine cell of origin is sufficient to transform a NE state to aggressive NEUROD1+ SCLC. This finding provides a solid rationale for using the human ESC system to better understand the function of human oncogenes and tumor suppressors from a neuroendocrine origin.

Weaknesses:<br /> 1. There is a major concern about the conclusion that MYC "yields a larger neuroendocrine compartment" related to Figures 4C and 4G, which is inadequately supported and likely inaccurate. There is overwhelming published data that while MYC can promote NEUROD1, it also tends to correlate with reduced ASCL1 and reduced NE fate (Mollaoglu et al, Cancer Cell, 2017; Zhang et al, TLCR, 2018; Ireland et al, Cancer Cell, 2020; Patel et al, Sci Advances, 2021). Most importantly, there is a lack of in vivo RP tumor controls to make the proper comparison to judge MYC's impact on neuroendocrine identity. RPM tumors are largely neuroendocrine compared to in vitro conditions, but since RP control tumors (in vivo) are missing, it is impossible to determine whether MYC promotes more or less neuroendocrine fate than RP controls. It is not appropriate to compare RPM tumors to in vitro RP cells when it comes to cell fate. Upon inspection of the sample identity in S1B, the fibroblast and basal-like cells appear to only grow in vitro and are not well represented in vivo; it is, therefore, unclear whether these are transformed or even lack RB/P53 or express MYC. Indeed, a close inspection of Figure S1B shows that RPM tumor cells have little ASCL1 expression, consistent with lower NE fate than expected in control RP tumors.

In addition, since MYC appears to require Notch signaling to induce NE fate (Ireland et al), the presence of DAPT in culture could enrich for NE fate despite MYC's presence. It's important to clarify in the legend of Fig 4A which samples are used in the scRNA-seq data and whether they were derived from in vitro or in vivo conditions (as such, Supplementary Figure S1B should be provided in the main figure). Given their conclusion is confusing and challenges robustly supported data in other models, it is critical to resolve this issue properly. I suspect when properly resolved, MYC actually consistently does reduce NE fate compared to RP controls, even though tumors are still relatively NE compared to completely distinct cellular identities such as fibroblasts.

2. The rigor of the conclusions in Figure 1 would be strengthened by comparing an equivalent number of RP animals in the renal capsule assay, which is n = 6 compared to n = 11-14 in the MYC conditions.

3. Statistical analysis is not provided for Figures 2A-2B, and while the results are compelling, may be strengthened by additional samples due to the variability observed.

4a. Related to Figure 3, primary tumors and liver metastases from RPM or RPM-T58A-expressing cells express NEUROD1 by immunohistochemistry (IHC) but the putative negative controls (RP) are not shown, and there is no assessment of variability from tumor to tumor, ie, this is not quantified across multiple animals.

4b. Relatedly, MYC has been shown to be able to push cells beyond NEUROD1 to a double-negative or YAP1+ state (Mollaoglu et al, Cancer Cell, 2017; Ireland et al, Cancer Cell, 2020), but the authors do not assess subtype markers by IHC. They do show subtype markers by mRNA levels in Fig 4B, and since there is expression of ASCL1, and potentially expression of YAP1 and POU2F3, it would be valuable to examine the protein levels by IHC in control RP vs. RPM samples.

5. Given that MYC has been shown to function distinctly from MYCL in SCLC models, it would have raised the impact and value of the study if MYC was compared to MYCL or MYCL fusions in this context since generally, SCLC expresses a MYC family member. However, it is quite possible that the control RP cells do express MYCL, and as such, it would be useful to show.

Reviewer #3 (Public Review):

Summary:<br /> The authors continue their study of the experimental model of small cell lung cancer (SCLC) they created from human embryonic stem cells (hESCs) using a protocol for differentiating the hESCs into pulmonary lineages followed by NOTCH signaling inactivation with DAPT, and then knockdown of TP53 and RB1 (RP models) with DOX inducible shRNAs. To this published model, they now add DOX-controlled activation of expression of a MYC or T58A MYC transgenes (RPM and RPMT58A models) and study the impact of this on xenograft tumor growth and metastases. Their major findings are that the addition of MYC increased dramatically subcutaneous tumor growth and also the growth of tumors implanted into the renal capsule. In addition, they only found liver and occasional lung metastases with renal capsule implantation. Molecular studies including scRNAseq showed that tumor lines with MYC or T58A MYC led surprisingly to more neuroendocrine differentiation, and (not surprisingly) that MYC expression was most highly correlated with NEUROD1 expression. Of interest, many of the hESCs with RPM/RPMT58A expressed ASCL1. Of note, even in the renal capsule RPM/RPMT58A models only 6/12 and 4/9 mice developed metastases (mainly liver with one lung metastasis) and a few mice of each type did not even develop a renal sub capsule tumor. The authors start their Discussion by concluding: " In this report, we show that the addition of an efficiently expressed transgene encoding normal or mutant human cMYC can convert weakly tumorigenic human PNEC cells, derived from a human ESC line and depleted of tumor suppressors RB1 and TP53, into highly malignant, metastatic SCLC-like cancers after implantation into the renal capsule of immunodeficient mice.".

Strengths:<br /> The in vivo study of a human preclinical model of SCLC demonstrates the important role of c-Myc in the development of a malignant phenotype and metastases. Also the role of c-Myc in selecting for expression of NEUROD1 lineage oncogene expression.

Weaknesses:<br /> There are no data on results from an orthotopic (pulmonary) implantation on generation of metastases; no comparative study of other myc family members (MYCL, MYCN); no indication of analyses of other common metastatic sites found in SCLC (e.g. brain, adrenal gland, lymph nodes, bone marrow); no studies of response to standard platin-etoposide doublet chemotherapy; no data on the status of NEUROD1 and ASCL1 expression in the individual metastatic lesions they identified.

Reviewer #1 (Public Review):

Summary:<br /> The authors were trying to achieve that Tgif1 expression is regulated by EAK1/2 and PTH in a time-dependent manner, and its roles in suppressing Pak3 for facilitating osteoblast adhesion. The authors further tried to show that the Tgif1-Pak3 signaling plays a significant role in osteoblast migration to the site of bone repair and bone remodeling.

Strengths:<br /> - In a previous study, it was demonstrated that Tgif1 is a target gene of PTH, and the absence of Tgif1 failed to increase bone mass by PTH treatment (Saito et al., Nat Commun., 2019). In this study, the authors found that Tgif1-Pak3 signaling prompts osteoblast migration through osteoblast adhesion to prompt bone regeneration. This novel finding provides a better understanding of how Tgif1 expression in osteoblasts regulates adherence, spreading, and migration during bone healing and bone remodeling.

- The authors demonstrated that ERK1/2 and PTH regulate Tgif1 expression in a time-dependent manner and its role in suppressing Pak3 through various experimental approaches such as luciferase assay, ChIP assay, and gene silencing. These results contribute to the overall strength of the article.

Weaknesses:<br /> -The authors need to further justify why they focused on Pak3 in the introduction by mentioning its known function for cell adhesion.

-Some results indicated statistically significant but small changes. The authors need to explain in the discussion part why they believe this is the major mechanism or why there may be some other possible mechanisms.

-The study does not include enough in vivo data to claim that this mechanism is crucial for bone healing and bone remodeling in vivo.

Reviewer #2 (Public Review):

Summary:<br /> Bolamperti S. et al. 2023 investigate whether the expression of TG-interacting factor (Tgif1) is essential for osteoblastic cellular activity regarding morphology, adherence, migration/recruitment, and repair. Towards this end, germ-line Tgif1 deletion (Tgif1-/-) mice or male mice lacking expression of Tgif1 in mature osteoblastic and osteocytic cells (Dmp1-Cre+; Tgif1fl/fl) and corresponding controls were studied in physiological, bone anabolic, and bone fracture-repair conditions. Both Tgif1-/- and Dmp1-Cre+; Tgif1fl/fl exhibited decreased osteoblasts on cancellous bone surfaces and adherent to collagen I-coated plates. Tgif1-/- mice exhibit impaired healing in the tibial midshaft fracture model, as indicated by decreased bone volume (BV/Cal.V), osteoid (OS/BS), and low osteoblasts (number and surface). Likewise, both Tgif1-/- and Dmp1-Cre+; Tgif1fl/fl show impaired PTH 1-34, (100 µg/kg, 5x/wk for 3 wks) osteoblast activation in vivo, as detected by increases in quiescent bone surfaces. Mechanistic in vitro studies then utilized primary osteoblasts isolated from Tgif1-/- mice and siRNA Tgif1 knockdown OCY454 cells to further investigate and identify the downstream Tgif1 target driving these osteoblastic impairments. In vitro, Tgif1-/- osteoblastic and Tgif1 knockdown OCY454 cells exhibit decreased migration, abnormal morphology, and decreased focal adhesions/cells. Unexpectantly though, localization assays revealed Tgif1 to primarily concentrate in the nucleus and not to co-localize with focal adhesions (paxillin, talin). Also, the expression of major focal adhesion components (paxillin, talin, FAK, Src, etc.) or the Cdc42 family was not altered by loss of Tgif1 expression. In contrast, PAK3 expression is markedly upregulated by loss of Tgif1. In silico analysis followed by mechanistic molecular assays involving ChIP, siRNA (Tgif1, PAK3), and transfection (rat PAK3 promoter) techniques show that Tgif1 physically binds to a specific site in the PAK3 promoter region. Further, the knockdown of PAK3 rescues the Tgif1-deficient abnormal morphology in OCY454 cells. This is the first study to identify the novel transcriptional repression of PAK3 by Tgif1 as well as the specific Tgif1 binding site within the PAK3 promoter.

Strengths:<br /> This work has a plethora of strengths. The co-authors achieved their aim of eliciting the role of Tgif1 expression in osteoblastic cellular functions (morphology, spreading/attachment, migration). Further, this work is the first to depict the novel mechanism of Tgif1 transcriptional repression of PAK3 by a thorough usage of mechanistic molecular assays (in silico analysis, ChIP, siRNA, transfection etc.). The conclusions are well supported and justified by these findings, as the appropriate controls, sample sizes (statistical power), statistics, and assays were fully utilized.

The claims and conclusions are justified by the data.

Weaknesses:<br /> The discussion section could be expanded with a few sentences regarding limitations to the current study and potential future directions.

Reviewer #1 (Public Review):

Summary:<br /> In this manuscript entitled "Association with TFIIIC limits MYCN accumulation in hubs of active promoters and chromatin accumulation of non-phosphorylated RNA polymerase II" the authors examine how the cohesin complex component (and RNA pol III associated factor) TFIIIC interacts with MYCN and controls transcription. They confirm that TFIIIC co-purifies with MYCN, dependent on its amino terminus, as shown in previous work. The authors also find that TFIIIC and MYCN are both found in promoter hubs and suggest that TFIIIC inhibits MYCN's association with these hubs. Finally, the authors indicate that TFIIIC/MYCN alters exosome function, and BRCA1-dependent effects, at MYCN-regulated loci.

Strengths:<br /> The authors utilize multiple experimental approaches to investigate the potential biological and genomic impacts of MYCN association with TFIIIC - the findings are interesting in suggesting that this interaction may limit or otherwise regulate MYC activity.

Weaknesses:<br /> (1) In Figure 1, the authors show that TF3C binds to the amino terminus of MYCN (Myc box I region), as shown previously. The data in Figure 1 B-D support, but do not rigorously confirm a 'direct' interaction because it has not been ruled out that accessory proteins mediating the association may be present in the mixture.

(2) The authors indicate in Figure 2 that TF3C has essentially no effect on MYCN-dependent gene expression and/or transcription elongation. Yet a previous study (PMID: 29262328) associated with several of the same authors concluded that TF3C positively affects transcription elongation. The authors make no attempt to reconcile these disparate results and need to clarify this point.

(3) Figures 2B and C show that unphosphorylated pol2 is TSS-centered, and Ser2-P pol2 occupation is centered beyond the TES. From this data, however, the reader can't tell how much of the phospho-Ser2- pol2 is centered on the TSS. The authors should include overall plots over TSS and TES, and also perhaps the gene-body to allow a better comparison for TSS and TES plotted for both antibodies over the collected gene sets.

(4) The authors see more TF3C at promoters in cells with MYCN (Figure 2F). What are the levels of TF3C in the absence and presence of MYCN?

(5) The finding that TF3C is increased at TSS (Figure 2F) doesn't necessarily indicate that 1) MYCN is recruiting TF3C there, and 2) that this is due to the phosphorylation status of pol2. It could mean many other things. The logic of conflating these 3 points based on the data shown is questionable.

(6) Figure 3A doesn't add much to the paper, as it is overplotted and no relationship is clear, except that Pol2 and MYCN occupy many of the same sites. Perhaps a less complex or different type of plot would allow the interactions to be better visible.

(7) That depletion of TF3C leads to increased promoter hubs may or may not have anything to do with its association with MYCN (Figure 4E). This could be a direct consequence of its known structural function in cohesin complexes, and the MYCN changes as a secondary consequence of this (also see point 4, above).

(8) Depletion of TF3C5 results in a loss of EXOSC5 (exosome) at TSS in the presence and absence of MYCN (Figure 5B). As TF3C5 is a cohesin, could this simply be a consequence of genomic structure changes?

(9) The authors suggest that RNA dynamics are affected by changes in exosome function (RNA degradation, etc). What effect, if any does TF3C depletion have on the overall gene expression profile?

Reviewer #2 (Public Review):

This manuscript reports several interesting observations that invite follow-up. The notion that hubs, and perhaps condensates that may (or may not embrace them) are functionally and physiologically important is an open issue at this time. The authors note that TFIIIC helps to prune extraneous connections from hubs, but do not comment that the connections that are maintained are also reinforced. At the same time only modest changes in gene expression are associated with expanded or decreased connections and changes in bound proteins. One interesting possibility might be that standard methods for assessing expression miss changes in global or background transcription. It seems that the TFIIIC-MYCN-ER connection has features that would help to suppress such background. The results invite a more global consideration of TFIIIC than as primarily RNAPIII/small RNA transcription factor and of MYCN as an E-box dependent transcription factor. The results use state-of-the-art methods to develop interesting new ideas that have the potential to instruct further studies that may reveal new mechanisms of action for TFIIIC and MYCN

Strengths:<br /> Use of a variety of methods to assess the genomic response to increased MYCN in the presence or absence of TFIIIC. Establishes in vitro and in vivo the TFIIIC-MYCN complex.

Weaknesses:<br /> Dynamic inferences are made without kinetic experiments.

Reviewer #3 (Public Review):

Summary:<br /> Vidal et al. investigated how TFIIIC may mediate MYCN effects on transcription. The work builds upon previous reports from the same group where they describe MYCN interactors in neuroblastoma cells (Buchel et al, 2017), which include TFIIIC, and their different roles in MYCN-dependent control of RNA polymerase II function (Herold et al, 2019) (Roeschert et al, 2021) (Papadopoulus et al, 2022). Using baculovirus expression systems, they confirm that MYCN-TFIIIC interaction is direct and likely relevant for neuroblastoma cell proliferation. However, transcriptomics analyses led them to conclude that TFIIC is largely dispensable for MYCN-dependent gene expression. Instead, they propose that TFIIC limits MYCN-mediated promoter-promoter 3D chromatin contacts, which would in turn facilitate the recruitment of the nascent RNA degradation machinery and restrict the accumulation of non-phosphorylated RNA polymerase II at promoters. How this mechanism may impact on MYCN-driven neuroblastoma cell biology remains to be elucidated.

Strengths:<br /> This study presents a nice variety of genomic datasets addressing the specific role of TFIIIC in MYCN-dependent functions. In particular, the technically challenging HiChIP sequencing experiments performed under various conditions provide very useful information about the interplay between MYCN and TFIIIC in the regulation of 3D chromatin contacts. The authors show that MYCN and TFIIIC participate both in unique and overlapping long-range chromatin contacts and that the expression of each of these proteins limits the function of the other. Together, their results suggest a dynamic and interconnected relationship between MYCN and TFIIIC in regulating 3D chromatin contacts.

Weaknesses:<br /> The connection between the three major findings presented in this study regarding the role of TFIIIC in the regulation of MYCN function remains unclear. Specifically, how the TFIIIC-dependent restriction of MYCN localization to promoter hubs enhances the association of factors involved in nascent RNA degradation to prevent the accumulation of inactive RNA polymerase II at promoters is not apparent. As they are currently presented, these findings appear as independent observations. Cross-comparison of the different datasets obtained may provide some insight into addressing this question.

Another concern involves the disparities in RNA polymerase II ChIP-seq results between this study and earlier ones conducted by the same group. In Figure 2, the authors demonstrate that activation of MYCN results in a reduction of non-phosphorylated RNA polymerase II across all expressed genes. This discovery contradicts prior findings obtained using the same methodology, where it was concluded that the expression of MYCN had no significant effect on the chromatin association of hypo-phosphorylated RNA polymerase II (Buchel et al, 2017). In this regard, the choice of the 8WG16 antibody raises concern, as fluctuations in the signal may be attributed to changes in the phosphorylation levels of the C-terminal domain. It remains unclear why the authors decided against using antibodies targeting the N-terminal domain of RNA polymerase II, which are unaffected by phosphorylation and consistently demonstrated a significant signal reduction upon MYCN activation in their previous studies (Buchel et al, 2017) (Herold et al, 2019). Similarly, the authors previously proposed that depletion of TFIIIC5 abrogates the MYCN-dependent increase of Ser2-phosphorylated RNA polymerase II (Buchel et al, 2017), whereas they now show that it has no obvious impact. These aspects need clarification.

Finally, the varied techniques employed to explore the role of TFIIIC in MYCN-dependent recruitment of nascent RNA degradation factors make it challenging to draw definitive conclusions about which factor is affected and which one is not. While conducting ChIPseq experiments for all factors may be beyond the scope of this manuscript, incorporating proximity ligation assays (PLA) or ChIP-qPCR assays with each factor would have enabled a more direct and comprehensive comparison.

Reviewer #1 (Public Review):

Interactions known to be important for melanosome transport include exon F and the globular tail domain (GTD) of MyoVa with Mlph. Motivated by a discrepancy between in vitro and cell culture results regarding necessary interactions for MyoVa to be recruited to the melanosome, the authors used a series of pull-down and pelleting assays experiments to identify an additional interaction that occurs between exon G of MyoVa and Mlph. This interaction is independent of and synergistic with the interaction of Mlph with exon F. However, the interaction of the actin-binding domain of Mlph can occur either with exon G or with the actin filament, but not both simultaneously. These data lead to a modified recruitment model where both exon F and exon G enhance the binding of Mlph to auto-inhibited MyoVa, and then via an unidentified switch (PKA?) the actin-binding domain of Mlph dissociates from MyoVa and interacts with the actin filament to enhance MyoVa processivity.

The only weakness noted is that the authors could have had a more complete story if they pursued whether PKA phosphorylation/dephosphorylation of Mlph is indeed the switch for the actin-binding domain of Mlph to interact with exon G versus the actin filament.

Reviewer #2 (Public Review):

The authors identify a third component in the interaction between myosin Va and melanophilin- an interaction between a 32-residue sequence encoded by exon-g in myosin Va and melanophilin's actin-binding domain. This interaction has implications for how melanosome motility may be regulated.

While this work is largely well done, I believe that additional work would be required to make a more compelling case (e.g. some affinity measurements, necessary controls for the dominant negative experiments).  First, the study provides just one more piece to a well-developed story (the role of exon-F and the GTD in myosin Va: melanophilin (Mlph) interaction), much of which was published 20 years ago by several labs. Second, the study does not demonstrate a physiological significance for their findings other than that exon-G plays an auxiliary role in the binding of myosin Va to Mlph. For example, what dictates the choice between Mlph's actin binding domain (ABD) binding to actin or to exon-G. Is it a PTM or local actin concentration? It is unlikely to be alternative splicing as exon-G is present in all spliced isoforms of myosin Va. And what changes re melanosome dynamics in cells between these two alternatives? Similarly, the paper does not provide any in vitro evidence that binding to exon-G instead of actin effects the processivity of a Rab27a/Myosin Va/Mlph transport complex. For example, if the ABD sticks to exon-G instead of actin, does that block Mlph's ability to promote processivity through its interaction with the actin filament during transport? In summary, given that the authors did not directly test their model either in vitro or in cells, I do not think this story represent a significant conceptual advance.

Reviewer #1 (Public Review):

Summary:<br /> The authors establish a recombinant insect cell expression and purification scheme for the antiviral Dicer complex of C. elegans. In addition to Dicer-1, the complex harbors two additional proteins, the RIG-I-like helicase DRH-1, and the dsRNA-binding protein RDE-4. The authors show that the complex prefers blunt-end dsRNA over dsRNAs that contain overhangs. Furthermore, whereas ATP-dependent dsRNA cleavage only exacerbates regular dsRNA cleavage activity, the presence of RDE-4 is essential to ATP-dependent and ATP-independent dsRNA cleavage. Single-particle cryo-EM studies of the ternary C. elegans Dicer complex reveal that the N-terminal domain of DRH-1 interacts with the helicase domain of DCR-1, thereby relieving its autoinhibitory state. Lastly, the authors show that the ternary complex is able to processively cleave long dsRNA, an activity primarily relying on the helicase activity of DRH-1.

Strengths:<br /> • First thorough biochemical characterization of the antiviral activity of C. elegans Dicer in complex with the RIG-I-like helicase DRH-1 and the dsRNA-binding protein RDE-4.<br /> • Discovery that RDE-4 is essential to dsRNA processing, whereas ATP hydrolysis is not.<br /> • Discovery of an autoinhibitory role of DRH-1's N-terminal domain (in analogy to the CARD domains of RIG-I).<br /> • First structural insights into the ternary complex DCR-1:DRH-1:RDE-4 by cryo-EM to medium resolution.<br /> • Trap experiments reveal that the ternary DCR-1 complex cleaves blunt-ended dsRNA processively. Likely, the helicase domain of DRH-1 is responsible for this processive cleavage.

Weaknesses:<br /> • Cryo-EM Structure of the ternary Dicer-1:DRH-1:RED-4 complex to only medium resolution.<br /> • High-resolution structure of the C-terminal domain of DRH-1 bound to dsRNA does not reveal the mechanism of how blunt-end dsRNA and overhang-containing one are being discriminated.<br /> • The cryo-EM structure of DCR1:DRH-1:RDE-4 in the presence of ATP only reveals the helicase and CTD domains of DRH-1 bound to dsRNA. No information on dsRNA termini recognition is presented. The paragraph seems detached from the general flow of the manuscript.<br /> • The antiviral DCR-1:DRH-1:RDE-4 complex shows largely homologous activities and regulation than Drosophila Dicer-2.

Reviewer #2 (Public Review):

Summary:<br /> To investigate the evolutionary relationship between the RNAi pathway and innate immunity, this study uses biochemistry and structural biology to investigate the trimeric complex of Dicer-1, DRH-1 (a RIGI homologue), and RDE-4, which exists in C. elegans. The three subunits were co-expressed to promote stable purification of the complex. This complex promoted ATP-dependent cleavage of blunt-ended dsRNAs. A detailed kinetic analysis was also carried out to determine the role of each subunit of the trimeric complex in both the specificity and efficiency of cleavage. These studies indicate that RDE-4 is critical for cleavage while DRC-1 is primarily involved in the specificity of the reaction, and DRH-1 promotes ATP hydrolysis. Finally, a moderate density (6-7 angstrom) cryo-EM structure is presented with attempts to position each of the components.

Strengths:<br /> 1. Newly described methods for studying the C. elegans DICER complex.<br /> 2. New structure, albeit only moderate resolution.<br /> 3. Kinetic study of the complex in the presence and absence of individual subunits and mutations, provides detailed insight into the contribution of each subunit.

Weaknesses:<br /> 1. Limited insight due to limited structural resolution.<br /> 2. No attempts to extend findings to other Dicer or RLR systems.

Reviewer #1 (Public Review):

Summary:<br /> In their manuscript, Kong Fang et al describe a robust pipeline for the isolation of small extracellular vesicles through a combination of size exclusion chromatography and miniaturized density gradient separation. Subsequently, they prove that the method is reproducible and suitable for small-volume operations while at the same time not compromising the quality of vesicles.

Strengths:<br /> The paper narrates a robust method for purifying high-quality sEVs from small amounts of blood plasma. They also demonstrate that through this approach, they can derive sEVs without compromising the protein composition, integrity of the vesicles, or contamination with other proteins or lipids.

Weaknesses:<br /> The paper is a nice summary of how to enrich sEVs from blood samples. Although well performed and substantiated with data, the paper primarily deals with method development and optimisation.

Reviewer #2 (Public Review):

Summary:<br /> In this work, the authors manage to optimize a simple and rapid protocol using SEC followed by DGCU to isolate sEVs with adequate purity and yield from small volumes of plasma. Isolated fractions containing sEVs using SEC, DGCU, SEC-DGCU, and DGCU-SEC are compared in terms of their yield, purity surface protein profile, and RNA content. Although the combined use of these methodologies has already been evaluated in previous works, the authors manage to adapt them for the use of small volumes of plasma, which allows working in 1.5 mL tubes and reducing the centrifugation time to 2 hours.

The authors finally find that although both the SEC-DGCU and DGCU-SEC combinations achieve isolates with high purity, the SEC-DGCU combination results in higher yields.

This work provides an interesting tool for the rapid obtention of sEVs with sufficient yield and purity for detailed characterization which could be very useful in research and clinical therapy.

Strengths:<br /> -The work is well-written and organized.<br /> -The authors clearly state the problem they want to address, that is, optimizing a method that allows sEV to be isolated from small volumes of plasma.<br /> -Although these methodologies have been tested in previous works, the authors manage to isolate sEVs of high purity and good performance through a simple and fast methodology.<br /> -The characteristics of all isolated fractions are exhaustively analyzed through various state-of-the-art methodologies.<br /> -They present a good interpretation of the results obtained through the methodologies used.

Weaknesses:<br /> -Lack of references that support some of the results obtained.<br /> -Although this work focuses on comparing different techniques and their combinations to find an optimal option, the authors do not use any statistical method that reliably shows the differences between these techniques, except when repeatability is measured.

Reviewer #1 (Public Review):

In recent years, these investigators have been engaged in a debate regarding the classification of the sacral parasympathetic system as "sympathetic" rather than "parasympathetic," based on shared developmental ontogeny of spinal preganglionic neurons. In this current study, these investigators conducted single-cell RNAseq analyses of four groups of autonomic neurons: paravertebral sympathetic neurons (stellate and lumbar train ganglia), prevertebral sympathetic neurons (coeliac-mesenteric ganglia), rostral parasympathetic ganglia (sphenopalatine ganglia), and the caudal pelvic ganglia (containing traditionally recognized sacral "parasympathetic cholinergic neurons," which the investigators sought to challenge in terms of nomenclature). The authors argued that the pelvic ganglionic neurons shared the expression of more genes with sympathetic ganglia, as opposed to parasympathetic ganglia. Additionally, the pelvic neurons did not express a set of genes observed in the rostral parasympathetic sphenopalatine ganglia. Based on these findings, they claimed that the sacral autonomic system should be considered sympathetic rather than parasympathetic.

However, noradrenergic sympathetic neurons and cholinergic neurons, by the virtue of expressing different neurotransmitters, could have distinct roles. It is true that some cholinergic neurons reside in the sympathetic train ganglia as well, such as those innervating the sweat gland and some vascular systems; in this sense, the pelvic ganglia share some features with sympathetic ganglia, except that the pelvic ganglia contain a much higher percentage of cholinergic neurons compared with sympathetic ganglia. It is much simpler and easier to divide the autonomic nervous system into sympathetic neurons that relieve noradrenaline versus parasympathetic neurons that relieve acetylcholine, and these two systems often act in antagonistic manners, even though in some cases, these two systems can work synergistically. As such, it is not justified to claim that "pelvic organs receive no parasympathetic innervation".

Reviewer #2 (Public Review):

Summary:<br /> Recent advances in single cell profiling of gene expression (RNA) permit the analysis of specialized cell types, an approach that has great value in the nervous system which is characterized by prodigious neuronal diversity. The novel data in this study focus primarily on genetic profiling to compare autonomic neurons from ganglia associated with the cranial parasympathetic outflow (sphenopalatine (also known as pteropalatine), the thoraco-lumbar sympathetic outflow (stellate, coeliac) and the sacral parasympathetic outflow (pelvic). Using statistical methods to reduce the dimensionality of the data and map gene expression, the authors provide interesting evidence that cranial parasympathetic and sacral sympathetic ganglia differ from each other and from sympathetic ganglia (Figures 1, S1 - S4). The authors interpret the mapping analysis as evidence that the cranial and sacral outflows differ so that calling them both parasympathetic is unjustified. Based on anatomical localization of markers (Figure 2 ) (mainly transcription factors) the authors show a similarity between the sympathetic and pelvic ganglion. In Figure 3 they present evidence that some pelvic ganglionic neurons are dually innervated by sympathetic preganglionic neurons and sacral preganglionic neurons. These observations are interpreted to mean that the pelvic ganglion is not parasympathetic, but rather a modified sympathetic ganglion - hence the title of the manuscript.

Strengths:<br /> The extensive use of single cell profiling in this work is both interesting and exciting. Although still in its early stages, it holds promise for a deepened understanding of autonomic development and function. As noted in the introduction, this study extends previous work by Professor Brunet and his associates.

Weaknesses:<br /> This work further documents differences between the cranial and sacral parasympathetic outflows that have been known since the time of Langley - 100 years ago. The approach taken by Brunet et al. has focused on late neonatal and early postnatal development, a time when autonomic function is still maturing. In addition, the sphenopalatine and other cranial ganglia develop from placodes and the neural crest, while sympathetic and sacral ganglia develop from the neural crest alone. How then do genetic programs specifying brainstem and spinal development differ and how can this account for kinship that Brunet documents between spinal and sacral ganglia? One feature that seems to set the pelvic ganglion apart is the mixture of 'sympathetic' and 'parasympthetic' ganglion cells and the convergence of preganglionic sympathetic and parasympathetic synapses on individual ganglion cells (Figure 3). This unusual organization has been reported before using microelectrode recordings (see Crowcroft and Szurszewski, J Physiol (1971) and Janig and McLachlan, Physiol Rev (1987)). Anatomical evidence of convergence in the pelvic ganglion has been reported by Keast, Neuroscience (1995). It should also be noted that the anatomy of the pelvic ganglion in male rodents is unique. Unlike other species where the ganglion forms a distributed plexus of mini-ganglia, in male rodents the ganglion coalesces into one structure that is easier to find and study. Interestingly the image in Figure 3A appears to show a clustering of Chat-positive and Th-positive neurons. Does this result from the developmental fusion of mini ganglia having distinct sympathetic and parasympathetic origins. In addition, Brunet et al dismiss the cholinergic and noradrenergic phenotypes as a basis for defining parasympathetic and parasympathetic neurons. However, see the bottom of Figure S4 and further counterarguments in Horn (Clin Auton Res (2018)). What then about neuropeptides, whose expression pattern is incompatible with the revised nomenclature proposed by Brunet et al.? Figure 1B indicates that VIP is expressed by sacral and cranial ganglion cells, but not thoracolumbar ganglion cells. The authors do not mention neuropeptide Y (NPY). The immunocytochemistry literature indicates that NPY is expressed by a large subpopulation of sympathetic neurons but never by sacral or cranial parasympathetic neurons.

The title of this paper is misleading because it implies a conclusion that is not adequately supported by the data and that is difficult for a general reader to parse. Independent assessments by two referees both agreed on title's problematic message. If one can get beyond the title, then the paper does contain data that is of interest. The authors compared single cell gene expression in neurons from the cranial sphenopalatine ganglion, paravertebral chain ganglia (stellate and lumbar), the prevertebral coeliac ganglion and the bladder ganglion. The cranial and pelvic ganglia are parasympathetic, while the paravertebral and prevertebral ganglia are sympathetic. The gene expression data identified differences between the cranial, sympathetic, and pelvic ganglia. Based primarily on this finding the authors concluded that the sacral bladder ganglion is not parasympathetic. Since some genes suggest a kinship between the pelvic and sympathetic neurons, the authors conclude that the pelvic neurons are pelvo-sympathetic - hence the title. This nomenclature does little to improve understanding of the autonomic motor system and it ignores important anatomical and functional properties that underlie existing definitions of the sympathetic and parasympathetic systems. The idea that the cranial and sacral autonomic outflows have some differences is not new (see for example Nilsson, 1983 and Janig, 2022). Since many of the genes identified in the present study are HOX genes and other transcription factors that specify the rostro-caudal axis during development, it is also not surprising that these genes suggest a kinship between sacral parasympathetic neurons and sympathetic neurons, all of which derive from the neural crest and are supplied by the spinal cord. The different profile of cranial parasympathetic neurons is also not surprising given that they derive from a mixture of placodal and neural crest progenitors and are supplied by the brainstem. (see my previous comments for anatomical and functional criteria that further support the existing nomenclature for the sympathetic and parasympathetic motor systems.

Reviewer #1 (Public Review):

This paper aims to address the establishment and maintenance of neural circuitry in the case of a massive loss of neurons. The authors used genetic manipulations to ablate the principal projection neurons, the mitral/tufted cells, in the mouse olfactory bulb. Using diphtheria toxin (Tbx21-Cre:: loxP-DTA line) the authors ablated progressively large numbers of M/T cells postnatally. By injecting diphtheria toxin (DT) into the Tbx21-Cre:: loxP-iDTR line, the authors were able to control the timing of the ablation in the adult stage. Both methods led to the successful elimination of a majority of M/TCs by 4 months of age. The authors made a few interesting observations. First, they found that the initial pruning of the remaining M/T cell primary dendrite was unaffected. However, in adulthood, a significant portion of these cells extended primary dendrites to innervate multiple glomeruli. Moreover, the incoming olfactory sensory neuron (OSN) axons, as examined for those expressing the M72 receptor, showed a divergent innervation pattern as well. The authors conclude that M/T cell density is required to maintain the dendritic structures and the olfactory map. To address the functional consequences of eliminating a large portion of principal neurons, the authors conducted a series of behavioral assays. They found that learned odor discrimination was largely intact. On the other hand, mating and aggression were reduced. The authors concluded that learned behaviors are more resilient than innate ones.

The study is technically sound, and the results are clear-cut. The most striking result is the contrast between the normal dendritic pruning during early development and the expanded dendritic innervation in adulthood. It is a novel discovery that can lead to further investigation of how the single-glomerulus dendritic innervation is maintained. The authors conducted a few experiments to address potential mechanisms, but it is inconclusive, as detailed below. It is also interesting to see that the massive neuronal loss did not severely impact learned odor discrimination. This result, together with previous studies showing nearly normal odor discrimination in the absence of large portions of the olfactory bulb or scrambled innervation patterns, attests to the redundancy and robustness of the sensory system. The discussion should take into account these other studies in a historical context.

Main comments:

1. In previous studies, it has been concluded that dendritic pruning unfolds independently, regardless of the innervation pattern or activity of the OSNs. The new observation bolsters this conclusion by showing that a loss of neighboring M/T cells does not affect the developmental process. A more nuanced discussion comparing the results of these studies would strengthen the paper.

2. The authors propose that a certain density of M/T is required to prevent the divergent innervation of primary dendrites, but the evidence is not sufficient to support this proposal. The experiment with low-dose DT injection to ablate a smaller portion of M/T cells did not change the percentage of cells innervating two or more glomeruli. The authors suggest that a threshold must be met, but this threshold is not determined. It would be possible to adjust the DT injection dose to find this threshold.

3. The authors suggest that neural activity is not required for this plasticity. The evidence was derived primarily from naris occlusion and neuronal silencing using Kir2.1. While the results are consistent with the notion, it is a rather narrow interpretation of how neural activity affects circuit configuration. Perturbation of neural activity also entails an increase in firing. Inducing the activity of the neurons may alter this plasticity. Silencing per se may induce a homeostatic response that expands the neurite innervation pattern to increase synaptic input to compensate for the loss of activity. Thus, further silencing the cells may not reduce multi-glomerular innervation, but an increased activity may.

4. There is a discrepancy between this study and the one by Fujimoto et al. (Developmental Cell; 2023), which shows that not only glutamatergic inputs to the primary dendrite can facilitate pruning of remaining dendrites but also Kir2.1 overexpression can significantly perturb dendritic pruning. This discrepancy is not discussed by the authors.

5. An alternative interpretation of the discrepancy between the apparent normal pruning by p10 and expanded dendritic innervation in adulthood is that there are more cells before P10, when ~25% of M/T cells are present, but at a later date only 1-3% are present. The relationship between the number of M/T cells and single glomerulus innervation has not been explored during postnatal development. It would be important to test this hypothesis.

6. The authors attribute the change in the olfactory map to the loss of M/T cells. Another obvious possibility is that the diffused projection is a response to the change in the olfactory bulb size. With less space to occupy, the axons may be forced to innervate neighboring glomeruli. It is not known how the total number of glomeruli is affected. This question could be addressed by tracking developmental changes in bulb volume and glomerular numbers.

7. The retained ability to discriminate odors upon reinforced training is not surprising in light of a number of earlier studies. For example, Slotnick and colleagues have shown that rats losing ~90% of the OB can retain odor discrimination. Weiss et al have shown that humans without an olfactory bulb can perform normal olfactory tasks. Gronowitz et al have used theoretical prediction and experimental results to demonstrate that perturbing the olfactory map does not have a major impact on olfactory discrimination.<br /> Fleischmann et al have shown that mice with a monoclonal nose can discriminate odors. The authors should discuss their results in these contexts.

8. It should be noted that odor discrimination resulting from reinforcement training does not mean normal olfactory function. It is a highly artificial situation as the animals are overtrained. It should not be used as a measure of the robustness of the olfactory sense. Natural odor discrimination (without training), detection threshold, and innate appetitive/aversive response to certain odors may be affected. These experiments were not conducted.

9. The social behaviors were conducted using relatively coarse measures (vaginal plug and display of aggression). Moreover, these behaviors are most likely affected by the disruption of the AOB mitral cells and have little to do with the dendritic pruning process described in the paper. It is misleading to lump social behaviors with innate responses to odors.

Reviewer #2 (Public Review):

The authors make the interesting observation that the developmental refinement of apical M/T cell dendrites into individual glomeruli proceeds normally even when the majority of neighboring M/T cells are ablated. At later stages, the remaining neurons develop additional dendrites that invade multiple glomeruli ectopically, and similarly, OSN inputs to glomeruli lose projection specificity as well. The authors conclude that the normal density of M/T neurons is not required for developmental refinement, but rather for maintaining specific connectivity in adults.

The observations are indeed quite striking; however, the authors' conclusions are not entirely supported by the data.

1. It is unclear whether the expression of diphtheria toxin that eventually leads to the ablation of the large majority of M/T neurons compromises the cell biology of the remaining ones.

2. The authors interpret the growth of ectopic dendrites later in life as a lack of maintenance of dendrite structure; however, maybe the observed changes reflect actually adaptations that optimize wiring for extremely low numbers of M/T neurons. The finding that olfactory behavior was less affected than predicted supports this interpretation.

3. The number of remaining M/T neurons is much higher at P10 than later. Can the relatively large number of remaining neurons (or their better health status) be the reason that dendrites refine normally at the early developmental stages rather than a (currently unknown) developmental capacity that preserves refinement?

4. While the effect of reduced M/T neuron density on both M/T dendrites and OSN axons is described well, the relationship between both needs to be characterized better: Is one effect preceding the other or do they occur simultaneously? Can one be the consequence of the other?

5. Page 7: the observation that not all neurons develop additional dendrites is not a sign of differences between cell types, it may be purely stochastic.

6. Page 8: the fact that activity blockade did not affect the formation of ectopic dendrites does not suggest that the process is not activity-dependent: both manipulations have the same effect and may just mask each other.

7. It remains unclear how the observed structural changes can explain the behavioral effects.

https://peculiargenres.commons.msu.edu/schedule/

Reviewer #1 (Public Review):

The authors use a combination of crop modeling and field experiments to argue that drought during seedling establishment likely severely impacts the yield of pearl millet, an important but understudied cereal crop and that rapid seedling root elongation could play a major role in mitigating this. They further argue that this trait has a strong genetic basis and that major polymorphisms in candidate genes can be identified using standard methods from modern genetics and genomics. Finally, they use homology with the model plant Arabidopsis thaliana to argue that the function of one putatively causal gene is to regulate root cell elongation.

The major strength of this paper is that it convincingly demonstrates how modern methods from plant breeding and model organisms can be combined to address questions of great practical importance in important but poorly understood crops. The notion that it is possible to connect single-locus polymorphism and cellular biology to drought tolerance and crop yield in pearl millet is not a trivial one.

The weakness is obvious: while the argument made is convincing, it must be recognized that the strength of the evidence is by no means of the level expected in a model organism. Conclusions could easily be wrong, and there is no direct evidence that regulatory variation in PgGRXC9 leads to higher crop yield via cell elongation and seedling drought tolerance. However, generating such evidence in a poorly studied crop would be a monumental undertaking, and should probably not be the priority of people working on pearl millet!

The utility of this work is that it suggests that it is practicable to gain valuable insight into crop adaptation by clever use of modern methods from a variety of sources.

Reviewer #2 (Public Review):

Carla de la Fuente et al., utilize a diversity of approaches to understand which plant traits contribute to the stress resilience of pearl millet in the Sahelian desert environment. By comparing data resulting from crop modeling of pearl millet growth and meteorological data from a span of 20 years, the authors clearly determined that early season drought resilience is contributed by accelerated growth of the seedling primary root, which confirms a hypothesis generated in a previous study, Passot et al., 2016. To determine the genetic basis for this trait, they performed a combination of GWAS, QTL analysis, and RNA sequencing and identified a previously unannotated coding sequence of a glutaredoxin C9-like protein, PgGRXC9, as the strongest candidate. Phenotypic analysis using a mutant of the closest Arabidopsis homolog AtROXY19 suggests the broad conservation of this pathway. Comparisons between the transcript of PgGRXC9 by in situ hybridization (this work) and AtROXY19 pattern expression (Belin et al., 2014) support the hypothesis that this pathway acts in the elongation zone of the root. Additional analysis of cell production and elongation rates in root apex in both pearl millet and A. thaliana suggests that PgGRXC9 specifically regulates primary root through the promotion of cell elongation. While several studies have established the connection between redox status of cells and root growth, the current study represents an important contribution to the field because of the agricultural importance of the plant studied, and the connection made between this developmental trait and stress resilience in a specific and stressful environmental context of the Sahelian desert.

Reviewer #1 (Public Review):

Trenker et al. report cryo-EM structures of HER4/HER2 heterodimers and HER4 homodimers bound to Neuregulin-1β (Nrg1β) and Betacellulin (BTC). As observed for prior cryo-EM structures of full-length or near full-length HER-family receptors only the extracellular regions are visualized, presumably owing to flexibility in the relative orientation of extra- and intra-cellular regions. The authors observe no appreciable differences between Nrg1β and BTC bound heterodimers, both ligands, in this case being high-affinity ligands, and modest "scissor-like" differences in the subunit relationships in HER4 homodimers with Nrg1β and BTC bound.

The authors also show that, as they showed for HER3, the HER4 dimerization arm is not indispensable for forming heterodimers with HER2 despite the HER4 dimerization arm forming a more canonical interaction with HER2. Perhaps most interestingly, the authors observe glycan interactions that appear to stabilize intra- and inter-subunit interactions in HER4 homodimers but that inter-subunit glycans are not present in HER2/HER4 heterodimers. The authors speculate that these glycan interactions may contribute to the apparent propensity of HER4 to homodimerize vs. heterodimerize with HER2.

I realize that an important role of reviewers is to provide authors with informed and critical comments, but I found this manuscript a well-written, thoughtful, and important contribution. My only note is that I am not an electron microscopist so have assumed the microscopy has been carried out expertly and rely on other reviewers to vet structure determinations.

Reviewer #1 (Public Review):

Summary:<br /> The paper is an attempt to explain a geographic paradox between infection prevalence and antimalarial resistance emergence. The authors developed a compartmental model that importantly contains antigenic strain diversity and in turn antigen-specific immunity. They find a negative correlation between parasite prevalence and the frequency of resistance emergence and validate this result using empirical data of chloroquine-resistance. Overall, the authors conclude that strain diversity is a key player in explaining observed patterns of resistance evolution across different geographic regions.

The authors pose and address the following specific questions:<br /> 1. Does strain diversity modulate the equilibrium resistance frequency given different transmission intensities?<br /> 2. Does strain diversity modulate the equilibrium resistance frequency and its changes following drug withdrawal?<br /> 3. Does the model explain biogeographic patterns of drug resistance evolution?

Strengths:<br /> The model built by the authors is novel. As emphasized in the manuscript, many factors (e.g., drug usage, vectorial capacity, population immunity) have been explored in models attempting to explain resistance emergence, but strain diversity (and strain specific immunity) has not been explicitly included and thus explored. This is an interesting oversight in previous models, given the vast antigenic diversity of Plasmodium falciparum (the most common human malaria parasite) and its potential to "drive key differences in epidemiological features".

The model also accounts for multiple infections, which is a key feature of malarial infections, with individuals often infected with either multiple Plasmodium species or multiple strains of the same species. Accounting for multiple infections is critical when considering resistance emergence, as with multiple infections there is within-host competition which will mediate the fitness of resistant genotypes. Overall, the model is an interesting combination of a classic epidemiological model (e.g., SIR) and a population genetics model.

In terms of major model innovations, the model also directly links selection pressure via drug administration with local transmission dynamics. This is accomplished by the interaction between strain-specific immunity, generalized immunity and host immune response.

Weaknesses:<br /> The authors emphasize several model limitations, including the specification of resistance by a single locus (thus not addressing the importance of recombination should resistance be specified by more than one locus); the assumption that parasites are independently and randomly distributed among hosts (contrary to empirical evidence); and the assumption of a random association between the resistant genotype and antigenic diversity. However, each of these limitations are addressed in the discussion.

Did the authors achieve their goals? Did the results support their conclusion?<br /> Returning to the questions posed by the authors:<br /> 1. Does strain diversity modulate the equilibrium resistance frequency given different transmission intensities? Yes. The authors demonstrate a negative relationship between prevalence/strain diversity and resistance frequency (Figure 2).

2. Does strain diversity modulate the equilibrium resistance frequency and its changes following drug withdrawal? Yes. The authors find that, under resistance invasion and some level of drug treatment, resistance frequency decreased with the number of strains (Figure 4). The authors also find that lower strain diversity results in a slower decline in resistant genotypes after drug withdrawal and higher equilibrium resistance frequency (Figure 6).

3. Does the model explain biogeographic patterns of drug resistance evolution? Yes. The authors find that their full model (which includes strain-specific immunity) produces the empirically observed negative relationship between resistance and prevalence/strain diversity, while a model only incorporating generalised immunity does not (Figure 8).

Utility of work to others and relevance within and beyond the field?<br /> This work is important because antimalarial drug resistance has been an ongoing issue of concern for much of the 20th century and now 21st century. Further, this resistance emergence is not equitably distributed across biogeographic regions, with South America and Southeast Asia experiencing much of the burden of this resistance emergence. Not only can widespread resistant strains be traced back to these two relatively low-transmission regions, but these strains remain at high frequency even after drug treatment ceases.

Reviewer #2 (Public Review):

Summary:<br /> The evolution of resistance to antimalarial drugs follows a seemingly counterintuitive pattern, in which resistant strains typically originate in regions where malaria prevalence is relatively low. Previous investigations have suggested that frequent exposures in high-prevalence regions produce high levels of partial immunity in the host population, leading to subclinical infections that go untreated. These subclinical infections serve as refuges for sensitive strains, maintaining them in the population. Prior investigations have supported this hypothesis; however, many of them excluded important dynamics, and the results cannot be generalized. The authors have taken a novel approach using a deterministic model that includes both general and adaptive immunity. They find that high levels of population immunity produce refuges, maintaining the sensitive strains and allowing them to outcompete resistant strains. While general population immunity contributed, adaptive immunity is key to reproducing empirical patterns. These results are robust across a range of fitness costs, treatment rates, and resistance efficacies. Given sufficient antigenic diversity and high transmission, sensitive parasites remain in circulation even when there is no cost to resistance. This work demonstrates that future investigations cannot overlook adaptive immunity and antigenic diversity.

Strengths:<br /> Overall, this is a very nice paper that makes a significant contribution to the field. It is well-framed within the body of literature and achieves its goal of providing a generalizable, unifying explanation for otherwise disparate investigations. The model is innovative. The approach is elegant and rigorous, with results that are supported across a broad range of parameters when considered within an equilibrium setting. Their exploration of geographical patterns of resistance makes the results of their simulations even more compelling. As such, this work will likely serve as a foundation for many future investigations.

Weaknesses:

Although the authors model resistance invasion, it does not align with empirical observations of the spread of resistance. For example, Plasmodium's mutation rate and population size mean that mutations providing chloroquine resistance should arise repeatedly even within a single infection. Nevertheless, Africa remained free of chloroquine resistant strains until a lineage was introduced from Asia. Upon introduction, it spread across the continent within ten years. The difference between the fate of chloroquine resistance originating in Africa versus chloroquine resistance originating in Asia cannot be attributed to changes in population immunity and treatment.

The source of this disparity may be in part attributable to the use of a deterministic, compartmental model, as the authors mention in the discussion. Strains are not explicitly modeled. This means that in terms of the distribution of strain diversity, the resistant and the sensitive compartments are identical, and the locus determining resistance is equally distributed across all strain backgrounds. However, substantial rates of linkage disequilibrium and clonal reproduction are found even in high transmission settings. The model assumptions may be met at equilibrium, but are not appropriate for most scenarios involving the invasion of a rare mutation.

Reviewer #1 (Public Review):

Summary:<br /> In this manuscript, Janssens et al. addressed the challenge of mapping the location of transcriptionally unique cell types identified by single nuclei sequencing (snRNA-seq) data available through the Fly Cell Atlas. They identified 100 transcripts for head samples and 50 transcripts for fly body samples allowing the identification of every unique cell type discovered through the Fly Cell Atlas. To map all of these cell types, the authors divided the fly body into head and body samples and used the Molecular Cartography (Resolve Biosciences) method to visualize these transcripts. This approach allowed them to build spatial tissue atlases of the fly head and body, to identify the location of previously unknown cell types and the subcellular localization of different transcripts. By combining snRNA-seq data from the Fly Cell Atlas with their spatially resolved transcriptomics (SRT) data, they demonstrated an automated cell type annotation strategy to identify unknown clusters and infer their location in the fly body. This manuscript constitutes a proof-of-principle study to map the location of the cells identified by ever-growing single-cell transcriptomic datasets generated by others.

Strengths:<br /> The authors used the Molecular Cartography (Resolve Biosciences) method to visualize 100 transcripts for head samples and 50 transcripts for fly body samples in high resolution. This method achieves high resolution by multiplexing a large number of transcript visualization steps and allows the authors to map the location of unique cell types identified by the Fly Cell Atlas.

Weaknesses:<br /> Combining single-nuclei sequencing (snRNA-seq) data with spatially resolved transcriptomics (SRT) data is challenging, and the methods used by the authors in this study cannot reliably distinguish between cells, especially in brain regions where the processes of different neurons are clustered, such as in neuropils. This means that a grid that the authors mark as a unique cell may actually be composed of processes from multiple cells.

Reviewer #2 (Public Review):

Summary:<br /> The landmark publication of the "Fly Atlas" in 2022 provided a single cell/nuclear transcriptomic dataset from 15 individually dissected tissues, the entire head, and the body of male and female flies. These data led to the annotation of more than 250 cell types. While certainly a powerful and data-rich approach, a significant step forward relies on mapping these data back to the organism in time and space. The goal of this manuscript is to map 150 transcripts defined by the Fly Atlas by FISH and in doing so, provide, for the first time, a spatial transcriptomic dataset of the adult fly. Using this approach (Molecular Cartography with Resolve Biosciences), the authors, furthermore, distinguish different RNA localizations within a cell type. In addition, they seek to use this approach to define previously unannotated clusters found in the Fly Atlas. As a resource for the community at large interested in the computational aspects of their pipeline, the authors compare the strengths and weaknesses of their approach to others currently being performed in the field.

Strengths:<br /> 1. The authors use Resolve Biosciences and a novel bioinformatics approach to generate a FISH-based spatial transcriptomics map. To achieve this map, they selected 150 genes (50 body; 100 head) that were highly expressed in the single nuclear RNA sequencing dataset and were used in the 2022 paper to annotate specific cell types; moreover, the authors chose several highly expressed genes characteristic of unannotated cell types. Together, the approach and generated data are important next steps in translating the transcriptomic data to spatial data in the organism.<br /> 2. Working with Resolve, the authors developed a relatively high throughput approach to analyze the location of transcripts in Drosophila adults. This approach confirmed the identification of particular cell types suggested by the FlyAtlas as well as revealed interesting subcellular locations of the transcripts within the cell/tissue type. In addition, the authors used co-expression of different RNAs to unbiasedly identify "new cell types". This pipeline and data provide a roadmap for additional analyses of other time points, female flies, specific mutants, etc.<br /> 3. The authors show that their approach reveals interesting patterns of mRNA distribution (e.g alpha- and beta-Trypsin in apical and basal regions of gut enterocytes or striped patterns of different sarcomeric proteins in body muscle). These observations are novel and reveal unexpected patterns. Likewise, the authors use their more extensive head database to identify the location of cells in the brain. They report the resolution of 23 clusters suggested by the single-cell sequencing data, given their unsupervised clustering approach. This identification supports the use of spatial cell transcriptomics to characterize cell types (or cell states).<br /> 4. Lastly, the authors compare three different approaches --- their own described in this manuscript, Tangram, and SpaGE - which allow integration of single cell/nuclear RNA-seq data with spatial localization FISH. This was a very helpful section as the authors compared the advantages and disadvantages (including practical issues, like computational time).

Weaknesses:<br /> 1. Experimental setup. It is not clear how many and, for some of the data, the sex of the flies that were analyzed. It appears that for the body data, only one male was analyzed. For the heads, methods say male and female heads, but nothing is annotated in the figures. As such, it remains unclear how robust these data are, given such a limited sample from one sex. As such, the claims of a spatial atlas of the entire fly body and its head ("a rosetta stone") are overstated. Also, the authors should clearly state in the main text and figure legends the sex, the age, how many flies, and how many replicates contributed to the data presented (not just the methods). What also adds to the confusion is the use of "n" in para 2 of the results. " ... we performed coronal sections at different depths in the head (n=13)..." 13 sections in total from 1 head or sections from 13 heads? Based on the body and what is shown in the figure, one assumes 13 sections from one head. Please clarify.<br /> 2. Probes selected: Information from the methods section should be put into the main text so that it is clear what and why the gene lists were selected. The current main text is confusing. If the authors want others to use their approach, then some testing or, at the very least, some discussion of lower expressed genes should be added. How useful will this approach be if only highly expressed genes can be resolved? In addition, while it is understood that the company has a propriety design algorithm for the probes, the authors should comment on whether the probes for individual genes detect all isoforms or subsets (exons and introns?), given the high level of splicing in tissues such as muscle.<br /> 3. Imaging: it isn't clear from the text whether the repeated rounds of imaging impacted data collection. In many of what appear to be "stitched" images, there are gradients of signal (eg, figure 2F); please comment. Also, since this a new technique, could a before and after comparison of the original images and the segmented images be shown in the supplemental data so that the reader can better appreciate how the authors assessed/chose/thresholded their data? More discussion of the accuracy of spot detection would be helpful.<br /> 4. The authors comment on how many RNAs they detected (first paragraph of results). How do these numbers compare to the total mRNA present as detected by single-cell or single-nuclear sequencing?<br /> 5. Using this higher throughput method of spatial transcriptomics, the authors discern different cell types and different localization patterns within a tissue/cell type.<br /> a. The authors should comment on the resolution provided by this approach, in terms of the detection of populations of mRNAs detected by low throughput methods, for example, in glia, motor neuron axons, and trachea that populate muscle tissue. Are these found in the images? Please show.<br /> b. The authors show interesting localization patterns in muscle tissue for different sarcomere protein-coding mRNAs, including enrichment of sls in muscle nuclei located near the muscle-tendon attachment sites. As this high throughput approach is newly being applied to the adult fly, it would increase confidence in these data, if the authors would confirm these data using a low throughput FISH technique. For example, do the authors detect such alternating "stripes" ( Act 88F, TpnC4, and Mhc) or enriched localization (sls) using FISH that doesn't rely on the repeated colorization, imaging, decolorization of the probes?<br /> 6. The authors developed an unbiased method to identify "new cell types" which relies on co-expression of different transcripts. Are these new cell types or a cell state? While expression is a helpful first step, without any functional data, the significance of what the authors found is diminished. The authors need to soften their statements.

Appraisal:<br /> The authors' goal is to map single cell/nuclear RNAseq data described in the 2022 Fly Atlas paper spatially within an organism to achieve a spatial transcriptomic map of the adult fly; no doubt, this is a critical next step in our use of 'omics approaches. While this manuscript does the hard work of trying to take this next step, including developing and testing a new pipeline for high throughput FISH and its analysis, it falls short, in its present form, in achieving this goal. The authors discuss creating a robust spatial map, based on one male fly. Moreover, they do not reveal principles of mRNA localization, as stated in the abstract; they show us patterns, but nothing about the logic or function of these patterns. This same criticism can be said of the identification of "new cell types, just based on RNA colocalization. In both cases (mRNA subcellular localization or cell type identification), further data in the form of validation with traditional low throughput FISH and genetic manipulations to assess the relation to cell function are required for the authors to make such claims.

Discussion of likely impact:<br /> If revised, these data, and importantly the approach, would impact those working on Drosophila adults as well as those working in other model systems where single cell/nuclear sequencing is being translated to the spatial localization within the organism. The subcellular localization data - for example, the size of transcripts and how that relates to localization or the patterns of sarcomeric protein localization in muscle - are intriguing, and would likely impact our thinking on RNA localization, transport, etc if confirmed. Lastly, the authors compare their computational approaches to those available in the field; this is valuable as this is a rapidly evolving field and such considerations are critical for those wishing to use this type of approach.

Reviewer #1 (Public Review):

Summary:

In this study, Jeong and Choi examine neural correlates of behavior during a naturalistic foraging task in which rats must dynamically balance resource acquisition with the risk of threat. Rats first learn to forage for sucrose reward from a spout, and when a threat is introduced (an attack-like movement from a "LobsterBot"), they adjust their behavior to continue foraging while balancing exposure to the threat, adopting anticipatory withdrawal behaviors to avoid encounter with the LobsterBot. Using electrode recordings targeting the medial prefrontal cortex (PFC), they identify heterogenous encoding of task variables across prelimbic and infralimbic cortex neurons, including correlates of distance to the reward/threat zone, and correlates of avoidance behavior. Based on analysis of population responses, they suggest that the prefrontal cortex switches between coding schemes to process spatial information or behavioral responses in a context-dependent manner. Characterization of the heterogenous coding scheme by which the frontal cortex represents information in different goal states is an important contribution to our understanding of brain mechanisms underlying flexible behavior in ecological settings.

Strengths:

As many behavioral neuroscience studies employ highly controlled task designs, relatively less is known about how the brain organizes navigation and behavioral selection in naturalistic settings, where environment states and goals are more fluid. Here, the authors take advantage of a natural challenge faced by many animals - how to forage for resources in an unpredictable environment - to investigate neural correlates of behavior when goal states are dynamic. Related to this, they also investigate how prefrontal cortex (PFC) activity can reorganize to support different functional "modes" (here, between a navigational mode and an action-selection mode) for flexible behavior. Overall, an important strength and real value of this study is the design of the behavioral experiment, which is trial-structured, permitting the use of standard methods to analyze neural data, yet rich enough to encourage and permit more natural behavior. The experiment is also phased to measure behavioral changes as animals first encounter a threat, and then learn to adapt their foraging strategy to its presence. Characterization of this adaptation process is itself quite interesting and sets a foundation for further study of threat learning and risk management in the foraging context. Finally, the characterization of single-neuron activity from the prefrontal cortex in this naturalistic setting is an important contribution to the field - previous studies have identified the neural correlates of spatial and behavioral variables in the frontal cortex, but the nature of how these representations co-exist or are dynamically adjusted when animals shift their goals is less clear.

Weaknesses:

While the task design in this study is intentionally stimulus-rich and places a minimal constraint on the animal to preserve naturalistic behavior, this is, unfortunately, a double-edged sword, as it also introduces additional variables that confound some of the neural analysis. Because of this, a general weakness of the study is a lack of clear interpretability of the task variable neural correlates. This is a limitation of the task, which includes many naturally correlated variables - however, I think with some additional analyses, the authors could strengthen some of their core arguments and significantly improve clarity.

For example, the authors argue, based on an ANN decoding analysis (Figure 2b), that PFC neurons encode spatial information - but the spatial coordinate that they decode (the distance to the active foraging zone) is itself confounded by the fact that animals exhibit different behavior in different sections of the arena. From the way the data are presented, it is difficult to tell whether the decoder performance reflects a true neural correlate of distance, or whether it is driven by behavior-associated activity that is evoked by different behaviors in different parts of the arena. The author's claim that PFC neurons encode spatial information could be substantiated with a more careful analysis of single-neuron responses to supplement the decoder analysis. For example, 1) They could show examples of single neurons that are active at some constant distance away from the foraging site, regardless of animal behavior, and 2) They could quantify how many neurons are significantly spatially modulated, controlling for correlates of behavior events. One possible approach to disambiguate this confound could be to use regression-based models of neuron spiking to quantify variance in neuron activity that is explained by spatial features, behavioral features, or both.

The authors also claim that the heterogenous encoding of spatial and behavioral variables in PFC neurons is structured in a particular way that depends on the animal's goal state and/or context (a navigational mode and an action-selection mode). The main evidence supporting this interpretation is a population vector analysis based on principal component projections of neural data (Figure 4), which shows that the population response is different, on average, in the encounter zone compared to the foraging and nesting zones. But again, the different "zones" are obligately correlated with different types of behavior/stimuli. Since some neurons are modulated by events unique to the encounter zone (e.g., licking sucrose water, withdrawing from the LobsterBot, etc.), differences in population activity patterns may simply reflect this behavior/event coding. To substantiate the claim that PFC neurons really switch between different coding "modes," the authors could include a version of this analysis where they have regressed out, or otherwise controlled for, these confounds. Otherwise, the claim that the authors have identified "distinctively different states of ensemble activity," as opposed to simple coding of salient task features, seems premature.

Reviewer #3 (Public Review):

Summary:

This study investigates how various behavioral features are represented in the medial prefrontal cortex (mPFC) of rats engaged in a naturalistic foraging task. The authors recorded electrophysiological responses of individual neurons as animals transitioned between navigation, reward consumption, avoidance, and escape behaviors. Employing a range of computational and statistical methods, including artificial neural networks, dimensionality reduction, hierarchical clustering, and Bayesian classifiers, the authors sought to predict from neural activity distinct task variables (such as distance from the reward zone and the success or failure of avoidance behavior). The findings suggest that mPFC neurons alternate between at least two distinct functional modes, namely spatial encoding and threat evaluation, contingent on the specific location.

Strengths:

This study attempts to address an important question: understanding the role of mPFC across multiple dynamic behaviors. The authors highlight the diverse roles attributed to mPFC in previous literature and seek to explain this apparent heterogeneity. They designed an ethologically relevant foraging task that facilitated the examination of complex dynamic behavior, collecting comprehensive behavioral and neural data. The analyses conducted are both sound and rigorous.

Weaknesses:

The primary concern with this study is the absence of direct evidence regarding the role of the mPFC in the foraging behavior of the rats. The ability to predict heterogeneous variables from the population activity of a specific brain area does not necessarily imply that this brain area is computing or using this information. In light of recent reports revealing the distributed nature of neural coding, conducting direct causal experiments would be essential to draw conclusions about the role of the mPFC in spatial encoding and/or threat evaluation. Alternatively, a comparison with the activity from a different brain region could provide valuable insights (or at the very least, a comparison between PL and IL within the mPFC). Moreover, given that high-dimensional movement has been shown to be reflected in the neural activity across the entire dorsal cortex, more thorough comparisons between the neural encoding of task variables and movement would help rule out the possibility that the heterogeneous encoding observed in the mPFC is merely a reflection of the rats' movements in different behavioral modes. Lastly, the main claim of the paper is that the mPFC population switches between different functional modes depending on the context. However, no dynamic analysis or switching model has been employed to directly support this hypothesis.

Conclusion:

To strengthen the argument and offer novel insights into the functions of the mPFC, it would be important to conduct a more comprehensive analysis if additional data cannot be provided.

Reviewer #2 (Public Review):

Summary:

Jeong & Choi (2023) use a semi-naturalistic paradigm to tackle the question of how the activity of neurons in the mPFC might continuously encode different functions. They offer two possibilities: either there are separate dedicated populations encoding each function, or cells alter their activity depending on the current goal of the animal. In a threat-avoidance task rats procured sucrose in an area of a chamber where, after remaining there for some amount of time, a 'Lobsterbot' robot attacked. To initiate the next trial rats had to move through the arena to another area before returning to the robot encounter zone. Therefore the task has two key components: threat avoidance and navigating through space. Recordings in the IL and PL of the mPFC revealed encoding that depended on what stage of the task the animal was currently engaged in. When animals were navigating, neuronal ensembles in these regions encoded distance from the threat. However, whilst animals were directly engaged with the threat and simultaneously consuming reward, it was possible to decode from a subset of the population whether animals would evade the threat. Therefore the authors claim that neurons in the mPFC switched between two functional modes: representing allocentric spatial information, and representing egocentric information pertaining to the reward and threat.

Strengths:

As the authors point out, whilst these multiple functions of activity in the mPFC have generally been observed in tasks dedicated to the study of a singular function, less work has been done in contexts where animals continuously switch between different modes of behaviour in a more natural way. Being able to assess whether previous findings of mPFC function apply in natural contexts is very valuable to the field, even outside of those interested in the mPFC directly. This also speaks to the novelty of the work; although mixed selectivity encoding of threat assessment and action selection has been demonstrated in some contexts (e.g. Grunfeld & Likhtik, 2018) understanding the way in which encoding changes on-the-fly in a self-paced task is valuable for verifying whether current understanding holds true.

The authors are also generally thoughtful in their analyses and use a variety of approaches to probe the information encoded in the recorded activity. In particular, they also use relatively close analysis of behaviour as well as manipulating the task itself by removing the threat to verify their own results. The use of such a rich task also allows them to draw comparisons, e.g. in different zones of the arena or different types of responses to threats, that a more reduced task would not otherwise allow.

Weaknesses:

The central question the paper seeks to answer is whether 'individual cells are dedicated to spatial representation and emotional stimuli processing or if they adapt their function to the current goal'. However, there does not seem to be a direct analysis that answers this question. It is not clear what proportion of each of the ensembles recorded is necessary for decoding distance from the threat, and whether it is these same neurons that directly 'switch' to responding to head entry or withdrawal in the encounter phase within the total population. The PCA gets closest to answering this question by demonstrating that activity during the encounter is different from activity in the nesting or foraging zones, but in principle this could be achieved by neurons or ensembles that did not encode spatial parameters. The population analyses are focused on neurons sensitive to behaviours relating to the threat encounter, but even before dividing into subtypes etc., this is at most half of the recorded population. And again it is difficult to ascertain how the final ensemble analysis of the avoidance response relates to the prior spatial encoding. As a result, the model of the results proposed in Fig. 7 cannot be validated by the data as is.

A second concern is also illustrated by Fig. 7: in the data presented, separate reward and threat encoding neurons were not shown - in the current study design, it is not possible to dissociate reward and threat responses as the data without the threat present were only used to study spatial encoding integrity. To be able to claim this working model, a key additional analysis is to compare PETHs around head entry and withdrawal for sucrose without attack. Alternatively, a small proportion of probe trials could have been added where rats did not receive any reward for being in the encounter zone. This would allow the authors to ascertain whether the elevated response of the Type 2 neurons in particular is partially driven by reward receipt.

Thirdly, the findings of this work are not mechanistic or functional but are purely correlational. For example, it is claimed that analysing activity around the withdrawal period allows for ascertaining their functional contributions to decisions. But without a direct manipulation of this activity, it is difficult to make such a claim. The authors later discuss whether the elevated response of Type 2 neurons might simply represent fear or anxiety motivation or threat level, or whether they directly contribute to the decision-making process. As is implicit in the discussion, the current study cannot differentiate between these possibilities. However, the language used throughout does not reflect this.

Fourthly, the authors mention the representation of different functions in 'distinct spatiotemporal regions' but the bulk of the analyses, particularly in terms of response to the threat, do not compare recordings from PL and IL although - as the authors mention in the introduction - there is prior evidence of functional separation between these regions.

Reviewer #1 (Public Review):

Summary:<br /> The authors aimed to infer the trajectories of long range and local neuronal synchrony across the Alzheimer's disease continuum, relative to neurodegeneration and cognitive decline. The trajectories are inferred using event-based models, which infer a set of data-driven disease stages from a given dataset. The authors develop an adapted event-based modelling approach, in which they characterise each stage as a particular biomarker increasing by a particular z-score deviation from controls. Fitting infers the optimal set of z-scores to use for each biomarker and the order in which each biomarker reaches each z-score. The authors apply this approach to data from 148 individuals (70 cognitively unimpaired older adults and 78 individual with mild cognitive impairment or Alzheimer's disease), identifying trajectories in which long-range (amplitude-envolope correlation) and local (regional spectral power) neuronal synchrony in the alpha and beta bands becomes abnormal prior to neurodegeneration (measured as the volume of the parahippocampal gyrus) and cognitive decline (measured using the mini-mental state examination).

Strengths:<br /> - The main strength is that the authors assess two models. In the first they derive a staging system based only on the volume of the parahippocampal gyrus and mini-mental state examination score. They then investigate how neuronal synchrony metrics change compared to this staging system. In the second they derive a staging system that also includes an average (combined long-range and local) neuronal synchrony metric and investigate how long-range and local synchrony metrics change relative to this staging system. This is a strength as the first model provides confidence that there is not overfitting to the neuronal synchrony data, and the second provides more detailed insights into the dynamics of the early neuronal synchrony changes.<br /> - Another strength is that the authors automatically infer the optimal z-scores to choose, rather than having to pre-select them manually, as in previous approaches.

Weaknesses:<br /> - The authors do not have a dataset for external validation.

Reviewer #2 (Public Review):

Summary: This work presented by Kudo and colleagues is of great importance to strengthen our understanding of electrophysiological changes in the course of AD. Although the main conclusions regarding functional connectivity and spectral power change through the course of the disease are not new and have been largely studied and theorised on, this article offers an innovative approach that certainly consolidates previous knowledge on the topic. Not only that, this article also broadens our knowledge presenting useful and important details on the specificity of frequency and cortical distribution of these early alterations. The main take-home message of this work is the early disruption of electrophysiological signatures that precedes detectable alterations in other more commonly used pathology markers (i.e. gray matter atrophy and cognitive impairment). More specifically, these signatures include long-range connectivity in the alpha and beta bands, and local synchrony (spectral power) in the same frequency bands.

Strengths: The present work has some major strengths that make it paramount for the advance of our understanding of AD electrophysiology. It is a very well written manuscript that, despite the complexity of the analyses employed, runs the reader through the different steps of the analysis in a pedagogic and clever way, making the points raised by the results easy to grasp. The methodology itself is carefully chosen and appropriate to the nature of the question posed by the researchers, as event-based models are well-suited for cross-sectional data.

The quality of the figures is outstanding; not only are they aesthetic but, more importantly, the figures convey information exceptionally well and facilitate comprehension of the main results.<br /> The conclusions of the paper are, in general, well described and discussed, and consider the state-of-the-art works of AD electrophysiology. Furthermore, even though the conclusions themselves are not groundbreaking at all (synaptic damage preceding structural and cognitive impairment is one of the epitomes of the pathological cascading model proposed by Jack in 2010), this article is innovative and groundbreaking in the way they address with clever analyses in a relatively large sample for neuroimaging standards.

Weaknesses: The authors increased the clarity of sample description after revisions (particularly control group characterization). However, even though it is true that a certain percentage of AB positivity is to be expected amongst cognitively healthy individuals, that doesn´t discard they are not expressing preclinical AD to some extent. I still feel that including only biomarker negative participants in the control group would increase the quality of the work. However, the sample is relatively well characterized as a whole and the results are interesting and in line with previous literature, thus limiting the apparent impact of these possible confounds.

Reviewer #1 (Public Review):

In this study, Lin et al developed a protocol termed MOCAT, to perform tissue clearing and labelling on large-scale FFPE mouse brain specimens. They have optimised protocols for dewaxing and adequate delipidation of FFPE tissues to enable deep immunolabelling, even for whole mouse brains. This was useful for the study of disease models such as in an astrocytoma model to evaluate spatial architecture of the tumour and its surrounding microenvironment. It was also used in a traumatic brain injury model to quantify changes in vasculature density and differences in monoaminergic innervation. They have also demonstrated the potential of multi-round immunolabelling using photobleaching, as well as expansion microscopy with FFPE samples using MOCAT.

Strengths:<br /> This paper has demonstrated, with some good imaging examples, that it is possible to perform deep immunostaining with detailed analysis on FFPE samples using MOCAT. The figures provided appeared to be largely convincing with good amount of details.

They have showcased different ways to perform analysis on cleared tissue. For example, the use of lectin-labelled blood vessels as a structural reference for multi-round immunolabelling was very useful. They have also demonstrated how to generate comparable quantitative data on various mouse disease models which will be important for future tissue-clearing studies.

Weaknesses:<br /> Although the authors have proven the feasibility of their techniques on FFPE samples, it is questionable whether this will translate well for human brain tissues. The vast majority of the study data was generated using rodent brain tissues and it appears the technique was only performed on human FFPE tissues no larger than 1 mm in thickness. The PFA/formalin fixation time for the tissue was also limited to 24 hours in this study. Whilst this may be true for most surgical specimens, whole brain specimens in brain banks will often have formalin fixation time exceeding 3 weeks. The issue of prolonged formalin fixation prior to embedding in paraffin wax was not addressed in this study.

Inherent differences in human and rodent brain tissues may affect the effectiveness of immunostaining. In this study, results on human brain specimens appeared to show a reduction in clarity and staining quality at greater imaging depth at 900 µm, particularly for MAP2 and GFAP (Figure 5).

In addition, there are inadequate details in the materials and methods section which may limit the readers' ability to successfully replicate the study or proposed method for tissue clearing. Further details on the optimisation of this protocol and brief details from previously published protocols were not described in the methods section.

Reviewer #2 (Public Review):

The manuscript details an investigation aimed at developing a protocol to render centimeter-scale formalin-fixed paraffin-embedded specimens optically transparent and suitable for deep immunolabeling. The authors evaluate various detergents and conditions for epitope retrieval such as acidic or basic buffers combined with high temperatures in entire mouse brains that had been paraffin-embedded for months. They use various protein targets to test active immunolabeling and light-sheet microscopy registration of such preparations to validate their protocol. The final procedure, called MOCAT pipeline, briefly involves 1% Tween 20 in citrate buffer, heated in a pressure cooker at 121 {degree sign}C for 10 minutes. The authors also note that part of the delipidation is achieved by the regular procedure.

Major Strengths<br /> - The simplicity and ease of implementation of the proposed procedure using common laboratory reagents distinguish it favorably from more complex methods.

- Direct comparisons with existing protocols and exploration of alternative conditions enhance the robustness and practicality of the methodology.

Major Weaknesses<br /> - There is no evidence of actual transparency of the entire mouse brain across different treatments. The suggested protocol is very good at removing lipids (as assessed by DiD staining) and by results of fluorescence registration deep within the brain. BUT, since in many places of the manuscript authors speak of "transparency" the reader will expect the typical picture in which control and processed brains are on top of a white graphical pattern that would evidence transparency (see as an example Figure 1 and 2 of Wan et al. 2018 (Neurophotonics. 2018 Jul;5(3):035007. doi: 10.1117/1.NPh.5.3.035007.)

- The manuscript lacks clarity on the applicability of MOCAT to regular formalin-fixed tissue and tissues other than the brain.

- Insufficient information is provided on the "epoxy treatment" or "hydrogel," and a more detailed explanation is warranted.

- The differences between passive and active immunolabeling, as well as photobleaching data, should be addressed for a comprehensive understanding.

- The assertion that MOCAT can be rapidly applied in hospital pathology departments seems overstated due to the limited availability of light-sheet microscopes outside research labs.

- The compatibility of MOCAT with genetically encoded fluorescent proteins remains unclear and warrants further investigation.

- The control of equivalent depths in cryosections for evaluating the intensity of DiD staining should be elaborated upon.

- The composition of NFC1 and NFC2 solutions for refractive index matching should be provided.

Final considerations<br /> The evidence presented supports the effectiveness of the proposed method in rendering thick FFPE samples transparent and facilitating repeated rounds of immunolabeling.

The developed procedure holds promise for advancing tissue and 3D-specific determination of proteins of interest in various settings, including hospitals, basic research, and clinical labs, particularly benefiting neuroscience research.

The methodological findings suggest that MOCAT could have broader applications beyond FFPE samples, differentiating it from other tissue-clearing approaches in that the equipment and chemicals needed are broadly accessible.

Reviewer #1 (Public Review):

Summary:<br /> In this manuscript, the authors set out to develop genetic tools that can specifically and comprehensively label Axo-Axonic Cells (AACs), also known as Chandelier cells. These AACs possess unique morphological and connectivity features, making them an ideal subject for studying various aspects of cell types across different experimental methods. To achieve both specificity and comprehensiveness in AAC labeling, the authors employ an intersectional strategy that combines lineage origin and molecular markers. This approach successfully targets AACs across the mouse brain and reveals their widespread distribution in various brain structures beyond the previously known regions. Additionally, the authors utilize rabies transneuronal labeling to provide a comprehensive overview of AACs, their variations, and input sources throughout the brain. This experimental approach offers a powerful model system for investigating the role of AACs in circuit development and function across diverse brain regions.

Strengths:<br /> Genetic Tools and Specificity: The authors' genetic tools show qualitative evidence of specificity for AACs, opening new avenues for targeted research on these cells. The use of intersectional strategies enhances the precision of AAC labeling.

Widespread Distribution: The study significantly broadens our understanding of AAC distribution, revealing their presence in brain regions beyond what was previously documented. This expanded knowledge is a valuable contribution to the field.

Transneuronal Labeling: The inclusion of rabies transneuronal labeling provides a comprehensive view of AACs, their variations, and input sources, allowing for a more holistic understanding of their role in neural circuits.

Weaknesses:<br /> Quantitative Analysis: While the claim of specificity appears qualitatively convincing, the manuscript could be improved with more quantitative analysis.

Comprehensiveness Claim: The assertion of comprehensiveness, implying labeling "almost all" AACs in all brain regions, is challenging to substantiate conclusively. Acknowledging the limitations of proving complete comprehensiveness and discussing them in the discussion section would be more appropriate than asserting it in the results section.

Local Inputs: While the manuscript focuses on inter-areal inputs to AACs, it would benefit from exploring local inputs as well. Identifying the local neurons that target AACs and analyzing their patterns could provide valuable insights into AAC function within specific brain regions.

Discussion Focus: The discussion section should delve deeper into the biological implications of the findings, moving beyond technical significance. Exploring similarities and differences in input patterns between AACs and other cell types, and linking them to the locations of starter cells or specific connectivity patterns in the brain, would enrich the discussion. For instance, investigating whether input patterns can be predicted based on the locations of starter cells or connectivity specificity could provide valuable insights.

Reviewer #2 (Public Review):

Summary:<br /> The goals of this study were to develop a genetic approach that would specifically and comprehensively target axo-axonic cells (AACs) throughout the brain and then to describe the patterns and characteristics of the targeted AACs in multiple, selected brain regions. The investigators have been successful in providing the most complete description of the regional distribution of putative (pAACs) throughout the brain to date. The supporting evidence is convincing, even though incomplete in some brain regions. The findings should serve as a guide for more detailed studies of AACs within each brain region and lead to new insights into the connectivity and functional organization of this important group of GABAergic interneurons.

Strengths:<br /> The study has numerous strengths. A major strength is the development of a unique intersectional genetic strategy that uses cell lineage (Nkx2.1) and molecular (Unc5b or Pthlh) markers to identify axo-axonic AACs specifically and, apparently, nearly completely throughout the mouse brain. While AACs have been described previously in the cerebral cortex, hippocampus, and amygdala, there has been no specific genetic marker that selectively identifies all AACs in these regions.

The current genetic strategy has labeled pAACs in a large number of additional brain regions, including the claustrum-insular complex, extended amygdala, and several olfactory centers. In general, the findings provide support for the specificity of the methods for targeting AACs, and include some examples of labeling near markers of axon initial segments. However, the Investigators are careful to refer to labeled neurons as "putative AACs" as they have not been fully characterized and their identity verified.

The descriptions and numerous low-magnification images of the brain provide a roadmap for subsequent, detailed studies of AACs in numerous brain regions. The overview and summaries of the findings in the Abstract, Introduction, and Discussion are particularly clear and helpful in placing the extensive regional descriptions of AACs in context.

Weaknesses:<br /> One weakness of the study is the lack of an illustration of the high-resolution cell labeling that can be achieved with the methods, including labeling of numerous rows of axon terminals in contact with axon initial segments. The initial images of the brain-wide distribution of putative AACs are necessarily presented at low magnification. Although the authors indicate that the cells have "highly characteristic AAC labeling patterns throughout the neocortex, hippocampus and BLA", these morphological details cannot be visualized by the reader at the current magnification, even when the images are enlarged on the computer screen. Some of the details become evident in later Figures, but an initial illustration of single cell labeling with confocal microscopy, or tracing of their characteristic axonal arbors, would support the specificity of the labeling in the low magnification images.

Table 1 indicates that the AAC identity of the cells has been validated in many brain regions but not in all. The methods used for validation have not been described and should be included for completeness. The authors are careful to acknowledge that labeled cells in some regions have not been validated and refer to such cells as pAACs.

The intersectional genetic methods included the use of the lineage marker Nkx2.1 with either Unc5b or Pthlh as the molecular marker. As described, the mice with intersectional targeting of Nkx2.1 and Unc5b appear to show the most specific brain-wide labeling for AACs, and the majority of the descriptions are from these mice. The targeting with Nkx2.1 and Pthlh is less convincing. The title for Figure 1 Supplemental Figure 3 suggests a similar AAC distribution in the Pthlh;Nkx2.1 mouse compared to the Unc5b;Nkx2.1 mouse. However, the descriptions of the individual panels suggest a number of inconsistencies and non-AAC labeling. The heavy labeling in the caudate and cells in layer 4 is particularly problematic. Based on the data presented, it appears that heavy labeling achieved in these mice could not be relied on for specific labeling of all AACs, although specific labeling could be achieved under some conditions, such as following tamoxifen administration at select ages.

The methods described for dense labeling and single-cell labeling are described briefly in the methods. Some discussion of the development of the methods would be useful, including how it was determined that methods for heavy labeling identified AACs specifically and completely.

Reviewer #3 (Public Review):

Summary:<br /> Raudales et al. aimed at providing an insight into the brain-wide distribution and synaptic connectivity of bona fide GABAergic inhibitory interneuron subtypes focusing on the axo-axonic cell (AAC), one of the most distinctive interneuron subtypes, which innervates the axon initial segments of glutamatergic projection neurons. They establish intersectional genetic strategies that enable them to specifically and comprehensively capture AACs based on their lineage (Nkx2.1) and marker expression (Unc5b, Pthlh). They find that AACs are deployed across essentially all the pallium-derived brain structures as well as the anterior olfactory nucleus, taenia tecta, and lateral septum. They show that AACs in distinct areas and layers of the neocortex as well as different subregions of the hippocampal formation display unique soma and synaptic density and morphological variations. Rabies virus-based retrograde monosynaptic input tracing reveals that AACs in the neocortex, the hippocampus, and the basolateral amygdala receive synaptic inputs from common as well as specific brain regions and supports the utility of this novel genetic approach. This study elucidates brain-wide neuroanatomical features and morphological variations of AACs with solid techniques and analysis. Their novel AAC-targeting strategies will facilitate the study of their development and function in different brain regions. The conclusions in this paper are well supported by the data. However, there are a few comments to strengthen this study.

1) The definition of putative AAC (pAAC) is unclear and Table 1 may not be accurate. Although the authors find synaptic cartridges of RFP-labeled cells in the claustro-insular complex and the dorsal endopiriform nuclei, they still consider these cells as pAACs (not validated). The authors claim that without examining the presence of synaptic cartridges, RFP-labeled cells in the hypothalamus and the bed nuclei of the stria terminalis (BNST) are pAACs while those in the L4 of the somatosensory cortex in Pthlh;Nkx2.1;Ai65 mice are non-AACs. In Table 1, the BNST is supposed to contain AACs (validated), but in the text, the authors claim that RFP-labeled cells in the BNST are pAACs. Could the authors clarify how AACs, pAACs, and non-AACs are defined?

2) The intersectional strategies presented in this study could also specifically capture developing AACs. If so, how early are AACs labeled in the brain? It would also be nice if the authors could add a simple schematic like Fig. 1a showing the time course of Pthlh expression.

Reviewer #1 (Public Review):

Summary:<br /> This describes the molecular identity of the intermediate status of cranial neural crest cells (NCCs) during the initial delamination process. Taking advantage of single-cell RNA seq, the authors identify new populations of cells during EMT characterized by a specific set of gene expressions, including Dlc1. Promigratory cranial NCCs differentiate through different trajectories depending on their cell cycle phases but converge into a common progenitor, then differentiate into mesenchymal cells expressing region-specific genes.

Strengths:<br /> Single-cell RNA seq data convincingly support what the authors claim. This is the first time to identify intermediate states between premigratory and migratory cranial NCCs. Silencing one of the marker genes, Dlc1, reduces the migratory activity of cranial NCCs. These findings deepen our understanding of the mechanism of EMT in general.

Weaknesses:<br /> Common and specific features between cranial and trunk NCCs could be described/discussed in-depth. Phenotypic relations between the reduction of delamination and defects found in Dlc1 mutant mice can be discussed.

Reviewer #2 (Public Review):

Zhao et al., focus on mechanisms through which cells convert from epithelium to mesenchyme and become migratory. This phenomenon of epithelial-to-mesenchymal transition (EMT) occurs during both embryonic development and cancer progression. During cancer progression, EMT seemingly includes cells at intermediate states as defined by the combinatorial expression of epithelial and mesenchymal markers. However, the importance of these markers and the role of these intermediate states remains unclear. Moreover, whether EMT during development also involves equivalent intermediate cell states is not known. To address this gap in knowledge, the authors devise a strategy to identify and characterize changes that an embryonic population of cells called the cranial neural crest undergo as they delaminate from the neuroepithelium and become a highly migratory population of mesenchymal cells that ultimately give rise to a broad range of derivatives.

To isolate and study the neural crest, the authors use embryos collected at E8.5 from two transgenic mouse lines. Wnt1-Cre;RosaeYFP labels Wnt1-positive neuroepithelial cells in the dorsolateral neural plate, which includes pre-migratory neural crest that resides in the dorsal neuroectoderm and neural plate border before induction (as well as some other lineages). Mef2c-F10N-LacZ leverages a neural crest cell-specific enhancer of Mef2c to control LacZ expression in the predominantly migratory neural crest. This dual genetic approach that allows the authors to distinguish and compare pre-migratory and migratory neural crest cells is a strength of the work. However, one potential weakness needing to be addressed is that some workers (e.g., Lewis et al., 2013) have reported phenotypic effects of Wnt1-Cre transgene expression including ectopic Wnt pathway activation, abnormal neuroepithelial development, and increases in CyclinD1 expression and cell proliferation. The authors should discuss the extent to which the results of their study were or were not influenced by these potentially confounding effects, especially since Wnt canonical signaling is known to regulate the G1/S transition and promote delamination of the neural crest.

To assay for the differential expression of genes involved in the EMT and migration of cranial neural crest, the authors perform single-cell RNA sequencing (scRNA-seq) using current methods. A strength is a large sample size per mouse line, and relatively high numbers of single cells analyzed. The authors identify six major cell/tissue types present in mouse E8.5 cranial tissues using known markers, which they then segregate into a cranial neural crest cluster using a well-reasoned bioinformatic strategy. The cranial neural crest cluster contains pre-migratory and migratory cells that they partition further into five subclusters and then characterize using the differential expression and combinatorial patterns of neural crest specifier genes, markers of pre-migratory neural crest, markers of early versus late migratory neural crest, markers of undifferentiated versus differentiated neural crest, tissue-specific markers, and region-specific markers. One weakness is that there is no attempt to map potential novel genes and/or pathways that also distinguish these clusters.

The authors then go on to subdivide the five cranial neural crest subclusters into almost two dozen smaller subclusters, again using the combinatorial expression of known markers (e.g., neural crest genes, cell junction genes, and cell cycle genes). A weakness is that the marker analysis and accompanying interpretation of the results rely heavily on the purported roles of different genes as described in the published work of others, which potentially introduces some untested assumptions and a bit of hand-waving into the study. Moreover, the limited correlation between mRNA and protein abundance for cell cycle markers is well documented in the literature but the authors rely heavily on gene expression to determine cell cycle status. Even though the authors add a compelling Edu/pHH3 double-labeling experiment and cell cycle inhibition studies, the work would be strengthened by including some analysis of protein expression to see if the cell cycle correlations hold up. Nonetheless, the subcluster and cell cycle analyses lead the authors to conclude that there are a series of intermediate cell states between neural crest EMT and delamination, and that cell cycle regulation is a defining feature and necessary component of those states. These novel findings are generally well supported by the data.

To test if there are spatiotemporal differences in the localization of neural crest cells during EMT in vivo, the authors apply a cutting-edge technique called signal amplification by exchange reaction for multiplexed fluorescent in situ hybridization (SABER-FISH), which they validate using standard in situ hybridization. The authors select specific marker genes that seem justified based on their scRNA-seq dataset, and they generate a series of convincing images and quantitative data that add valuable depth to the story.

As a functional test of their hypothesis that one of the genes indicative of an EMT intermediate stage (i.e., Dlc1) is essential for neural crest migration, the authors use a lentivirus-mediated knockdown strategy. A strength is that the authors include appropriate scramble and cell death controls as part of their experimental design. However, a weakness is that the authors do not justify why they chose a knockdown strategy, which has its limitations including its systemic injection into the amniotic cavity, its likely global and more variable effects, and its need to be conducted in culture. Why the authors did not instead use a Wnt1-Cre-mediated deletion of Dlc1, which would have been "cleaner" and more specific to the neural crest, is not clear (maybe so they could specifically target different Dcl1 isoforms?). Also, the authors use Sox10 as a marker to count neural crest cells, but Sox10 may only label a subset of neural crest cells and thus some unaffected lineages may not have been counted. The authors should mention what is known about the regulation of Dcl1 by Sox10 in the neural crest. Although the data are persuasive, a second marker for counting neural crest cells following knockdown would make the analysis more robust. Can the authors explain why they did not simply use the Mef2c-F10N-LacZ line and count LacZ-positive cells (if fluorescence signal was required for the quantification workflow, then could they have used an anti-beta Galactosidase antibody to label cells)?

Overall, this is a first-rate study with many more strengths than weaknesses. The authors generate high-quality data, and their interpretations are reasonable and balanced. Another strength is the writing, which is clear and well organized, and the figures (including supplemental), which are excellent and provide unambiguous visualization of some very complex data sets. The methods are state-of-the-art and are effectively executed, and they will be useful to the broader cell and developmental biology community. The work contains well-substantiated findings and supports the conclusion that EMT is a highly dynamic, multi-step process, which was previously thought to be more-or-less binary. Such findings will alter the way the field thinks about EMT in neural crest and the work will likely serve as an important example alongside cancer metastasis.

Reviewer #3 (Public Review):

Summary:<br /> Zhao et al. address the question of whether intermediate states of the epithelial-to-mesenchymal transition (EMT) exist in a natural developmental context as well as in cancer cells. This is important not only for our understanding of these developmental systems but also for their development as resources for new anti-cancer approaches. Guided by single-cell RNA sequencing analysis of delaminating mouse cranial neural crest cells, they identify two distinct populations with transcriptional signatures intermediate between neuroepithelial progenitors and migrating crest. Both clusters are intermediate spatially and actively cycling, with one in S-phase and one in G2/M. They show that blocking progression through S phase prior to the onset of delamination and knockdown of intermediate state marker Dlc1 both reduce the number of migratory cells that have completed EMT. Overall, the work provides a modern take and new insights into the classical developmental process of neural crest delamination.

Strengths:<br /> • Deep analysis of the scRNAseq dataset revealed previously unappreciated cell populations intermediate between premigratory and migratory crest.<br /> • The observation that delaminating/intermediate neural crest cells appear to be in S or G2/M phase is interesting and worth reporting, though the ultimate significance remains unclear, given that they do not make distinct derivatives depending on their cycle state.<br /> • The authors employ new methods for multiplex spatial imaging to more accurately define their populations of interest and their relative positions.<br /> • The authors present evidence that intermediate state gene Dlc1 (a Rho GAP) is not just a marker but functionally required for neural crest delamination in mice, as previously shown in chicken.

Weaknesses:<br /> • Similar experiments involving blockade of cell cycle progression and Dlc1 dose manipulation were previously performed in chick models, as noted in the discussion. The newly-defined intermediate states give added context to the results, but they are not entirely novel.<br /> • The putative intermediate cells differentially express mRNAs for genes involved in cell adhesion, polarity, and protrusion relative to bona fide premigratory cells (Fig. 2E). This is persuasive evidence, but only differentially expressed genes are shown. Discussing those markers that have not yet changed, e.g. Cdh1 or Zo1 (?), would be instructive and help to clarify the order of events.<br /> • It is unclear whether the two putative intermediate state clusters differ other than their stage of the cell cycle. Based on the trajectory analysis in Fig. 3C-D, the authors state that these two populations form simultaneously and independently but then merge into a single population. However, without further differential expression, it seems more plausible that they represent a single population that is temporarily bifurcated due to cell cycle asynchrony.<br /> • The authors do not present an in-depth comparison of these neural crest intermediate states to previously reported cancer intermediate states. This analysis would reveal how similar the signatures are and thus how extrapolatable these and future findings in delaminating neural crest are to different types of cancer.<br /> • Lines 265-289 (Fig. 4): The aphidicolin treatments appear to have been started before NC delamination begins in earnest, so the fact that there are any migratory SOX10+ neural crest in the treated embryos at all indicates that progression through S-phase is not explicitly required for delamination. The authors surmise that the successfully delaminated cells may instead have been in G2/M phase (perhaps representing cluster 10') already at the start of treatment and thus able to progress through EMT, while S phase intermediate and true premigratory cells were not. This is plausible. However, the reduction in SOX10+ cells may be in part or wholly attributable to inhibition of proliferation AFTER delamination. Showing that there are premigratory NCCs in G2/M at ~E8.0 would bolster the argument that this population is present from the earliest stages.

Reviewer #1 (Public Review):

In this manuscript, Seba et al., investigate the mechanism of chromosome organization by the MukBEF complex in E. coli. They use a combination of Hi-C and ChIP analysis to understand the steps of MukBEF regulation: its unloading from DNA (how MukBEF activity is prevented in the terminus regions of the chromosome by MatP), and its loading onto DNA (how DNA replication influences MukBEF association with the chromosome). Seba et al., induce chromosomal rearrangements to flip the sections of the ter region, thus perturbing matS site numbers and position. They find that MukBEF activity is prevented around matS sites and that higher matS density has greater effect on MukBEF. Separately, using replication mutants and inducible MukBEF expression, they find that MukBEF can associate with the chromosome even in the absence of replication (as seen by the emergence of long-range contacts). However, ChIP data suggests that MukBEF binding to DNA is enriched on newly replicated DNA.

Altogether, this work provides a valuable and comprehensive view of MukBEF-mediated chromosome organization, with insights on the mechanism of the exclusion of MukBEF from the terminus region of the chromosome. The use of the programmed genetic rearrangements is powerful and allows the authors to provide clear and convincing evidence for MukBEF exclusion from ter by matS sites. It is particularly striking to see that MukBEF can promote long-range contacts even in chromosomal regions between two matS, but the complex is excluded from the matS 'zones'. Experiments using cells blocked for replication show that MukBEF can influence chromosome organization in the absence of replication as well. While previous studies have reported some evidences in support of both of the above conclusions, the experiments described here offer a clear and direct demonstration of the same.

Reviewer #2 (Public Review):

Summary:<br /> Chromosome organization in E. coli and related species ('transversal') deviates starkly from the pattern more commonly found in bacteria ('longitudinal'). The underlying mechanisms and the physiological roles, however, are not well understood. This manuscript by Seba et al. investigates the activity and regulation of MukBEF in chromosome folding in E. coli. Using a construct for inducible expression of MukBEF, the authors first demonstrate that the initiation of long-range chromosome contacts (likely by loop extrusion) is not restricted to few positions on the chromosome and rather widely distributed but excluding the replication terminus region. Using ChIP-Seq, the authors show that the distribution of MukBEF over the chromosome is consistent with widely distributed loading and moreover indicate a connection of chromosome folding and DNA replication with newly replicated DNA shower an increased tendency for MukBEF binding. To dissect this further, they then redistribute matS sites on the chromosome by a clever strategy based on large-scale transpositions. The results reveal that matS-free DNA segments undergo MukBEF dependent folding regardless of their position relative to the origin of replication, being consistent with a broad distributed loading of MukBEF. By fine-mapping with smaller transposition events, they show that few matS sites are sufficient to impede MukBEF activity. Surprisingly, however, E. coli and most related genomes harbor many matS sites, which are particularly highly concentrated near the chromosome dimer resolution dif site (Fig. 5).

This is a well-executed and well-presented study. The findings show that the MatP/matS system acts locally and independent of DNA replication to restrict MukBEF in the replication terminus region. Few of the many matS sites are sufficient for MukBEF restriction. The main conclusions of the work are clear and well supported by the data.

Reviewer #3 (Public Review):

Seba et al. investigate whether chromosomal recruitment of the E. coli SMC complex MukBEF is initiated at a single site, how MukBEF activity is excluded from the replication terminus region, and whether its recruitment and activity depend on DNA replication. Upon induction of MukBEF, the authors find that chromosomal long-range contacts increase globally rather than from a single site. Using large-scale chromosome rearrangements, they show that matS sites can insulate separate areas of high MukBEF activity from each other. This suggests that MukBEF loads at multiple sites in the genome. Finally, the authors propose that MukBEF associates preferentially with newly replicated DNA, based on ChIP-seq experiments after DNA replication arrest.

The conclusions of the paper are well supported by the data. The ratiometric contact analyses and range-of-contact analyses are compelling and nicely show the interplay between MukBEF and its proposed unloader MatP/matS. I particularly enjoyed the chromosome re-arrangement experiments, which lend strong support to the idea that MukBEF activity is independent of a centralized loading site.<br /> The enrichment of MukBEF in newly replicated regions is convincing, despite somewhat small effect sizes. The suggestion that matS density controls MukBEF activity is appealing, but will need additional support from more systematic studies. It is based on a comparison of only two strains (looking at different combinations of three matS sites), and the effect size is small. As it is, differences in matS sequence composition and genomic context cannot be factored out.

Overall, the work is an important advance in our understanding of bacterial chromosome organization. It will be of broad interest to chromosome biologists and bacterial cell biologists.

Reviewer #1 (Public Review):

In this study, the authors seek to characterize the role of splicing factor SRSF1 during spermatogenesis using Vasa-Cre;Srsf1Fl/del mice model. The authors first revealed that spermatogonia-related genes (e.g., Plzf, Id4, Setdb1, Stra8, Tial1/Tiar, Bcas2, Ddx5, Srsf10, Uhrf1, and Bud31) were bound by SRSF1 in the mouse testes by CLIP-seq. The authors convincingly demonstrated that specific deletion of SRSF1 in mouse gem cells with vasa-cre lead to NOA by impairing homing and failure survival of spermatogonia. To investigate the molecular mechanisms of SRSF1 in spermatogonia, further multiomics analysis including CLIP-seq, IP-MS, and RNA-seq were conducted. The results showed that SRSF1 coordinated with other RNA splicing-related proteins to directly bind and regulate the expression of nine spermatogonia-related genes especially Tial1/Tiar via alternative splicing. The authors revealed the critical role of SRSF1-mediated AS in precursor SSCs homing and survival, which may provide a framework to elucidate the molecular mechanisms of the posttranscriptional network underlying the formation of SSC pools and the establishment of niches. This work will be of interest to stem cell and reproductive biologists. The experiments are well-designed and conducted, and the overall methods and results are convincing except for the claim that altered splicing of the Tial1 transcript mediates the effect of SRSF1 loss.

Reviewer #2 (Public Review):

Summary<br /> The authors seek to characterize the role of splicing factor SRSF1 during spermatogenesis. Using a conditional deletion of Srsf1 in germ cells, they find that SRSF1 is required for male fertility. Via immunostaining and RNA-seq analysis of the Srsf1 conditional knockout (cKO) testes, combined with SRSF1 CLIP-seq and IP-MS data from the testis, they ultimately conclude that Srsf1 is required for homing of precursor spermatogonial stem cells (SCCs) due to alternative splicing.

Strengths<br /> The overall methods and results are robust. The histological analysis of the Srsf1 cKO traces the origins of the fertility defect to the postnatal testis, and the authors have generated interesting datasets characterizing SRSF1's RNA targets and interacting proteins specifically in the testis.

Ultimately, the authors have shown that SRSF1's effects on alternative splicing are required to establish spermatogenesis. In the absence of Srsf1, the postnatal gonocytes do not properly mature into spermatogonia and consequently never initiate spermatogenesis.

Reviewer #3 (Public Review):

In this study, Sun et al examine the role of the splicing factor SRSF1 in spermatogenesis in mice. Alternative splicing is important for spermatogenic development, but its regulation and major developmental roles during spermatogenesis are not well understood. The authors set out to better define both SRSF1 function in testes and the contribution of alternative splicing. They generate several large 'omics datasets to define SRSF1 targets in testis, including RNA interactions by CLIP-seq in whole testis, protein interactions by IP-mass spec in whole testis, and RNA sequencing to detect expression levels and splice variants. They also examine the phenotype of germline conditional knockouts (cKO) for Srsf1, using the early-acting Vasa-Cre, and find a severe depletion of germ cells starting at 7 days post partum (dpp) and culminating with a lack of germ cells (Sertoli Cell Only Syndrome) by adulthood. They detect differences in gene expression as well as differences in splicing between control and knockout, including 9 genes that are downregulated, experience alternative splicing, and whose transcripts are also bound by SRSF1, and identify the Tial1/Tiar transcript as one of these targets. They conclude that SRSF1 is required for homing and self-renewal of precursor spermatogonial stem cells, and suggest that this role may be mediated in part though its regulation of Tial1/Tiar splicing.

Strengths of the paper include detailed phenotyping of the Srsf1 cKO, which convincingly supports the Sertoli Cell Only phenotype, establishes the timing of the first appearance of the spermatogonial defect, and provides new insight into the role of splicing factors and SRSF1 specifically in spermatogenesis. Another strength is the generation of CLIP-seq, IP-MS, and RNA-seq datasets which will be a useful resource for the field of germ cell development. Overall, the results support the claims made. While the study does not provide a full mechanistic understanding of how alternative splicing mediated by SRSF1 affects SSC precursors, the contributions are novel and useful, and will be of interest to the fields of alternative splicing and male reproductive biology.

Reviewer #1 (Public Review):

The manuscript aims to provide mechanistic insight into the activation of PI3Kbeta by its known regulators tyrosine phosphorylated peptides, GTP-loaded Rac1 and G-protein beta-gamma subunits. To achieve this the authors have used supported lipid bilayers, engineered recombinant peptides and proteins (often tagged with fluorophores) and TIRF microscopy to enable bulk (averages of many molecules) and single molecule quantitation. The great strength of this approach is the precision and clarity of mechanistic insight. Although the study does not use "in transfecto" or in vivo models the experiments are performed using "physiologically-based" conditions and provide a powerful insight into core regulatory principles that will be relevant in vivo.<br /> The results are beautiful, high quality, well controlled and internally consistent (and with other published work that overlaps on some points) and as a result are compelling. The primary conclusion is that the primary regulator of PI3Kbeta are tyrosine phosphorylated peptides (and by inference tyrosine phsophorylated receptors/adaptors) and that the other activators can synergise with that input but have relatively weak impacts on their own.

Although the methodology is not easily imported, for reasons of both cost and the experience needed to execute them well, the results have broad importance for the field and reverse an impression that had built in large parts of the broader signalling and PI3K communities that all of the inputs to PI3Kbeta were relatively equivalent, however, these conclusions were based on "in cell" or in vivo studies that were very difficult to interpret clearly.

Reviewer #2 (Public Review):

The manuscript of Duewell et al has made critical observations that help to understand the mechanisms of activation of the class IA PI3Ks. By using single-molecule kinetic measurements, the authors have made outstanding progress toward understanding how PI3Kbeta is uniquely activated by phosphorylated tyrosine kinase receptors, Gbeta/gamma heterodimers and the small G protein Rac1. While previous studies have defined these as activators of PI3Kbeta, the current manuscript makes clear the quantitative limitations of these previous observations. Most previous quantitative in vitro studies of PI3Kbeta activation have used soluble peptides derived from bis-phosphorylated receptors to stimulate the enzyme. These soluble peptides stimulate the enzyme, and even stimulate membrane interaction. Although these previous studies showed that the release of p85-mediated autoinhibition unmasks an intrinsic affinity of the enzyme for lipid membranes, they ignored what would be the consequence of these peptide sequences being present in the context of intrinsic membrane proteins. The current manuscript shows that the effect of membrane-conjugated peptides on the enzyme activity is profound, in terms of recruiting the enzyme to membranes. In this context, the authors show that G proteins associated with the membranes have an important contribution to membrane recruitment, but they also have a profound allosteric effect on the activity on the membrane, These are observations that would not have been possible with bulk measurements, and they do not simply recapitulate observations that were made for other class IA PI3Ks.

An important observation that the authors have made is that Gbeta/gamma heterodimers and RAc1 alone have almost no ability to recruit PI3Kbeta to the membranes that they are using, and this is central to one of the most profoundly novel activation mechanisms offered by the manuscript. The authors propose that the nSH2- and Gbeta/gamma binding sites partially overlap, so that Gbeta/gamma can only bind once the nSH2 domain releases the p110beta subunit. This mechanism would mean that once the nSH2 is engaged by membrane-congugated pY, the Gbg heterodimer can bind and increase the association of the enzyme with membranes. Indeed, this increased membrane association is observed by the authors. However, the authors also show that this increased recruitment to membranes accounts for relatively little increase in activity, and that the far greater component of activation is due to an allosteric effect of the membrane association on the activity of the enzyme. The proposal for competition between Gbg binding and the nSH2 is consistent with the behavior of an nSH2 mutant that cannot bind to pY and which, consequently, does not vacate the Gbg-binding site. In addition to the outstanding contribution to understanding the kinetics of activation of PI3Kbeta, the authors have offered the first structural interpretation for the kinetics of Gbg activation in synergy with pY activation. The proposal for an overlapping nSH2/Gbg binding site is supported by predictions made by John Burke, using alphafold multimer. Although there is no experimental structure to support this structural model, it is consistent with HDX-MS analyses that were published previously.

Reviewer #1 (Public Review):

In this revised preprint the authors investigate whether a presumably allosteric P2RX7 activating compound that they previously discovered reduces fibrosis in a bleomycin mouse model. They chose this particular model as publicly available mRNA data indicate that the P2RX7 pathway is downregulated in idiopathic pulmonary fibrosis patients compared to control individuals. In their revised manuscript, the authors use three proxies of lung damage, Ashcroft score, collagen fibers, and CD140a+ cells, to assess lung damage following the administration of bleomycin. These metrics are significantly reduced on HEI3090 treatment. Additional data implicate specific immune cell infiltrates and cytokines, namely inflammatory macrophages and damped release of IL-17A, as potential mechanistic links between their compound and reduced fibrosis. Finally, the researchers transplant splenocytes from WT, NLRP3-KO, and IL-18-KO mice into animals lacking the P2RX7 receptor to specifically ascertain how the transplanted splenocytes, which are WT for P2RX7 receptor, respond to HEI3090 (a P2RX7 agonist). Based on these results, the authors conclude that HEI3090 enhanced IL-18 production through the P2RX7-NLRP3 inflammasome axis to dampen fibrosis.

These findings could be interesting to the field, as there are conflicting results as to whether NLRP3 activation contributes to fibrosis and if so, at what stage(s) (e.g., acute damage phase versus progression). The revised manuscript is more convincing in that three orthogonal metrics for lung damage were quantified.

However, deletion of the P2RX7 receptor itself reduces the extent of fibrosis, suggesting that P2RX7 signaling can be pro-fibrotic. In the absence of P2RX7, the effects of HEI3900 are also abolished, suggesting that HEI3900 acts in part via P2RX7 signaling. This suggests a paradox that P2RX7 signaling can be both detrimental and beneficial in fibrosis and there is need for a better understanding of when P2RX7 signaling is beneficial and when it is detrimental in lung fibrosis. HEI3900-induced activation of P2RX7 seems to be beneficial but this primarily is shown for when fibrosis is already established. As the P2RX7 genetic deletion mouse model has less fibrosis, P2RX7 signaling and inflammasome activation may be deleterious during the formation of disease but it is also possible that HEI3900 has other beneficial effects that are not directly related to P2RX7.

Molecularly, additional evidence on specificity, such as thermal proteome profiling and direct biophysical binding experiments, would also enhance the authors' argument that the compound indeed binds P2RX7 directly and specifically. Since all small molecules have some degree of promiscuity, the absence of an additional P2RX7 modulator, or direct recombinant IL-18 administration, is needed to orthogonally validate the functional importance of this pathway. Another way the authors could probe pathway specificity would involve co-administering α-IL-18 with HEI3090 in several key experiments (similar to Figure 4L).

Reviewer #2 (Public Review):

In the study by Hreich et al, the potency of P2RX7-specific positive modulator HEI3090, developed by the authors, for the treatment of Idiopathic pulmonary fibrosis (IPF) was investigated. Recently, the authors have shown that HEI3090 can protect against lung cancer by stimulating dendritic cell P2RX7, resulting in IL-18 production that stimulates IFN-γ production by T and NK cells (DOI: 10.1038/s41467-021-20912-2). Interestingly, HEI3090 increases IL-18 levels only in the presence of high eATP. Since the treatment options for IPF are limited, new therapeutic strategies and targets are needed. The authors first show that P2RX7/IL-18/IFNG axis is downregulated in patients with IPF. Next, they used a bleomycin-induced lung fibrosis mouse model to show that the use of a positive modulator of P2RX7 leads to the activation of the P2RX7/IL-18 axis in immune cells that limits lung fibrosis onset or progression. Mechanistically, treatment with HEI3090 enhanced IL-18-dependent IFN-γ production by lung T cells leading to a decreased production of IL-17 and TGFβ, major drivers of IPF. The major novelty is the use of the small molecule HEI3090 to stimulate the immune system to limit lung fibrosis progression by targeting the P2RX7, which could be potentially combined with current therapies available. Overall, the study was well performed and the manuscript is clear.

Reviewer #1 (Public Review):

Summary:<br /> The study follows the role of yeast eIF2A protein as potential translation initiation factor engaged in the non-canonical translation initiation under stress conditions and as a substitute for eIF2. Using ribosome profiling, RNA-Seq and reporter based assays authors evaluated the role of eIF2A protein under regular or stress conditions (cells starved for branched amino acids). Authors found that yeast cells depleted of eIF2A protein do not change significantly their translation initiation, or translation in general. In the contrast to previously reported data for human homolog yeast eIF2A does not significantly contribute to regulation of the uORFs, regardless if they start with canonical AUG or near cognate start codons. eIF2A is not involved in the repression of IRES element in URE2 gene or has a role in purine biosynthesis. It appears that in yeast eIF2A contributes to regulation of very limited number of mRNAs (32 with significant changes in translation efficiency), where only 17 of such messages indeed are consistent with eIF2A deletion and single mRNA (HKR1) could be validated in reporter assay.

Strengths:<br /> The strength of the manuscript is complete analysis and unbiased approach using genomic analysis methods (ribosome profiling and RNA-seq) as well as reporter validation studies. Additional strength of the manuscript is scientific rigor and statistics associated with data analyses, clear data presentation and discussion of the results in the context of the previous studies and results.

Weaknesses:<br /> none noted

Reviewer #2 (Public Review):

Summary:<br /> Gaikwad et al. investigated the role of eIF2A in translational response to stress in yeast. For this purpose, the authors conducted ribosome profiling under SM treatment in eIF2A-depleted strain. Data analysis revealed that eIF2A did not influence translation from mRNAs bearing uORFs or cellular IRESes, in the stress condition, broadly. The authors found that only a small number of mRNAs were supported by eIF2A. The data should be helpful for researchers in the fields.

Major points:<br /> 1. The weakness of this work is the lack of clarification on the function of eIF2A in general. The novelty of this study was limited.

2. Related to this, it would be worth investigating common features in mRNAs selectively regulated (surveyed in Figure 3A). Also, it would be worth analyzing the effect of eIF2A deletion on elongation (ribosome occupancy on each codon and/or global ribosome footprint distribution along CDS) and termination/recycling (footprint reads on stop codon and on 3′ UTR).

3. Regarding Figure 3D, the reporters were designed to include promoter and 5′ UTR of the target genes. Thus, it should be worth noting that reporter design was based on the assumption that eIF2A-dependency in translation regulation was not dependent on 3′ UTR or CDS region. The reason why the effects on ribosome profiling-supported mRNAs could not be recapitulated in reporter assay may originate from this design. This should be also discussed.

4. Related to the point above, the authors claimed that eIF2A affects "possibly only one" (HKR1) mRNA. However, this was due to the reporter assay which is technically variable and could not allow some of the constructs to pass the authors' threshold. Authors may be worth considering better wording for this point.

5. For Figure 3D, it would be worth considering to test all the #-marked genes (in Figure 3C) in this set up.

6. In box plots, the authors should provide the statistical tests, at least where the authors explained in the main text.

Reviewer #3 (Public Review):

Summary:

The authors have undertaken a study to rigorously characterize the possible role of eIF2A in regulating translation in yeast. The authors test for a role of eIF2A in the absence or presence of cellular stress and conclude that eIF2A does not play any significant role in regulating translation initiation in yeast.

The authors have used rigorous experimental approaches, including genome wide ribosome profiling analysis in the absence or presence of stress, to show that eIF2A does not function in translation initiation on most mRNAs in yeast. Interestingly, the authors do identify a small number of mRNAs that possess some eIF2A dependency, so they constructed reporters to rigorously test them. One mRNA, HKR1, appears to possess a degree of eIF2A-dependent translation regulation.

No role of eIF2A in translation initiation is apparent and one limitation of the study is that the authors do not determine what function eIF2A plays in yeast.

Reviewer #2 (Public Review):

Summary:

In this manuscript, the goal of the authors is to understand the process of mature sprout formation from mini-sprouts to develop new blood vessels during angiogenesis. For this, they use their earlier experimental setup of engineered blood vessels in combination with a modified spatio-temporal model for Notch signalling. The authors first study the role of VEGF on Tip (Delta-rich) and Stalk (Notch-rich) patterning. The Tip cells are further examined for their space-time dynamics as Mini-sprouts and mature Sprouts. The Notch signalling model is later supplemented with a phenomenological _random uniform model_ for Sprout selection as a plausible mechanism for Sprout formation from Mini-Sprouts. Finally, the authors look into the role of fibronectin in the Sprout formation process. Overall, the authors propose that VEGF interacts with Notch signalling in blood vessels to generate spatially disordered and co-localized Tip cells. VEGF and fibronectin then provide external cues to dynamically modulate mature Sprout formation from Mini-Sprouts that could control the location and density of developing blood vessels with a process that is consistent with a Turing-like mechanism.

Strengths and Weaknesses

In this manuscript, work motivation, problem definition, experimental procedures, analysis techniques, mathematical methods (including the parameters), and findings are all presented quite clearly. Moreover, the authors carefully indicate whenever they make any assumptions, and do not mix unproven hypothesis with deduced or known facts. The experimental techniques and most of the mathematical methods used in this paper are borrowed from the earlier works of the corresponding authors, and thus are not completely novel. However, the use of these ideas to provide a simple elucidation of the role of VEGF and fibronectin in Sprout formation, in an otherwise complex system, is very interesting and useful. Some of the data analysis methods presented in the paper - (i) quantification of Tip spatial patterns (Fig. 3) and (ii) Sprout temporal dynamics using Sankey diagram (Fig. 4) - seem quite novel to me in the context of Notch signalling literature. Similarly, the authors also provide a new mechanism (VEGF) to obtain disordered Delta-Notch patterning without explicitly including _noise_ in the system (Fig. 2 and Fig. S1). The authors also systematically quantify the statistics of spacing between the Sprouts and show that the Sprouts have a tendency to be away from each other, something that they could also partially recapitulate by additionally including a novel _random uniform model_ for Sprout selection (Fig. 5). Although the association between fibronectin and angiogenesis is known in the literature, in this manuscript, the authors could clearly demonstrate that fibronectin is present in high and low levels, respectively, around Sprouts and Mini-sprouts (Fig. 6). A combination of these findings could then motivate the authors to hypothesize, as mentioned above, a Turing-like mechanism for Sprout formation, something that I find interesting.

Although I find the relative simplicity of the experimental system and theoretical model and the clear findings they generate appealing, some aspects raise a few questions. The authors experimentally find 20 +- 0.08 percent of Tip cells in the model blood-vessels that is consistent with the salt-and-pepper pattern seen in Notch signalling model (~25 %). However, it is not clear to me if the reverse is true, i.e., 25% of Tip cells automatically imply a salt-and-pepper pattern - the authors do not seem to provide a direct experimental evidence. Furthermore, the authors use their Notch signalling model on a regular hexagonal lattice, but there is a large variability in the cell sizes (Fig. 3) in the experimental system. Since it is observed in the literature that signalling depends on the contact area between the neighbouring cells, it is not clear how that would affect the findings presented in this paper. Similarly, since some of the cells are quite small compared to the others, I worry how appropriate it is to express the distance between the Tip cells in terms of _cell numbers_ (Fig. 3). Regarding Sprout classification, as per Table 1, a bridge of two cells is formed as per early-stage-I mechanism for Sprout. On the other hand, the entire data interpretation of experiments seems to be based on early Stage II and matured stage in that same table (also Figs. 3 and 4) in which only one Tip cell seems to be counted per mature Sprout. However, if some Sprouts are formed via early stage-I mechanism, a projection in 2D for analysis would give a count of __two__ adjacent Tip cells, but corresponding to a __single__ Sprout. It could be possible that the presence of such two-cell Sprouts affects the statistics of inter-Sprout distances (Fig. 5). Finally, I find the proposed mechanism of Sprout formation dynamics to be somewhat unsatisfactory. Other than the experimental evidence regarding the spacing of Sprouts and the fibronectin levels around Sprouts and Mini-sprouts (Figs. 4 and 5), there is very little evidence to support the hypothesis about a Turing-like mechanism for Sprouting. Moreover, it seems to me that Turing patterns can appear in a wide variety of settings and could be applied to the current problem in an abstract manner without making any meaningful connections with the system variables. Also, from a modeling point of view, cell migration and mechanics, are expected to take a major part in Sprout formation, while cell division and inclusion would most likely influence Tip-Stalk cell formation. However, it seems that in the present work, these effects are coarse-grained into Notch signalling parameters and the Sprout selection model, thus making any experimental connection quite vague.

Overall Assessment

I feel that the authors, on the whole, do achieve their main goals. Although I have a few concerns that I have raised above, overall, I find the work presented in this manuscript to be a solid addition to the broad field of collective cell dynamics. The authors use well established experimental and mathematical methods while adding a few novel analysis techniques and modeling ideas to provide a compelling, albeit incomplete, picture of Sprout formation during angiogenesis. While the direct application of this work in the context of angiogenesis is obvious, the broad set of ideas and techniques (discussed above) in this work would also be useful to researchers who work on Notch signalling in morphogenesis, collective cell migration, and epithelial-mesenchymal-transition.

Reviewer #1 (Public Review):

The authors succeeded in establishing experimental and mathematical models for the formation of new blood vessels. The experimental model relies on temporal imaging of multilcellular projections and lumen formation from a single blood vessel embedded in an engineered extracellular matrix. The mathematical model combines both discrete and continuum elements. It would be helpful to understand how the authors came up with phenotypic classes for analyzing their live imaging data. On the modeling side, it would be useful to see whether the claims about Turing patterns could be supported by either a mean-field model or a more thorough parametric analysis of the discreet continuum model. The authors did a good job in comparing their VEGF/Notch mechanism to the EGF/Notch vulval patterning mechanism in C. elegans. The authors might want to look into the literature from studies of the tracheal patterning system in Drosophila when the combined actions of the FGF and Notch signaling specify tip and stalk cells. The similarities are quite striking and are worth noting.

Reviewer #1 (Public Review):

In their study, Osorio-Valeriano and colleagues seek to understand how bacterial-specific polymerizing proteins called bactofilins contribute to morphogenesis. They do this primarily in the stalked budding bacterium Hyphomonas neptunium, with supporting work in a spiral-shaped bacterium, Rhodospirillum rubrum. Overall the study incorporates bacterial genetics and physiology, imaging, and biochemistry to explore the function of bactofilins and cell wall hydrolases that are frequently encoded together within an operon. They demonstrate an important, but not essential, function for BacA in morphogenesis of H. neptunium. Using biochemistry and imaging, they show that BacA can polymerize and that its localization in cells is dynamic and cell-cycle regulated. They further demonstrate that BacA likely limits movement of the elongasome into the stalk, spatially confining its activity. The authors then focus on lmdC, which encodes a putative M23 endopeptidase upstream of bacA in H. neptunium, and find that is essential for viability. The purified LmdC C-terminal domain could cleave E. coli peptidoglycan in vitro suggesting that it is a DD-endopeptidase. LmdC interacts directly with BacA in vitro and co-localizes with BacA in cells. To expand their observations, the authors then explore a related endopeptidase/bactofilin pair in R. rubrum; those observations support a function for LmdC and BacA in R. rubrum morphogenesis as well.

An overall strength of this study is the breadth and completeness of approaches used to assess bactofilin and endopeptidase function in cells and in vitro. The authors establish a clear function for BacA in morphogenesis in two bacterial systems, and demonstrate a physical relationship between BacA and the cell wall hydrolase LmdC that may be broadly conserved. The eventual model the authors favor for BacA regulation of morphogenesis in H. neptunium is that it serves as a diffusion barrier and limits movement of morphogenetic machinery like the elongasome into the elongating stalk and/or bud.

The data presented illuminate aspects of bacterial morphogenesis and the physical and functional relationship between polymerizing proteins and cell wall enzymes in bacteria, a recurring theme in bacterial cell biology with a variety of underlying mechanisms. Bactofilins in particular are relatively recently discovered and any new insights into their functions and mechanisms of action are valuable. The findings presented here are likely to interest those studying bacterial morphogenesis, peptidoglycan, and cytoskeletal function.

Reviewer #2 (Public Review):

This is an excellent study. It starts with the identification of two bactofilins in H. neptunium, a demonstration of their important role for the determination of cell shape and discovery of an associated endopeptidase to provide a convincing model for how these two classes of proteins interact to control cell shape. This model is backed up by a quantitative characterisation of their properties using high-resolution imaging and image analysis methods.

Overall, all evidence is very convincing and I do not have many recommendations on how to improve the manuscript.

In my opinion, there are only two issues that I have with the paper:

1. The single particle dynamics of BacA is presented and analysed and I would like to give some suggestions on how to maybe extract even more information from the already acquired data:

1.1. Presentation: Figure 5A is only showing projections of single particle time-lapse movies. To convince the reader that it was indeed possible to detect single molecules it would be helpful if the authors present individual snapshots and intensity traces. In case of single molecules these will show step wise bleaching<br /> 1.2. Analysis: Figure 5B and Supplement Figure 1 are showing the single particle tracking results, revealing that there are two populations of BacA-YFP in the cell. However, this data does not show if individual BacA particles transition between these two populations or not. A more detailed analysis of the existing data, where one can try to identify confinement events in single particle trajectories could be very revealing and help to understand the behaviour of BacA in more detail.

2. The title of Fig. 3 says that BacA and BacD copolymerise, however, the data presented to confirm this conclusions is actually rather weak. First, the Alphafold prediction does not show the co-polymer, and second, the in vitro polymerisation experiments were only done with BacA in the absence of BacD. Accordingly, the only evidence that supports this is their colocalization in fluorescence microscopy. I suggest to either weaken the statement or change the title and add more evidence.

Finally, did the authors think about biochemical experiments to study the interaction between the cytoplasmic part of LmdC and the bactofilins? These could further support their model.

Joint Public Review:

Summary:

This paper reports how mycobacterial cAMP level is increased under stressful conditions and that the increase is important in the survival of the bacterium in animal hosts.

Strengths:

The authors show that under different stresses the response regulator PhoP represses a phosphodiesterase (PDE) that degrades cAMP specifically. Identification of a PDE specific to cAMP is significant progress in understanding Mtb pathogenesis. An increase in cAMP apparently increases bacterial survival upon infection. On the practical side, the reduction of cAMP by increasing PDE can be a means to attenuate the growth of the bacilli. The results have wider implications since PhoP is implicated in controlling diverse mycobacterial stress responses and many bacterial pathogens modulate host cell cAMP level. The results here are straightforward, internally consistent, and of both theoretical and applied interests.

Weaknesses:

Repression of PDE promoter by binding of phosphorylated PhoP could have been shown at higher precision. The binding is now somewhere along a roughly 500 bp region. Although the regulation of PDE is shown to be by transcriptional repression only, it has been described as a homeostatic mechanism. The latter would have required a demonstration of both repression and activation by negative feedback.

Reviewer #1 (Public Review):

The paper aims to determine the impact of forest cover and fragmentation on the prevalence of malaria in non-human primates. The paper uses existing spatial datasets, as well as data obtained through published studies on zoonotic malaria. The findings of this study are important, as forest loss is still occurring in the tropics which will impact human infections of zoonotic malaria.

Reviewer #2 (Public Review):

This is the first comprehensive study aimed at assessing the impact of landscape modification on the prevalence of P. knowlesi malaria in non-human primates in Southeast Asia. This is a very important and timely topic both in terms of developing a better understanding of zoonotic disease spillover and the impact of human modification of landscape on disease prevalence.

This study uses the meta-analysis approach to incorporate the existing data sources into a new and completely independent study that answers novel research questions linked to geospatial data analysis. The challenge, however, is that neither the sampling design of previous studies nor their geospatial accuracy are intended for spatially-explicit assessments of landscape impact. On the one hand, the data collection scheme in existing studies was intentionally opportunistic and does not represent a full range of landscape conditions that would allow for inferring the linkages between landscape parameters and P. knowlesi prevalence in NHP across the region as a whole. On the other hand, the absolute majority of existing studies did not have locational precision in reporting results and thus sweeping assumptions about the landscape representation had to be made for the modeling experiment. Finally, the landscape characterization was oversimplified in this study, making it difficult to extract meaningful relationships between the NHP/human intersection on the landscape and the consequences for P. knowlesi malaria transmission and prevalence.

Despite study limitations, the authors point to the critical importance of understanding vector dynamics in fragmented forested landscapes as the likely primary driver in enhanced malaria transmission. This is an important conclusion particularly when taken together with the emerging evidence of substantially different mosquito biting behaviors than previously reported across various geographic regions.

Another important component of this study is its recognition and focus on the value of geospatial analysis and the availability of geospatial data for understanding complex human/environment interactions to enable monitoring and forecasting potential for zoonotic disease spillover into human populations. More multi-disciplinary focus on disease modeling is of crucial importance for current and future goals of eliminating existing and preventing novel disease outbreaks.

Reviewer #1 (Public Review):

Summary

This article by Zhai et al, investigates sterol transport in bacteria. Synthesis of sterols is rare in bacteria but occurs in some, such as, M capsulatus where the sterols are found primarily in the outer membrane. In a previous paper the authors discovered an operon consisting of five genes, with two of these genes encoding demethylases involved in sterol demethylation. In this manuscript the authors set out to investigate the functions of the other three genes in the operon. Interestingly, through a bioinformatic analysis they show that they are an inner membrane transporter of the RND family, a periplasmic binding protein and an outer membrane associated protein, all potentially involved with lipid transport, so providing a means of transporting the lipids to the outer membrane. These proteins are then extensively investigated through lipid pulldowns, binding analysis on all three, and X-ray crystallography and docking of the latter two.

Strengths<br /> The lipid pulldowns and associated MST binding analysis are convincing, clearly showing that sterols are able to bind to these proteins. The structures of BstB and BstC are high resolution with excellent maps that allow docking studies to be carried out. These structures are distinct from sterol binding proteins in eukaryotes.

Weaknesses<br /> While the docking and molecular dynamics studies are consistent with the binding of sterols to BstB and BstC, this is not backed up particularly well. Their discussion, however, is measured and clearly provides a strong case for further investigation.

Reviewer #2 (Public Review):

Summary:<br /> In eukaryotes, sterols are crucial for signaling and regulating membrane fluidity, however, the mechanism governing cholesterol production and transport across the cell membrane in bacteria remains enigmatic. The manuscript by Zhai et al. sheds light on this topic by uncovering three potential cholesterol transport proteins. Through comprehensive bioinformatics analysis, the authors identified three genes bstA, bstB, and bstC encoding proteins which share homology with transporters, periplasmic binding proteins, and periplasmic components superfamily, respectively. Furthermore, the authors confirmed the specific interaction between these three proteins and C-4 methylated sterols and determined the structures of BstB and BstC. Combining these structural insights with molecular dynamics simulation, they postulated several plausible substrate binding sites within each protein.

Strengths:<br /> The authors have identified 3 proteins that seem likely to be involved in sterol transport between the inner and outer membrane. The structures are of high quality, and the sterol binding experiments support a role for these proteins in sterol transport.

Weaknesses:<br /> While the author's model is very plausible, direct evidence for a role of BstABC in transport, or that the 3 proteins function together in a single pathway, is limited.

Reviewer #3 (Public Review):

Summary:<br /> The work in this manuscript builds on prior efforts by this team to understand how sterols are biosynthesized and utilized in bacteria. The study reports a new function for three genes encoded near sterol biosynthesis enzymes, suggesting the resulting proteins function as a sterol transport system. Biochemical and structural characterization of the two soluble components of the pathway establishes that both proteins can bind sterols, with a preference for 4-methylated derivatives. High-resolution x-ray structures of the apoproteins reveal hydrophobic cavities of the appropriate size to accommodate these substrates. Docking and molecular dynamics simulations confirm this observation and provide specific insights into residues involved in substrate binding.

Strengths:<br /> The manuscript is comprehensive and well-written. The annotation of a new function in a set of proteins related to bacterial sterol usage is exciting and likely to enable further study of this phenomenon - which is currently not well understood. The work also has implications for improving our understanding of lipid usage in general among bacterial organisms.

Reviewer #1 (Public Review):

Summary:

This paper makes important contributions to the structural analysis of the DNA replication-linked nucleosome assembly machine termed Chromatin Assembly Factor-1 (CAF-1). The authors focus on the interplay of domains that bind DNA, histones and replication clamp protein PCNA.

Strengths:<br /> The authors analyze soluble complexes containing full-length versions of all three fission yeast CAF-1 subunits, an important accomplishment given that many previous structural and biophysical studies have focused on truncated complexes. New data here supports previous experiments indicating that the KER domain is a long alpha helix that binds DNA. Via NMR, the authors discover structural changes at the histone binding site, defined here with high resolution. Most strikingly, the experiments here show that for the S. pombe CAF-1 complex, that the WHD domain at the C-terminus of the large subunit lacks DNA binding activity observed in the human and budding yeast homologs, indicating a surprising divergence in the evolution of this complex. Together, these are important contributions to the understanding of how the CAF-1 complex works.

Weaknesses:<br /> 1. Given the strong structural predication about the roles of residues L359 and F380 (Fig. 2f), mutation of these residues would be the definitive test of their contribution to histone binding.

2. Could it be that the apparent lack of histone deposition by the delta-WHD mutant complex occurs because this mutant complex is unstable when added to the Xenopus extract?

Reviewer #2 (Public Review):

Summary:<br /> The authors describe the structure-functional relationship of domains in S. pombe CAF-1, which promotes DNA replication-coupled deposition of histone H3-H4 dimer. The authors nicely showed that the ED domain with an intrinsically disordered structure binds to histone H3-H4, that the KER domain binds to DNA and that, in addition to a PIP box, the KER domain also contributes to the PCNA binding. The ED and KER domains as well as the WHD domain are essential for nucleosome assembly in vitro. The ED, KER domains and the PIP box are important for the maintenance of heterochromatin.

Strengths:<br /> The combination of structural analysis using NMR and Alphafold2 modeling with biophysical and biochemical analysis provided strong evidence on the role of the different domain structures of the large subunit of SpCAF-1, spPCF-1 in the binding to histone H3-H4, DNA as well as PCNA. The conclusion was further supported by genetic analysis of the various pcf1 mutants. The large amounts of data provided in the paper support the authors' conclusion very well.

Weaknesses:

Reviewer #3 (Public Review):

Summary: The study conducted by Ouasti et al. is an elegant investigation of fission yeast CAF-1, employing a diverse array of technologies and genetic alterations to dissect its functions and their interdependence. These functions play a critical role in specifying interactions vital for DNA replication, heterochromatin maintenance, and DNA damage repair, and their dynamics involve multiple interactions. The authors have extensively utilized various in vitro and in vivo tools to validate their model and emphasize the dynamic nature of this complex.

Strengths: Their work is supported by robust experimental data from multiple techniques, including NMR and SAXS, which validate their molecular model. They conducted in vitro interactions using EMSA and isothermal microcalorimetry, in vitro histone deposition using Xenopus high-speed egg extract, and systematically generated and tested various genetic mutants for functionality in in vivo assays. They successfully delineated domain-specific functions using in vitro assays and could validate their roles to large extent using genetic mutants. One significant revelation from this study is the unfolded nature of the acidic domain, observed to fold when binding to histones. Additionally, the authors also elucidated the role of the long KER helix in mediating DNA binding and enhancing the association of CAF-1 with PCNA. The paper effectively addresses its primary objective.

Weaknesses: A few relatively minor unresolved aspects persist, which, if clarified or experimentally addressed by the authors, could further bolster the study.<br /> 1. The precise function of the WHD domain remains elusive. Its deletion does not result in DNA damage accumulation or defects in heterochromatin maintenance. This raises questions about the biological significance of this domain and whether it is dispensable. While in vitro assays revealed defects in chromatin assembly using this mutant (Figure 5), confirming these phenotypes through in vivo assays would provide additional assurance that the lack of function is not simply due to the in vitro system lacking PTMs or other regulatory factors.<br /> 2. The observation of increased Pcf2-gfp foci in pcf1-ED* cells, particularly in mono-nucleated (G2-phase) and bi-nucleated cells with septum marks (S-phase), might suggest the presence of replication stress. This could imply incomplete replication in specific regions, leading to the persistence of Caf1-ED*-PCNA factories throughout the cell cycle. To further confirm this, detecting accumulated single-stranded DNA (ssDNA) regions outside of S-phase using RPA as an ssDNA marker could be informative.<br /> 3. Moreover, considering the authors' strong assertion of histone binding defects in ED* through in vitro assays (Figure 2d and S2a), these claims could be further substantiated, especially considering that some degree of histone deposition might still persist in vivo in the ED* mutant (Figure 7d, viable though growth defective double ED*+hip1D mutants). For example, the approach, akin to the one employed in Fig. 6a (FLAG-IPs of various Pcf1-FLAG-tagged mutants), could also enable a comparison of the association of different mutants with histones and PCNA, providing a more thorough validation of their findings.<br /> 4. It would be valuable for the authors to speculate on the necessity of having disordered regions in CAF1. Specifically, exploring the overall distribution of these domains within disordered/unfolded structures could provide insightful perspectives. Additionally, it's intriguing to note that the significant disparities observed among mutants (ED*, PIP*, and KER*) in in vitro assays seem to become more generic in vivo, except for the indispensability of the WHD-domain. Could these disordered regions potentially play a crucial role in the phase separation of replication factories? Considering these questions could offer valuable insights into the underlying mechanisms at play.

Reviewer #1 (Public Review):

The study investigates the role of PARP-1 in transcriptional regulation. Biochemical and ChIP-seq analyses demonstrate specific binding of PARP-1 to active histone marks, particularly H4K20me, in polytene chromosomes of Drosophila third instar larvae. Under heat stress conditions, PARP-1's dynamic repositioning from the Hsp70 promoter to its gene body is observed, facilitating gene activation. PARP-1, in conjunction with PR-Set7, plays a crucial role in the activation of Hsp70 and a subset of heat shock genes, coinciding with an increase in H4K20me1 levels at these gene loci. This study proposes that H4K20me1 is a key facilitator of PARP-1 binding and gene regulation. However, there are several critical concerns that are yet to be addressed. The experimental validation and demonstration of results in the main manuscript are scant. Recent developments in the area are omitted, as an important publication hasn't been discussed anywhere in the work (PMID: 36434141). The proposed mechanism operates quite selectively, and any extrapolations require intensive scientific evidence.

Major Comments:

1. PARP1 hypomorphic mutant validation data must be provided at RNA levels as the authors have mentioned about its global reduction in RNA levels.

2. The authors should provide immunoblot data for global Poly (ADP) ribosylation levels in PARP1 hypomorphic mutant condition as compared to the control. They must also provide the complete details of the mouse anti-pADPr antibody used in their immunoblot in Figure 5B.

3. PR-Set7 mutant validation results should be provided in the main manuscript, as done by the authors using qRT-PCR. Also, immunoblot data for the PR-set7 null condition should be supplemented in the main manuscript as the authors have already mentioned their anti-PR-Set7 (Rabbit, 1:1000, Novus Biologicals, 44710002) antibody in the materials and methods section.

4. The authors have probably missed out on a very important recent report (PMID: 36434141), suggesting the antagonistic nature of the PARP1 and PR-SET7 association. In light of these important observations, the authors must check for the levels of PR-Set7 in PARP1 hypomorphic conditions.

5. Also, the results of the aforementioned study should be adequately discussed in the present study along with its implications in the same.

6. Gene transcriptional activation requires open chromatin and RNA polymerase II binding to the promoter. Since, differentially expressed genes in both PR-Set7 null and PARP1 hypomorph mutants, co-enriched with PARP-1 and H4K20me1 were mainly upregulated, the authors should provide RNA polymerase II occupancy data of these genes via RNA-Pol II ChIP-seq to further attest their claims.

7. As discussed in Figure 4, the authors found transcriptional activation of group B genes even after a significant reduction of H3K20me1 in their gene body after heat shock. Given the dynamic equilibrium shift in epigenetic marks that regulate gene expression and their locus-specific transcriptional regulation, the authors should further look for the enrichment of other epigenetic marks and even H4K20me1 specific demethylases such as PHF8 (PMID: 20622854), and their cross-talk with PARP1 to further bridge the missing links of this tale. This will add more depth to this work.

Reviewer #2 (Public Review):

Summary:<br /> This study from Bamgbose et al. identifies a new and important interaction between H4K20me and Parp1 that regulates inducible genes during development and heat stress. The authors present convincing experiments that form a mostly complete manuscript that significantly contributes to our understanding of how Parp1 associates with target genes to regulate their expression.

Strengths:<br /> The authors present 3 compelling experiments to support the interaction between Parp1 and H4K20me, including:

1) PR-Set7 mutants remove all K4K20me and phenocopy Parp mutant developmental arrest and defective heat shock protein induction.

2) PR-Set7 mutants have dramatically reduced Parp1 association with chromatin and reduced poly-ADP ribosylation.

3) Parp1 directly binds H4K20me in vitro.

Weaknesses:<br /> 1) The histone array experiment in Fig1 strongly suggests that PARP binds to all mono-methylated histone residues (including H3K27, which is not discussed). Phosphorylation of nearby residues sometimes blocks this binding (S10 and T11 modifications block binding to K9me1, and S28P blocks binding to K27me1). However, H3S3P did not block H3K4me1, which may be worth highlighting. The H3K9me2/3 "blocking effect" is not nearly as strong as some of these other modifications, yet the authors chose to focus on it. Rather than focusing on subtle effects and the possibility that PARP "reads" a "histone code," the authors should consider focusing on the simple but dramatic observation that PARP binds pretty much all mono-methylated histone residues. This result is interesting because nucleosome mono-methylation is normally found on nucleosomes with high turnover rates (Chory et al. Mol Cell 2019)- which mostly occurs at promoters and highly transcribed genes. The author's binding experiments could help to partially explain this correlation because PARP could both bind mono-methylated nucleosomes and then further promote their turnover and lower methylation state.

2) The RNAseq analysis of Parp1/PR-Set7 mutants is reasonable, but there is a caveat to the author's conclusion (Line 251): "our results indicate H4K20me1 may be required for PARP-1 binding to preferentially repress metabolic genes and activate genes involved in neuron development at co-enriched genes." An alternative possibility is that many of the gene expression changes are indirect consequences of altered development induced by Parp1 or PR-Set7 mutants. For example, Parp1 could activate a transcription factor that represses the metabolic genes that they mention. The authors should consider discussing this possibility.

3) The section on the inducibility of heat shock genes is interesting but missing an important control that might significantly alter the author's conclusions. Hsp23 and Hsp83 (group B genes) are transcribed without heat shock, which likely explains why they have H4K20me without heat shock. The authors made the reasonable hypothesis that this H4K20me would recruit Parp-1 upon heat shock (line 270). However, they observed a decrease of H4K20me upon heat shock, which led them to conclude that "H4K20me may not be necessary for Parp1 binding/activation" (line 275). However, their RNA expression data (Fig4A) argues that both Parp1 and H40K20me are important for activation. An alternative possibility is that group B genes indeed recruit Parp1 (through H4K20me) upon heat shock, but then Parp1 promotes H3/H4 dissociation from group B genes. If Parp1 depletes H4, it will also deplete H4K20me1. To address this possibility, the authors should also do a ChIP for total H4 and plot both the raw signal of H4K20me1 and total H4 as well as the ratio of these signals. The authors could also note that Group A genes may similarly recruit Parp1 and deplete H3/H4 but with different kinetics than Group B genes because their basal state lacks H4K20me/Parp1. To test this possibility, the authors could measure Parp association, H4K20methylation, and H4 depletion at more time points after heat shock at both classes of genes.

Reviewer #1 (Public Review):

Summary:<br /> Ngoune et al. present compelling evidence that Slender cells are challenged to infect tsetse flies. They explore the experimental context of a recent important paper in the field, Schuster et al., that presents evidence suggesting the proliferative Slender bloodstream T.brucei can infect juvenile tsetse flies. Schuster et al. was disruptive to the widely accepted paradigm that the Stumpy bloodstream form is solely responsible for tsetse infection and T.brucei transmission potential.

Evidence presented here shows that in all cases, Stumpy form parasites are exponentially more capable of infecting tsetse flies. They further show that Slender cells do not infect mature flies.

However, they raise questions of immature tsetse immunological potential and field transmission potential that their experiments do not address. Specifically, they do not show that teneral tsetse flies are immunocompromised, that tsetse flies must be immunocompromised for Slender infection nor that younger teneral tsetse infection is not pertinent to field transmission.

Strengths:<br /> Experimental Design is precise and elegant, outcomes are convincing. Discussion is compelling and important to the field. This is a timely piece that adds important data to a critical discussion of host:parasite interactions, of relevance to all parasite transmission.

Weaknesses:<br /> As above, the authors dispute the biological relevance of teneral tsetse infection in the wild, without offering evidence to the contrary. Statements need to be softened for claims regarding immunological competence or relevance to field transmission.

Reviewer #2 (Public Review):

Summary:<br /> In contrast to the recent findings reported by Schuster S et al., this brief paper presents evidence suggesting that the stumpy form of T. brucei is likely the most pre-adapted form to progress through the life cycle of this parasite in the tsetse vector.

Strengths:<br /> One significant experimental point is that all fly infection experiments are conducted in the absence of "boosting" metabolites like GlcNAc or S-glutathione. As a result, flies infected with slender trypanosomes present very low or nonexistent infection rates. This provides important experimental evidence that the findings of Schuster S and colleagues may need to be revisited.

Weaknesses:<br /> However, I believe the authors should have included their own set of experiments demonstrating that the presence of these metabolites in the infectious bloodmeal enhances infection rates in flies receiving blood meals containing slender trypanosomes. Considering the well-known physiological variabilities among flies from different facilities, including infection rates, this would have strengthened the experimental evidence presented by the authors.

Reviewer #3 (Public Review):

The dogma in the Trypanosome field is that transmission by Tsetse flies is ensured by stumpy forms. This has been recently challenged by the Engstler lab (Schuster et al. ), who showed that slender forms can also be transmitted by teneral flies. In this work, the authors aimed to test whether transmission by slender forms is possible and frequent. The authors observed that most stumpy forms infections with teneral and adult flies were successful while only 1 out of 24 slender form infections were successful.

In this revised version of the manuscript, the authors made some text changes and included statistical testing as a new section of the Materials and Methods. It seems the comparison of midgut infection in adult vs teneral flies was significant in most of the conditions. However, the critical comparison is still missing: within each type of fly (adult or teneral), was the MG infection significantly different between slender and stumpy forms?

Given no additional experiments were performed, it remains unknown why this work and Schuster et al. reached different conclusions. As a result it remains unclear in which conditions slender forms could be important for transmission. Several variables could explain differences between the two groups: the strain used, the presence or absence of N-acetylglucosamine and/or glutathione, how Tsetse colonies were maintained, thorough molecular and cellular characterisation of slender and stumpy forms (to avoid using intermediate forms as slender forms), comparison to recent field parasite strains.

Joint Public Review:

The authors develop reporter constructs in E. coli that are repressed by the mammalian Musashi-1 (MSI-1) RNA-binding protein. Using a set of rigorously controlled experiments, the authors convincingly show that MSI-1 can be directed to control translation, and that translational control by MSI-1 can be modulated allosterically by oleic acid. This is a potentially useful tool for synthetic biologists, with the advantage over transcriptional regulation that one gene in an operon could be targeted. The authors' MSI-1-regulated reporter constructs could also be useful for mechanistic studies of MSI-1.

The authors initial construct design led to only weak regulation by MSI-1, presumably because the MSI-1 binding sites were not suitably positioned to repress translation initiation. A more rationally designed construct led to considerably greater repression. A minor weakness of the paper is that the authors used their initial, weakly regulated construct to assess the effect of MSI-1 binding site mutations and for their mathematical modeling; these experiments would be better suited to the more strongly regulated construct.

Reviewer #1 (Public Review):

Summary:<br /> The authors aim to address a critical challenge in the field of bioinformatics: the accurate and efficient identification of protein binding sites from sequences. Their work seeks to overcome the limitations of current methods, which largely depend on multiple sequence alignments or experimental protein structures, by introducing GPSite, a multi-task network designed to predict binding residues of various molecules on proteins using ESMFold.

Strengths:<br /> 1. Benchmarking. The authors provide a comprehensive benchmark against multiple methods, showcasing the performances of a large number of methods in various scenarios.

2. Accessibility and Ease of Use. GPSite is highlighted as a freely accessible tool with user-friendly features on its website, enhancing its potential for widespread adoption in the research community.

Weaknesses:<br /> 1. Lack of Novelty. The method primarily combines existing approaches and lacks significant technical innovation. This raises concerns about the original contribution of the work in terms of methodological development. Moreover, the paper reproduces results and analyses already presented in previous literature, without providing novel analysis or interpretation. This further diminishes the contribution of this paper to advancing knowledge in the field.

2. Benchmark Discrepancies. The variation in benchmark results, especially between initial comparisons and those with PeSTo. GPSite achieves a PR AUC of 0.484 on the global benchmark but a PR AUC of 0.61 on the benchmark against PeSTo. For consistency, PeSTo should be included in the benchmark against all other methods. It suggests potential issues with the benchmark set or the stability of the method. This inconsistency needs to be addressed to validate the reliability of the results.

3. Interface Definition Ambiguity. There is a lack of clarity in defining the interface for the binding site predictions. Different methods are trained using varying criteria (surfaces in MaSIF-site, distance thresholds in ScanNet). The authors do not adequately address how GPSite's definition aligns with or differs from these standards and how this issue was addressed. It could indicate that the comparison of those methods is unreliable and unfair.

While GPSite demonstrates the potential to surpass state-of-the-art methods in protein binding site prediction, the evidence supporting these claims seems incomplete. The lack of methodological novelty and the unresolved questions in benchmark consistency and interface definition somewhat undermine the confidence in the results. Therefore, it's not entirely clear if the authors have fully achieved their aims as outlined.

The work is useful for the field, especially in disease mechanism elucidation and novel drug design. The availability of genome-scale binding residue annotations GPSite offers is a significant advancement. However, the utility of this tool could be hampered by the aforementioned weaknesses unless they are adequately addressed.

Reviewer #2 (Public Review):

Summary:<br /> This work provides a new framework, "GPsite" to predict DNA, RNA, peptide, protein, ATP, HEM, and metal ions binding sites on proteins. This framework comes with a webserver and a database of annotations. The core of the model is a Geometric featurizer neural network that predicts the binding sites of a protein. One major contribution of the authors is the fact that they feed this neural network with predicted structure from ESMFold for training and prediction (instead of native structure in similar works) and a high-quality protein Language Model representation. The other major contribution is that it provides the public with a new light framework to predict protein-ligand interactions for a broad range of ligands.

The authors have demonstrated the interest of their framework with mostly two techniques: ablation and benchmark.

Strengths:<br /> The performance of this framework as well as the provided dataset and web server make it useful to conduct studies.

The ablations of some core elements of the method, such as the protein Language Model part, or the input structure are very insightful and can help convince the reader that every part of the framework is necessary. This could also guide further developments in the field. As such, the presentation of this part of the work can hold a more critical place in this work.

Weaknesses:<br /> Overall, we can acknowledge the important effort of the authors to compare their work to other similar frameworks. Yet, the lack of homogeneity of training methods and data from one work to the other makes the comparison slightly unconvincing, as the authors pointed out. Overall, the paper puts significant effort into convincing the reader that the method is beating the state of the art. Maybe, there are other aspects that could be more interesting to insist on (usability, interest in protein engineering, and theoretical works).

Reviewer #3 (Public Review):

Summary<br /> The authors of this work aim to address the challenge of accurately and efficiently identifying protein binding sites from sequences. They recognize that the limitations of current methods, including reliance on multiple sequence alignments or experimental protein structure, and the under-explored geometry of the structure, which limit the performance and genome-scale applications. The authors have developed a multi-task network called GPSite that predicts binding residues for a range of biologically relevant molecules, including DNA, RNA, peptides, proteins, ATP, HEM, and metal ions, using a combination of sequence embeddings from protein language models and ESMFold-predicted structures. Their approach attempts to extract residual and relational geometric contexts in an end-to-end manner, surpassing current sequence-based and structure-based methods.

Strengths<br /> 1. The GPSite model's ability to predict binding sites for a wide variety of molecules, including DNA, RNA, peptides, and various metal ions.<br /> 2. Based on the presented results, GPSite outperforms state-of-the-art methods in several benchmark datasets.<br /> 3. GPSite adopts predicted structures instead of native structures as input, enabling the model to be applied to a wider range of scenarios where native structures are rare.<br /> 4. The authors emphasize the low computational cost of GPSite, which enables rapid genome-scale binding residue annotations, indicating the model's potential for large-scale applications.

Weaknesses<br /> 1. One major advantage of GPSite, as claimed by the authors, is its efficiency. Although the manuscript mentioned that the inference takes about 5 hours for all datasets, it remains unclear how much improvement GPSite can offer compared with existing methods. A more detailed benchmark comparison of running time against other methods is recommended (including the running time of different components, since some methods like GPSite use predicted structures while some use native structures).<br /> 2. Since the model uses predicted protein structure, the authors have conducted some studies on the effect of the predicted structure's quality. However, only the 0.7 threshold was used. A more comprehensive analysis with several different thresholds is recommended.<br /> 3. To demonstrate the robustness of GPSite, the authors performed a case study on human GR containing two zinc fingers, where the predicted structure is not perfect. The analysis could benefit from more a detailed explanation of why the model can still infer the binding site correctly even though the input structural information is slightly off.<br /> 4. To analyze the relatively low AUC value for protein-protein interactions, the authors claimed that it is "due to the fact that protein-protein interactions are ubiquitous in living organisms while the Swiss-Prot function annotations are incomplete", which is unjustified. It is highly recommended to support this claim by showing at least one example where GPSite's prediction is a valid binding site that is not present in the current Swiss-Prot database or via other approaches.<br /> 5. The authors reported that many GPSite-predicted binding sites are associated with known biological functions. Notably, for RNA-binding sites, there is a significantly higher proportion of translation-related binding sites. The analysis could benefit from a further investigation into this observation, such as the analyzing the percentage of such interactions in the training site. In addition, if there is sufficient data, it would also be interesting to see the cross-interaction-type performance of the proposed model, e.g., train the model on a dataset excluding specific binding sites and test its performance on that class of interactions.

Reviewer #1 (Public Review):

Summary:<br /> The authors have developed a zebrafish model of glioblastoma and characterized this, with a particular focus on the role of recruited myeloid cells in the tumours. Microglia/macrophages in the tumours are proposed to have an inflammatory phenotype and are engaged in phagocytosis. Knockout of Irf7 and Irf8 genes enhanced tumour initiation. Depleting mature myeloid cell types with chlodronate also enhanced tumour intitiation. It is proposed that in early-stage tumours, microglia/macrophages have tumour suppressive activity.

Strengths:<br /> The authors have generated a novel glioblastoma model in zebrafish. Two key strengths of the zebrafish model are that early-stage tumours can be studied and in vivo visualization can be readily performed. The authors show a video of microglia/macrophages adopting the ameboid phenotype in tumours (as is observed in human tumours) and engaging in phagocytosis. Video 1 was very impressive in my opinion and shows the model is a very useful tool to study microglia/macrophage:glioblastoma cell interactions. The irf7/irf8 knockdown and the chlodronate experiments are consistent with a role for mature myeloid cells in suppressing tumour initiation, suggesting that the model may also be very valuable in understanding immune surveillance in glioblastoma initiation.

Weaknesses:<br /> EGFRvIII is mainly associated with the classical subtype, so the mesenchymal subtype might be unexpected here. This could be commented on. Some more histologic characterization of the tumours would be helpful. Are they invasive, do larger tumours show necrosis and microvascular proliferation? This would help with understanding the full potential of the new model. Current thinking in established human glioblastoma is that the M1/M2 designations for macrophages are not relevant, with microglia macrophage populations showing a mixture of pre- and anti-inflammatory features. Ideally, there would be a much more detailed characterization of the intratumoral microglia/macrophage population here, as single markers can't be relied upon. Phagocytosis could have antitumour effects through the removal of live cancer cells, or could be cancer-promoting if apoptotic cancer cells are being rapidly cleared with concomitant activation of an immunosuppressive phenotype in the phagocytes (i.e. efferocytosis). It may be possible to distinguish between these two types of phagocytosis experimentally. Do the irf7/8 and chlodronate experiments distinguish between effects on microglia/macrophages and dendritic cells?

Reviewer #2 (Public Review):

Summary:<br /> Glioblastoma is a common primary brain cancer, that is difficult to treat and has a low survival rate. The lack of genetically tractable and immunocompetent vertebrate animal models has prevented the discovery of new therapeutic targets and limited efforts for screening pharmaceutical agents for the treatment of the disease. Here Weiss et al., express oncogenic variants frequently observed in human glioblastoma within zebrafish lacking the tumor suppressor TP53 to generate a patient-relevant in vivo model. The authors demonstrate that loss of TP53 and overexpression of EGFR, PI3KCA, and mScarlet (p53EPS) in neural progenitors and radial glia leads to visible fluorescent brain lesions in live zebrafish. The authors performed RNA expression analysis that uncovered a molecular signature consistent with human mesenchymal glioblastoma and identified gene expression patterns associated with inflammation. Live imaging revealed high levels of immune cell infiltration and associations between microglia/macrophages and tumor cells. To define functional roles for regulators of inflammation on specific immune-related responses during tumorigenesis, transient CRISPR/Cas9 gene targeting was used to disrupt interferon regulator factor proteins and showed Inflammation-associated irf7 and irf8 are required to inhibit p53EPS tumor formation. Further, experiments to deplete the macrophages using clodronate liposomes suggest that macrophages contribute to the suppression of tumor engraftment following transplantation. The authors' conclusions are largely supported by the data and the experiments are thoroughly controlled throughout. Taken together, these results provide new insights into the regulation of glioblastoma initiation and growth by the surrounding microenvironment and provide a novel in vivo platform for the discovery of new molecular mechanisms and testing of therapeutics.

Strengths/Weaknesses:<br /> The authors convincingly show that co-injection of activated human EGFRviii, PI3KCAH1047R, and mScarlet into TP53 null zebrafish promotes the formation of fluorescent brain lesions and glioblastoma-like tumor formation. The authors state that oncogenic MAPK/AKT pathway activation drives this glial-derived tumor formation. It would be important to include a wild-type or uninjected control for the pERK and pAKT staining shown in Fig1 I-K to aid in the interpretation of these results. Likewise, quantification of the pERK and pAKT staining would be useful to demonstrate the increase over WT, and would also serve to facilitate comparison with the similar staining in the KPG model (Supp Fig 2D).

The authors use a transplantation assay to further test the tumorigenic potential of dissociated cells from glial-derived tumors. Listing the percentage of transplants that generate fluorescent tumor would be helpful to fully interpret these data. Additionally, it was not clear based on the description in the results section that the transplantation assay was an "experimental surrogate" to model the relapse potential of the tumor cells. This is first mentioned in the discussion. The authors may consider adding a sentence for clarity earlier in the manuscript as it helps the reader better understand the logic of the assay.

The authors nicely show high levels of immune cell infiltration and associations between microglia/macrophages and tumor cells. However, a quantification of the emergence of macrophages over time in relation to tumor initiation and growth would provide significant support to the observations of tumor suppressive activity of the phagocytes. Along these lines, the inclusion of a statement about when leukocytes emerge during normal development would be informative for those not familiar with the zebrafish model.

From the data provided in Figure 4G and Supp Fig 7b, the authors suggest that "increased p53EPS tumor initiation following Ifr gene knock-down is a consequence of irf7 and irf8 loss-of-function in the TME". Given the importance of the local microenvironment highlighted in this study, spatial information in the form of in situ hybridization to identify the relevant location of the expression change would be important to support this conclusion.

The authors used neutral red staining that labels lysosomal-rich phagocytes to assess enrichment at the early stages of tumor initiation. The images in Figure 3 panel A should be labeled to denote the uninjected controls to aid in the interpretation of the data. In Supplemental Figure 6, the neutral red staining in the irf8 CRISPR-injected larvae looks to be increased, counter to the quantification. Can the authors comment if the image is perhaps not representative?

Reviewer #1 (Public Review):

Summary:<br /> In this study, the authors investigate a very interesting but often overlooked aspect of abstract vs. concrete processing in language. Specifically, they study if the differences in processing of abstract vs. concrete concepts in the brain are static or dependent on the (visual) context in which the words occur. This study takes a two-step approach to investigate how context might affect the perception of concepts. First, the authors analyze if concrete concepts, expectedly, activate more sensory systems while abstract concepts activate higher-order processing regions. Second, they measure the contextual situatedness vs. displacement of each word with respect to the visual scenes it is spoken in and then evaluate if this contextual measure correlates with more activation in the sensory vs. higher-order regions respectively.

Strengths:<br /> This study raises a pertinent and understudied question in language neuroscience. It also combines both computational and meta-analytic approaches.

Weaknesses:<br /> Overall, the study had many intermediary steps that required manual subsection / random sampling and variable choices (like the time lag of analysis) with almost no visualization and interpretation of how these choices affect the observed results. The approach was also roundabout.

Peaks and Valleys Analysis:<br /> 1. Doesn't this method assume that the features used to describe each word, like valence or arousal, will be linearly different for the peaks and valleys? What about non-linear interactions between the features and how they might modulate the response?<br /> 2. Doesn't it also assume that the response to a word is infinitesimal and not spread across time? How does the chosen time window of analysis interact with the HRF? From the main figures and Figures S2-S3 there seem to be differences based on the timelag.<br /> 3. Were the group-averaged responses used for this analysis?<br /> 4. Why don't the other terms identified in Figure 5 show any correspondence to the expected categories? What does this mean? Can the authors also situate their results with respect to prior findings as well as visualize how stable these results are at the individual voxel or participant level? It would also be useful to visualize example time courses that demonstrate the peaks and valleys.

Estimating contextual situatedness:<br /> 1. Doesn't this limit the analyses to "visual" contexts only? And more so, frequently recognized visual objects?<br /> 2. The measure of situatedness is the cosine similarity of GloVE vectors that depend on word co-occurrence while the vectors themselves represent objects isolated by the visual recognition models. Expectedly, "science" and the label "book" or "animal" and the label "dog" will be close. But can the authors provide examples of context displacement? I wonder if this just picks up on instances where the identified object in the scene is unrelated to the word. How do the authors ensure that it is a displacement of context as opposed to the two words just being unrelated? This also has a consequence on deciding the temporal cutoff for consideration (2 seconds).<br /> 3. While the introduction motivated the problem of context situatedness purely linguistically, the actual methods look at the relationship between recognized objects in the visual scene and the words. Can word surprisal or another language-based metric be used in place of the visual labeling? Also, it is not clear how the process identified in (2) above would come up with a high situatedness score for abstract concepts like "truth".<br /> 4. It is a bit hard to see the overlapping regions in Figures 6A-C. Would it be possible to show pairs instead of triples? Like "abstract across context" vs. "abstract displaced"? Without that, and given (2) above, the results are not yet clear. Moreover, what happens in the "overlapping" regions of Figure 3?

Miscellaneous comments:<br /> 1. In Figure 3, it is surprising that the "concrete-only" regions dominate the angular gyrus and we see an overrepresentation of this category over "abstract-only". Can the authors place their findings in the context of other studies?<br /> 2. The following line (Pg 21) regarding the necessary differences in time for the two categories was not clear. How does this fall out from the analysis method?<br /> 3. Both categories overlap **(though necessarily at different time points)** in regions typically associated with word processing.

Reviewer #2 (Public Review):

Summary:<br /> This study tests a plausible and intriguing hypothesis that one cause of the differences in the neural underpinnings of concrete and abstract words is differences in their grounding in the current sensory context. The authors reasoned that, in this case, an abstract word presented with a relevant visual scene would be processed in a more similar way to a concrete word. Typically, abstract and concrete words are tested in isolation. In contrast, this study takes advantage of naturalistic movie stimuli to assess the neural effects of concreteness in both abstract and concrete words (the speech within the film), when the visual context is more or less tied to the word meaning (measured as the similarity between the word co-occurrence-based vector for the spoken word and the average of this vector across all present objects). This novel approach allows a test of the dynamic nature of abstract and concrete word processing, and as such could extend the literature and add a useful perspective accounting for differences in processing these word types.

The critical contrasts needed to test the key hypothesis are not presented or not presented in full within the core text. To test whether abstract processing changes when in a situated context, the situated abstract condition would first need to be compared with the displaced abstract condition as in Supplementary Figure 6. Then to test whether this change makes the result closer to the processing of concrete words, this result should be compared to the concrete result. The correlations shown in Figure 6 in the main text are not focused on the differences in activity between the situated and displaced words or comparing the correlation of these two conditions with the other (concrete/abstract) condition. As such they cannot provide conclusive evidence as to whether the context is changing the processing of concrete/abstract words to be closer to the other condition. Additionally, it should be considered whether any effects reflect the current visual processing only or more general sensory processing.

Overall, the study would benefit from being situated in the literature more, including a) a more general understanding of the areas involved in semantic processing (including areas proposed to be involved across different sensory modalities and for verbal and nonverbal stimuli), and b) other differences between abstract and concrete words and whether they can explain the current findings, including other psycholinguistic variables which could be included in the model and the concept of semantic diversity (Hoffman et al.,). It would also be useful to consider whether difficulty effects (or processing effort) could explain some of the regional differences between abstract and concrete words (e.g., the language areas may simply require more of the same processing not more linguistic processing due to their greater reliance on word co-occurrence). Similarly, the findings are not considered in relation to prior comparisons of abstract and concrete words at the level of specific brain regions.

The authors use multiple methods to provide a post hoc interpretation of the areas identified as more involved in concrete, abstract, or both (at different times) words. These are designed to reduce the interpretation bias and improve interpretation, yet they may not successfully do so. These methods do give some evidence that sensory areas are more involved in concrete word processing. However, they are still open to interpretation bias as it is not clear whether all the evidence is consistent with the hypotheses or if this is the best interpretation of individual regions' involvement. This is because the hypotheses are provided at the level of 'sensory' and 'language' areas without further clarification and areas and terms found are simply interpreted as fitting these definitions. For instance, the right IFG is interpreted as a motor area, and therefore sensory as predicted, and the term 'autobiographical memory' is argued to be interoceptive. Language is associated with the 'both' cluster, not the abstract cluster, when abstract >concrete is expected to engage language more. The areas identified for both vs. abstract>concrete are distinguished in the Discussion through the description as semantic vs. language areas, but it is not clear how these are different or defined. Auditory areas appear to be included in the sensory prediction at times and not at others. When they are excluded, the rationale for this is not given. Overall, it is not clear whether all these areas and terms are expected and support the hypotheses. It should be possible to specify specific sensory areas where concrete and abstract words are predicted to be different based on a) prior comparisons and/or b) the known locations of sensory areas. Similarly, language or semantic areas could be identified using masks from NeuroSynth or traditional meta-analyses. A language network is presented in Supplementary Figure 7 but not interpreted, and its source is not given. Alternatively, there could be a greater interpretation of different possible explanations of the regions found with a more comprehensive assessment of the literature. The function of individual regions and the explanation of why many of these areas are interpreted as sensory or language areas are only considered in the Discussion when it could inform whether the hypotheses have been evidenced in the results section.

Additionally, these methods attempt to interpret all the clusters found for each contrast in the same way when they may have different roles (e.g., relate to different senses). This is a particular issue for the peaks and valleys method which assesses whether a significantly larger number of clusters is associated with each sensory term for the abstract, concrete, or both conditions than the other conditions. The number of clusters does not seem to be the right measure to compare. Clusters differ in size so the number of clusters does not represent the area within the brain well. Nor is it clear that many brain regions should respond to each sensory term, and not just one per term (whether that is V1 or the entire occipital lobe, for instance). The number of clusters is therefore somewhat arbitrary. This is further complicated by the assessment across 20 time points and the inclusion of the 'both' category. It would seem more appropriate to see whether each abstract and concrete cluster could be associated with each different sensory term and then summarise these findings rather than assess the number of abstract or concrete clusters found for each independent sensory term. In general, the rationale for the methods used should be provided (including the peak and valley method instead of other possible options e.g., linear regression).

The measure of contextual situatedness (how related a spoken word is to the average of the visually presented objects in a scene) is an interesting approach that allows parametric variation within naturalistic stimuli, which is a potential strength of the study. This measure appears to vary little between objects that are present (e.g., animal or room), and those that are strongly (e.g., monitor) or weakly related (e.g., science). Additional information validating this measure may be useful, as would consideration of the range of values and whether the split between situated (c > 0.6) and displaced words (c < 0.4) is sufficient.

Finally, the study assessed the relation of spoken concrete or abstract words to brain activity at different time points. The visual scene was always assessed using the 2 seconds before the word, while the neural effects of the word were assessed every second after the presentation for 20 seconds. This could be a strength of the study, however almost no temporal information was provided. The clusters shown have different timings, but this information is not presented in any way. Giving more temporal information in the results could help to both validate this approach and show when these areas are involved in abstract or concrete word processing. Additionally, no rationale was given for this long timeframe which is far greater than the time needed to process the word, and long after the presence of the visual context assessed (and therefore ignores the present visual context).

Reviewer #3 (Public Review):

Summary:<br /> The primary aim of this manuscript was to investigate how context, defined from visual object information in multimodal movies, impacts the neural representation of concrete and abstract conceptual knowledge. The authors first conduct a series of analyses to identify context-independent regional responses to concrete and abstract concepts in order to compare these results with the networks observed in prior research using non-naturalistic paradigms. The authors then conduct analyses to investigate whether the regional response to abstract and concrete concepts changes when the concepts are either contextually situated or displaced. A concept is considered displaced if the visual information immediately preceding the word is weakly associated with the word whereas a concept is situated if the association is high. The results suggest that, when ignoring context, abstract and concrete concepts engage different brain regions with overlap in core language areas. When context is accounted for, however, similar brain regions are activated for processing concrete and situated abstract concepts and for processing abstract and displaced concrete concepts. The authors suggest that contextual information dynamically changes the brain regions that support the representation of abstract and concrete conceptual knowledge.

Strengths:<br /> There is significant interest in understanding both the acquisition and neural representation of abstract and concrete concepts, and most of the work in this area has used highly constrained, decontextualized experimental stimuli and paradigms to do so. This manuscript addresses this limitation by using multimodal narratives which allows for an investigation of how context-sensitive the regional response to abstract and concrete concepts is. The authors characterize the regional response in a comprehensive way.

Weaknesses:<br /> The context measure is interesting, but I'm not convinced that it's capturing what the authors intended. In analysing the neural response to a single word, the authors are presuming that they have isolated the window in which that concept is processed and the observed activation corresponds to the neural representation of that word given the prior context. I question to what extent this assumption holds true in a narrative when co-articulation blurs the boundaries between words and when rapid context integration is occurring. Further, the authors define context based on the preceding visual information. I'm not sure that this is a strong manipulation of the narrative context, although I agree that it captures some of the local context. It is maybe not surprising that if a word, abstract or concrete, has a strong association with the preceding visual information then activation in the occipital cortex is observed. I also wonder if the effects being captured have less to do with concrete and abstract concepts and more to do with the specific context the displaced condition captures during a multimodal viewing paradigm. If the visual information is less related to the verbal content, the viewer might process those narrative moments differently regardless of whether the subsequent word is concrete or abstract. I think the claims could be tailored to focus less generally on context and more specifically on how visually presented objects, which contribute to the ongoing context of a multimodal narrative, influence the subsequent processing of abstract and concrete concepts.

Reviewer #1 (Public Review):

The manuscript by Wagstyl et al. describes an extensive analysis of gene expression in the human cerebral cortex and the association with a large variety of maps capturing many of its microscopic and macroscopic properties. The core methodological contribution is the computation of continuous maps of gene expression for >20k genes, which are being shared with the community. The manuscript is a demonstration of several ways in which these maps can be used to relate gene expression with histological features of the human cortex, cytoarchitecture, folding, function, development and disease risk. The main scientific contribution is to provide data and tools to help substantiate the idea of the genetic regulation of multi-scale aspects of the organisation of the human brain. The manuscript is dense, but clearly written and beautifully illustrated.

Reviewer #2 (Public Review):

This is a valuable contribution that will facilitate brain transcriptomic analyses and the joint analyses of gene expression and structural and functional imaging. The methods used are solid, and the authors conducted a wide range of analyses to demonstrate the value of the dense gene expression data.

Reviewer #1 (Public Review):

Despite numerous studies on quinidine therapies for epilepsies associated with GOF mutant variants of Slack, there is no consensus on its utility due to contradictory results. In this study Yuan et al. investigated the role of different sodium selective ion channels on the sensitization of Slack to quinidine block. The study employed electrophysiological approaches, FRET studies, genetically modified proteins and biochemistry to demonstrate that Nav1.6 N- and C-tail interacts with Slack's C-terminus and significantly increases Slack sensitivity to quinidine blockade in vitro and in vivo. This finding inspired the authors to investigate whether they could rescue Slack GOF mutant variants by simply disrupting the interaction between Slack and Nav1.6. They find that the isolated C-terminus of Slack can reduce the current amplitude of Slack GOF mutant variants co-expressed with Nav1.6 in HEK cells and prevent Slack induced seizures in mouse models of epilepsy. This study adds to the growing list of channels that are modulated by protein-protein interactions, and is of great value for future therapeutic strategies.

Reviewer #2 (Public Review):

This is a very interesting paper about the coupling of Slack and Nav1.6 and the insight this brings to the effects of quinidine to treat some epilepsy syndromes.

Slack is a sodium-activated potassium channel that is important to hyperpolarization of neurons after an action potential. Slack is encoded by KNCT1 which has mutations in some epilepsy syndromes. These types of epilepsy are treated with quinidine but this is an atypical antiseizure drug, not used for other types of epilepsy. For sufficient sodium to activate Slack, Slack needs to be close to a channel that allows robust sodium entry, like Nav channels or AMPA receptors. but more mechanistic information is not available. Of particular interest to the authors is what allows quinidine to be effective in reducing Slack.

In the manuscript, the authors show that Nav, not AMPA receptors, are responsible for Slack's sensitization to quinidine blockade, at least in cultured neurons (HeK293, primary cortical neurons). Most of the paper focuses on the evidence that Nav1.6 promotes Slack sensitivity to quinidine.

Reviewer #3 (Public Review):

Yuan et al., set out to examine the role of functional and structural interaction between Slack and NaVs on the Slack sensitivity to quinidine. Through pharmacological and genetic means they identify NaV1.6 as the privileged NaV isoform in sensitizing Slack to quinidine. Through biochemical assays, they then determine that the C-terminus of Slack physically interacts with the N- and C-termini of NaV1.6. Using the information gleaned from the in vitro experiments the authors then show that virally-mediated transduction of Slack's C-terminus lessens the extent of SlackG269S-induced seizures. These data uncover a previously unrecognized interaction between a sodium and a potassium channel, which contributes to the latter's sensitivity to quinidine.

Reviewer #1 (Public Review):

In this preprint, Zhang et al. describe a new tool for mapping the connectivity of mouse neurons. Essentially, the tool leverages the known peculiar infection capabilities of Rabies virus: once injected into a specific site in the brain, this virus has the capability to "walk upstream" the neural circuits, both within cells and across cells: on one hand, the virus can enter from a nerve terminal and infect retrogradely the cell body of the same cell (retrograde transport). On the other hand, the virus can also sometimes spread to the presynaptic partners of the initial target cells, via retrograde viral transmission.

Similarly to previously published approaches with other viruses, the authors engineer a complex library of viral variants, each carrying a unique sequence ('barcode'), so they can uniquely label and distinguish independent infection events and their specific presynaptic connections, and show that it is possible to read these barcodes in-situ, producing spatial connectivity maps. They also show that it is possible to read these barcodes together with endogenous mRNAs, and that this allows spatial mapping of cell types together with anatomical connectivity.

The main novelty of this work lies in the combined use of rabies virus for retrograde labeling together with barcoding and in-situ readout. Previous studies had used rabies virus for retrograde labeling, albeit with low multiplexing capabilities, so only a handful of circuits could be traced at the same time. Other studies had instead used barcoded viral libraries for connectivity mapping, but mostly focused on the use of different viruses for labeling individual projections (anterograde tracing) and never used a retrograde-infective virus.

The authors creatively merge these two bits of technology into a powerful genetic tool, and extensively and convincingly validate its performance against known anatomical knowledge. The authors also do a very good job at highlighting and discussing potential points of failure in the methods.

Unresolved questions, which more broadly affect also other viral-labeling methods, are for example how to deal with uneven tropism (ie. if the virus is unable or inefficient in infecting some specific parts of the brain), or how to prevent the cytotoxicity induced by the high levels of viral replication and expression, which will tend to produce "no source networks", neural circuits whose initial cell can't be identified because it's dead. This last point is particularly relevant for in-situ based approaches: while high expression levels are desirable for the particular barcode detection chemistry the authors chose to use (gap-filling), they are also potentially detrimental for cell survival, and risk producing extensive cell death (which indeed the authors single out as a detectable pitfall in their analysis). This is likely to be one the major optimisation space for future implementations of this barcoding approach.

Overall the paper is well balanced, the data are well presented and the conclusions are strongly supported by the data. Impact-wise, the method is definitely going to be very useful for the neurobiology community.

Reviewer #2 (Public Review):

Although the trans-synaptic tracing method mediated by the rabies virus (RV) has been widely utilized to infer input connectivity across the brain to a genetically defined population in mice, the analysis of labeled pre-synaptic neurons in terms of cell-type has been primarily reliant on classical low-throughput histochemical techniques. In this study, the authors made a significant advance toward high-throughput transcriptomic (TC) cell typing by both dissociated single-cell RNAseq and the spatial TC method known as BARseq to decode a vast array of molecularly labeled ("barcoded") RV vector library. First, they demonstrated that a barcoded RV vector can be employed as a simple retrograde tracer akin to AAVretro. Second, they provided a theoretical classification of neural networks at the single-cell resolution that can be attained through barcoded-RV and concluded that the identification of the vast majority (ideally 100%) of starter cells (the origin of RV-based trans-synaptic tracing) is essential for the inference of single-cell resolution neural connectivity. Taking this into consideration, the authors opted for the BARseq-based spatial TC that could, in principle, capture all the starter cells. Finally, they demonstrated the proof-of-concept in the somatosensory cortex, including infrared connectivity from 381 putative pre-synaptic partners to 31 uniquely barcoded-starter cells, as well as many insightful estimations of input convergence at the cell-type resolution in vivo. Collectively, this work will establish a cornerstone for future advancements in rabies-barcode technology.

This revised version incorporates imaging data to assess the stringency of identifying the starter cells in comparison with conventional protein-based detection methods. Additionally, it encompasses insightful discussions concerning potential limitations and offers perspectives on future improvements. The method section is systematically subdivided with subsection numbers, facilitating the cross-referencing of the corresponding sections in the main text and figure legends. I posit that adopting this stylistic approach as the standard for manuscripts delineating innovative methodological strides would be prudent. The clarity of the figure legends has been significantly enhanced, contributing to a more accessible understanding of the figure panels. In sum, this manuscript is articulate and thorough, epitomizing scientific rigor.

Reviewer #3 (Public Review):

The manuscript by Zhang and colleagues attempts to combine genetically barcoded rabies viruses with spatial transcriptomics in order to genetically identify connected pairs. The major shortcoming with the application of a barcoded rabies virus, as reported by 2 groups prior, is that with the high dropout rate inherent in single cell procedures, it is difficult to definitively identify connected pairs. By combining the two methods, they are able to establish a platform for doing that, and provide insight into connectivity, as well as pros and cons of their method, which is well thought out and balanced.

The authors did a nice job of addressing my comments which mainly centered around the presentation of data, specificity, and wording.

Reviewer #2 (Public Review):

Summary: In the revised manuscript, the authors aim to investigate brain-wide activation patterns following administration of the anesthetics ketamine and isoflurane, and conduct comparative analysis of these patterns to understand shared and distinct mechanisms of these two anesthetics. To this end, they perform Fos immunohistochemistry in perfused brain sections to label active nuclei, use a custom pipeline to register images to the ABA framework and quantify Fos+ nuclei, and perform multiple complementary analyses to compare activation patterns across groups.

In the latest revision, the authors have made some changes in response to our previous comments on how to fix the analyses. However, the revised analyses were not changed correctly and remain flawed in several fundamental ways.

Critical problems:

(1) Before one can perform higher level analyses such as hiearchal cluster or network hub (or PC) analysis, it is fundamental to validate that you have significant differences of the raw Fos expression values in the first place. First of all, this means showing figures with the raw data (Fos expression levels) in some form in Figures 2 and 3 before showing the higher level analyses in Figures 4 and 5; this is currently switched around. Second and most importantly, when you have a large number of brain areas with large differences in mean values and variance, you need to account for this in a meaningful way. Changing to log values is a step in the right direction for mean values but does not account well for differences in variance. Indeed, considering the large variances in brain areas with high mean values and variance, it is a little difficult to believe that all brain regions, especially brain areas with low mean values, passed corrections for multiple comparisons test. We suggested Z-scores relative to control values for each brain region; this would have accounted for wide differences in mean values and variance, but this was not done. Overall, validation of anesthesia-induced differences in Fos expression levels is not yet shown.

(2) Let's assume for a moment that the raw Fos expression analyses indicate significant differences. They used hierarchal cluster analyses as a rationale for examining 53 brain areas in all subsequent analyses of Fos expression following isoflurane versus home cage or ketamine versus saline. Instead, the authors changed to 201 brain areas with no validated rationale other than effectively saying 'we wanted to look at more brain areas'. And then later, when they examined raw Fos expression values in Figures 4 and 5, they assess 43 brain areas for ketamine and 20 brain areas for isoflurane, without any rationale for why choosing these numbers of brain areas. This is a particularly big problem when they are trying to compare effects of isoflurane versus ketamine on Fos expression in these brain areas - they did not compare the same brain areas.

Less critical comments:

(3) The explanation of hierarchical level's in lines 90-95 did not make sense.

(4) I am still perplexed by why the authors consider the prelimbic and infralimbic cortex 'neuroendocrine' brain areas in the abstract. In contrast, the prelimbic and infralimbic were described better in the introduction as "associated information processing" areas.

5- It looks like overall Fos levels in the control group Home (ISO) are a magnitude (~10-fold) lower than those in the control group Saline (KET) across all regions shown. This large difference seems unlikely to be due to a biologically driven effect and seems more likely to be due to a technical issue, such as differences in staining or imaging between experiments. The authors discuss this issue but did not answer whether the Homecage-ISO experiment or at least the Fos labeling and imaging performed at the same time as for the Saline-Ketamine experiment?

Reviewer #3 (Public Review):

The present study presents a comprehensive exploration of the distinct impacts of Isoflurane and Ketamine on c-Fos expression throughout the brain. To understand the varying responses across individual brain regions to each anesthetic, the researchers employ principal component analysis (PCA) and c-Fos-based functional network analysis. The methodology employed in this research is both methodical and expansive. Notably, the utilization of a custom software package to align and analyze brain images for c-Fos positive cells stands out as an impressive addition to their approach. This innovative technique enables effective quantification of neural activity and enhances our understanding of how anesthetic drugs influence brain networks as a whole.

The primary novelty of this paper lies in the comparative analysis of two anesthetics, Ketamine and Isoflurane, and their respective impacts on brain-wide c-Fos expression. The study reveals the distinct pathways through which these anesthetics induce loss of consciousness. Ketamine primarily influences the cerebral cortex, while Isoflurane targets subcortical brain regions. This finding highlights the differing mechanisms of action employed by these two anesthetics-a top-down approach for Ketamine and a bottom-up mechanism for Isoflurane. Furthermore, this study uncovers commonly activated brain regions under both anesthetics, advancing our knowledge about the mechanisms underlying general anesthesia.

Reviewer #1 (Public Review):

Summary:<br /> The authors ran a series of experiments with separate subject populations, different stimuli, and on two different MRI scanners (one 3T, one 7T) to establish a scenes-selective region on the intraparietal gyrus that they decided to name PIGS. I think that IPA (intraparietal place area) would also have been a good choice with an allusion to a beverage rather than a domestic animal. The authors show that PIGS can be detected robustly through a series of experiments. They anatomically and functionally separate PIGS from nearby V6, which encodes optic flow. The authors determined that PIGS encodes ego-motion.

Strengths:<br /> The robust detection of PIGS in several experiments with different sets of participants and on different scanners makes these results convincing. The functional differentiation is well executed.

Weaknesses:<br /> The distinction of PIGS from nearby OPA, which has also been implied in navigation and ego-motion, is not as clear as it could be.

Impact:<br /> Overall, this is a valuable contribution to the cognitive neuroscience of the visual system. It shows that there is still room for discovering details of visual processing, given recent advances in scanning technology, statistical methods, and larger sample sizes.

Reviewer #2 (Public Review):

Summary<br /> The authors report an extensive series of neuroimaging experiments (at both 3T and 7T) to provide evidence for a scene-selective visual area in the human posterior parietal cortex (PIGS) that is distinct from the main three (parahippocampal place area, PPA; occipital place area, OPA; medial place area, MPA) typically reported in the literature. Further, they argue that in comparison with the other three, this region may specifically be involved in representing ego-motion in natural contexts. The characterization of this scene-selective region provides a useful reference point for studies of scene processing in humans.

Strengths<br /> One of the major strengths of the work is the extensive series of experiments reported, showing clear reproducibility of the main finding and providing functional insight into the region studied. The results are clearly presented and for the most part, convincing.

Weaknesses<br /> One of the major weaknesses of the work is the failure to relate the current results to other findings in the literature, making it hard to assess whether it is is a "previously undescribed scene-selective site".

First, the scene-selective region identified appears to overlap with regions that have previously been identified in terms of their retinotopic properties. In particular, it is unclear whether this region overlaps with V7/IPS0 and/or IPS1. This is particularly important since prior work has shown that OPA often overlaps with v7/IPS0 (Silson et al, 2016, Journal of Vision). The findings would be much stronger if the authors could show how the location of PIGS relates to retinotopic areas (other than V6, which they do currently consider). I wonder if the authors have retinotopic mapping data for any of the participants included in this study. If not, the authors could always show atlas-based definitions of these areas (e.g. Wang et al, 2015, Cerebral Cortex).

Second, recent studies have reported a region anterior to OPA that seems to be involved in scene memory (Steel et al, 2021, Nature Communications; Steel et al, 2023, The Journal of Neuroscience; Steel et al, 2023, biorXiv). Is this region distinct from PIGS? Based on the figures in those papers, the scene memory-related region is inferior to V7/IPS0, so characterizing the location of PIGS to V7/IPS0 as suggested above would be very helpful here as well.

If PIGS overlaps with either of V7/IPS0 or the scene memory-related area described by Steel and colleagues, then arguably it is not a newly defined region (although the characterization provided here still provides new information).

Another reason that it would be helpful to relate PIGS to this scene memory area is that this scene memory area has been shown to have activity related to the amount of visuospatial context (Steel et al, 2023, The Journal of Neuroscience). The conditions used to show the sensitivity of PIGS to ego-motion also differ in the visuospatial context that can be accessed from the stimuli. Even if PIGS appears distinct from the scene memory area, the degree of visuospatial context is an alternative account of what might be represented in PIGS.

Reviewer #3 (Public Review):

Summary:<br /> The authors report a scene-selective area in the posterior intraparietal gyrus (PIGS). This area lies outside the classical three scene-selective regions (PPA/TPA, RSC/MPA, TOS/OPA), and is selective for ego-motion.

Strengths:<br /> The authors firmly establish the location and selectivity of the new area through a series of well-crafted controlled experiments. They show that the area can be missed with too much smoothing, thus providing a case for why it has not been previously described. They show that it appears in much the same location in different subjects, with different magnetic field strengths, and with different stimulus sets. Finally, they show that it is selective for ego-motion - defined as a series of sequential photographs of an egocentric trajectory along a path. They further clarify that the area is not generically motion-selective by showing that it does not respond to biological motion without an ego-motion component to it. All statistics are standard and sound; the evidence presented is strong.

Weaknesses:<br /> There are few weaknesses in this work. If pressed, I might say that the stimuli depicting ego-motion do not, strictly speaking, depict motion, but only apparent motion between 2m apart photographs. However, this choice was made to equate frame rates and motion contrast between the 'ego-motion' and a control condition, which is a useful and valid approach to the problem. Some choices for visualization of the results might be made differently; for example, outlines of the regions might be shown in more plots for easier comparison of activation locations, but this is a minor issue.

This is a very strong paper.

Reviewer #1 (Public Review):

Summary:<br /> The present study evaluates the role of visual experience in shaping functional correlations between extrastriate visual cortex and frontal regions. The authors used fMRI to assess "resting-state" temporal correlations in three groups: sighted adults, congenitally blind adults, and neonates. Previous research has already demonstrated differences in functional correlations between visual and frontal regions in sighted compared to early blind individuals. The novel contribution of the current study lies in the inclusion of an infant dataset, which allows for an assessment of the developmental origins of these differences.

The main results of the study reveal that correlations between prefrontal and visual regions are more prominent in the blind and infant groups, with the blind group exhibiting greater lateralization. Conversely, correlations between visual and somato-motor cortices are more prominent in sighted adults. Based on these data, the authors conclude that visual experience plays an instructive role in shaping these cortical networks. This study provides valuable insights into the impact of visual experience on the development of functional connectivity in the brain.

Strengths:<br /> The dissociations in functional correlations observed among the sighted adult, congenitally blind, and neonate groups provide strong support for the study's main conclusion regarding experience-driven changes in functional connectivity profiles between visual and frontal regions.

In general, the findings in sighted adult and congenitally blind groups replicate previous studies and enhance the confidence in the reliability and robustness of the current results.

Split-half analysis provides a good measure of robustness in the infant data.

Weaknesses:<br /> There is some ambiguity in determining which aspects of these networks are shaped by experience.

This uncertainty is compounded by notable differences in data acquisition and preprocessing methods, which could result in varying signal quality across groups. Variations in signal quality may, in turn, have an impact on the observed correlation patterns.

The study's findings could benefit from being situated within a broader debate surrounding the instructive versus permissive roles of experience in the development of visual circuits.

Reviewer #2 (Public Review):

Summary:<br /> Tian et al. explore the developmental organs of cortical reorganization in blindness. Previous work has found that a set of regions in the occipital cortex show different functional responses and patterns of functional correlations in blind vs. sighted adults. In this paper, Tian et al. ask: how does this organization arise over development? Is the "starting state" more like the blind pattern, or more like the adult pattern? Their analyses reveal that the answer depends on the particular networks investigated; some functional connections in infants look more like blind than sighted adults; other functional connections look more like sighted than blind adults; and others fall somewhere in the middle, or show an altogether different pattern in infants compared with both sighted and blind adults.

Strengths:<br /> The question raised in this paper is extremely important: what is the starting state in development for visual cortical regions, and how is this organization shaped by experience? This paper is among the first to examine this question, particularly by comparing infants not only with sighted adults but also blind adults, which sheds new light on the role of visual (and cross-modal) experience. Another clear strength lies in the unequivocal nature of many results. Many results have very large effect sizes, critical interactions between regions and groups are tested and found, and infant analyses are replicated in split halves of the data.

Weaknesses:<br /> A central claim is that "infant secondary visual cortices functionally resemble those of blind more than sighted adults" (abstract, last paragraph of intro). I see two potential issues with this claim. First, a minor change: given the approaches used here, no claims should be made about the "function" of these regions, but rather their "functional correlations". Second (and more importantly), the claim that the secondary visual cortex in general resembles blind more than sighted adults is still not fully supported by the data. In fact, this claim is only true for one aspect of secondary visual area functional correlations (i.e., their connectivity to A1/M1/S1 vs. PFC). In other analyses, the infant secondary visual cortex looks more like sighted adults than blind adults (i.e., in within vs. across hemisphere correlations), or shows a different pattern from both sighted and blind adults (i.e., in occipito-frontal subregion functional connectivity). It is not clear from the manuscript why the comparison to PFC vs. non-visual sensory cortex is more theoretically important than hemispheric changes or within-PFC correlations (in fact, if anything, the within-PFC correlations strike me as the most important for understanding the development and reorganization of these secondary visual regions). It seems then that a more accurate conclusion is that the secondary visual cortex shows a mix of instructive effects of vision and reorganizing effects of blindness, albeit to a different extent than the primary visual cortex.

Relatedly, group differences in overall secondary visual cortex connectivity are particularly striking as visualized in the connectivity matrices shown in Figure S1. In the results (lines 105-112), it is noted that while the infant FC matrix is strongly correlated with both adult groups, the infant group is nonetheless more strongly correlated with the blind than sighted adults. I am concerned that these results might be at least partially explained by distance (i.e., local spread of the bold signal), since a huge portion of the variance in these FC matrices is driven by stronger correlations between regions within the same system (e.g., secondary-secondary visual cortex, frontal-frontal cortex), which are inherently closer together, relative to those between different systems (e.g., visual to frontal cortex). How do results change if only comparisons between secondary visual regions and non-visual regions are included (i.e., just the pairs of regions within the bold black rectangle on the figure), which limits the analysis to long-rang connections only? Indeed, looking at the off-diagonal comparisons, it seems that in fact there are three altogether different patterns here in the three groups. Even if the correlation between the infant pattern and blind adult pattern survives, it might be more accurate to claim that infants are different from both adult groups, suggesting both instructive effects of vision and reorganizing effects of blindness. It might help to show the correlation between each group and itself (across independent sets of subjects) to better contextualize the relative strength of correlations between the groups.

It is not clear that differences between groups should be attributed to visual experience only. For example, despite the title of the paper, the authors note elsewhere that cross-modal experience might also drive changes between groups. Another factor, which I do not see discussed, is possible ongoing experience-independent maturation. The infants scanned are extremely young, only 2 weeks old. Although no effects of age are detected, it is possible that cortex is still undergoing experience-independent maturation at this very early stage of development. For example, consider Figure 2; perhaps V1 connectivity is not established at 2 weeks, but eventually achieves the adult pattern later in infancy or childhood. Further, consider the possibility that this same developmental progression would be found in infants and children born blind. In that case, the blind adult pattern may depend on blindness-related experience only (which may or may not reflect "visual" experience per se). To deal with these issues, the authors should add a discussion of the role of maturation vs. experience and temper claims about the role of visual experience specifically (particularly in the title).

The authors measure functional correlations in three very different groups of participants and find three different patterns of functional correlations. Although these three groups differ in critical, theoretically interesting ways (i.e., in age and visual/cross-modal experience), they also differ in many uninteresting ways, including at least the following: sampling rate (TR), scan duration, multi-band acceleration, denoising procedures (CompCor vs. ICA), head motion, ROI registration accuracy, and wakefulness (I assume the infants are asleep).

Addressing all of these issues is beyond the scope of this paper, but I do feel the authors should acknowledge these confounds and discuss the extent to which they are likely (or not) to explain their results. The authors would strengthen their conclusions with analyses directly comparing data quality between groups (e.g., measures of head motion and split-half reliability would be particularly effective).

Reviewer #3 (Public Review):

Summary:<br /> This study aimed to investigate whether the differences observed in the organization of visual brain networks between blind and sighted adults result from a reorganization of an early functional architecture due to blindness, or whether the early architecture is immature at birth and requires visual experience to develop functional connections. This question was investigated through the comparison of 3 groups of subjects with resting-state functional MRI (rs-fMRI). Based on convincing analyses, the study suggests that: 1) secondary visual cortices showed higher connectivity to prefrontal cortical regions (PFC) than to non-visual sensory areas (S1/M1 and A1) in sighted infants like in blind adults, in contrast to sighted adults; 2) the V1 connectivity pattern of sighted infants lies between that of sighted adults (stronger functional connectivity with non-visual sensory areas than with PFC) and that of blind adults (stronger functional connectivity with PFC than with non-visual sensory areas); 3) the laterality of the connectivity patterns of sighted infants resembled those of sighted adults more than those of blind adults, but sighted infants showed a less differentiated fronto-occipital connectivity pattern than adults.

Strengths:<br /> - The question investigated in this article is important for understanding the mechanisms of plasticity during typical and impaired development, and the approach considered, which compares different groups of subjects including, neonates/infants and blind adults, is highly original.

- Overall, the analyses considered are solid and well-detailed. The results are quite convincing, even if the interpretation might need to be revised downwards, as factors other than visual experience may play a role in the development of functional connections with the visual system.